Current U.S. drug shortages
1153 products are currently listed as in shortage by the FDA. Status and availability are reported by manufacturers.
| Drug & presentation | Company | Availability | Updated |
|---|---|---|---|
| Amino Acid Injection PROSOL 20% SULFITE FREE IN PLASTIC CONTAINER, Injection, 2.76 g/100 mL; 1.96 g/100 mL; 600 mg/100 mL; 1.02 g/100 mL;… | Baxter Healthcare | Available | Sep 17, 2026 |
| Amino Acid Injection Travasol, Injection, 2.07 g/100 mL; 1.15 g/100 mL; 1.03 g/100 mL; 480 mg/100 mL; 600 mg/100 mL; 730 mg/100 mL; 580… | Baxter Healthcare | Available | Sep 17, 2026 |
| Amino Acid Injection Plenamine, Injection, 0.15 (NDC 0264-4500-00) | B. Braun Medical Inc. | Available | Sep 22, 2026 |
| Amino Acid Injection Plenamine, Injection, 0.15 (NDC 0264-4500-05) | B. Braun Medical Inc. | Available | Sep 22, 2026 |
| Amino Acid Injection Aminosyn-PF 10%, Injection, 0.1 (NDC 0990-4179-05) | Otsuka ICU Medical LLC | Unavailable | Sep 16, 2026 |
| Amino Acid Injection Aminosyn II 10% In Plastic Container, Injection, 0.1 (NDC 0990-7172-17) | Otsuka ICU Medical LLC | Available | Sep 16, 2026 |
| Amino Acid Injection Travasol, Injection, 2.07 g/100 mL; 1.15 g/100 mL; 1.03 g/100 mL; 480 mg/100 mL; 600 mg/100 mL; 730 mg/100 mL; 580… | Baxter Healthcare | Unavailable | Sep 17, 2026 |
| Amino Acid Injection Premasol 10% Sulfite Free in VIAFLEX Plastic Container, Injection, 0.1 (NDC 0338-1130-03) | Baxter Healthcare | Available | Sep 17, 2026 |
| Amino Acid Injection Premasol 10% Sulfite Free in VIAFLEX Plastic Container, Injection, 0.1 (NDC 0338-1130-06) | Baxter Healthcare | Available | Sep 17, 2026 |
| Amino Acid Injection Clinisol 15% Sulfite Free In Plastic Container, Injection, 0.15 (NDC 0338-0502-06) | Baxter Healthcare | Available | Sep 17, 2026 |
| Amino Acid Injection TrophAmine 10%, Injection, 0.1 (NDC 0264-1933-10) | B. Braun Medical Inc. | Available | Sep 22, 2026 |
| Amino Acid Injection Clinisol 15% Sulfite Free In Plastic Container, Injection, 0.15 (NDC 0338-0502-03) | Baxter Healthcare | Available | Sep 17, 2026 |
| Amino Acid Injection Aminosyn-PF 7%, Injection, 0.07 (NDC 0990-4178-03) | Otsuka ICU Medical LLC | Unavailable | Sep 16, 2026 |
| Amino Acid Injection Travasol, Injection, 2.07 g/100 mL; 1.15 g/100 mL; 1.03 g/100 mL; 480 mg/100 mL; 600 mg/100 mL; 730 mg/100 mL; 580… | Baxter Healthcare | Available | Sep 17, 2026 |
| Amino Acid Injection Premasol 10% Sulfite Free in VIAFLEX Plastic Container, Injection, 0.1 (NDC 0338-1130-04) | Baxter Healthcare | Available | Sep 17, 2026 |
| Amino Acid Injection Aminosyn II 15% In Plastic Container, Injection, 0.15 (NDC 0990-7171-17) | Otsuka ICU Medical LLC | Available | Sep 16, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Lannett Company, Inc. | Available | Sep 15, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Elite Laboratories, Inc. | Available | Sep 16, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Aurobindo Pharma USA | Unavailable | Jul 21, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Aurobindo Pharma USA | Unavailable | Jul 21, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Sunrise Pharmaceutical, Inc. | Available | Sep 16, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Alvogen | Available | Sep 17, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Oryza Pharmaceuticals Inc. | Unavailable | Sep 16, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Sunrise Pharmaceutical, Inc. | Available | Sep 16, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Oryza Pharmaceuticals Inc. | Unavailable | Sep 16, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Aurobindo Pharma USA | Unavailable | Jul 21, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Sunrise Pharmaceutical, Inc. | Available | Sep 16, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Sunrise Pharmaceutical, Inc. | Available | Sep 16, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Sandoz Inc. | Available | Sep 18, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Lannett Company, Inc. | Available | Sep 15, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Lannett Company, Inc. | Available | Sep 15, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Oryza Pharmaceuticals Inc. | Unavailable | Sep 16, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Sandoz Inc. | Available | Sep 18, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Granules Pharmaceuticals Inc. | Unavailable | Sep 18, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Aurobindo Pharma USA | Unavailable | Jul 21, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | SpecGx LLC | Available | Aug 20, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Elite Laboratories, Inc. | Available | Sep 16, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Alvogen | Available | Sep 17, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | SpecGx LLC | Limited Availability | Aug 20, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Elite Laboratories, Inc. | Available | Sep 16, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | SpecGx LLC | Limited Availability | Aug 20, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Adderall, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 57844-110-01) | Teva Pharmaceuticals USA, Inc. | Available | Sep 15, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Adderall, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 57844-115-01) | Teva Pharmaceuticals USA, Inc. | Available | Sep 15, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Sunrise Pharmaceutical, Inc. | Available | Sep 16, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Granules Pharmaceuticals Inc. | Unavailable | Sep 18, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Oryza Pharmaceuticals Inc. | Unavailable | Sep 16, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Teva Pharmaceuticals USA, Inc. | Available | Sep 15, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Sandoz Inc. | Available | Sep 18, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Epic Pharma, LLC | Limited Availability | Sep 15, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Adderall, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 57844-117-01) | Teva Pharmaceuticals USA, Inc. | Available | Sep 15, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Alvogen | Available | Sep 17, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Teva Pharmaceuticals USA, Inc. | Available | Sep 15, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Teva Pharmaceuticals USA, Inc. | Limited Availability | Sep 15, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Teva Pharmaceuticals USA, Inc. | Limited Availability | Sep 15, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Lannett Company, Inc. | Available | Sep 15, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Alvogen | Available | Sep 17, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | SpecGx LLC | Limited Availability | Aug 20, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Lannett Company, Inc. | Available | Sep 15, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Adderall, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 57844-105-01) | Teva Pharmaceuticals USA, Inc. | Available | Sep 15, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Sandoz Inc. | Available | Sep 18, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Elite Laboratories, Inc. | Available | Sep 16, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Epic Pharma, LLC | Limited Availability | Sep 15, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Teva Pharmaceuticals USA, Inc. | Available | Sep 15, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Adderall, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 57844-112-01) | Teva Pharmaceuticals USA, Inc. | Unavailable | Sep 15, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Elite Laboratories, Inc. | Available | Sep 16, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Granules Pharmaceuticals Inc. | Unavailable | Sep 18, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Teva Pharmaceuticals USA, Inc. | Available | Sep 15, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Adderall, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 57844-120-01) | Teva Pharmaceuticals USA, Inc. | Available | Sep 15, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Granules Pharmaceuticals Inc. | Unavailable | Sep 18, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Sunrise Pharmaceutical, Inc. | Available | Sep 16, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Granules Pharmaceuticals Inc. | Unavailable | Sep 18, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Lannett Company, Inc. | Available | Sep 15, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Adderall, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 57844-130-01) | Teva Pharmaceuticals USA, Inc. | Available | Sep 15, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | SpecGx LLC | Available | Aug 20, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Oryza Pharmaceuticals Inc. | Unavailable | Sep 16, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Granules Pharmaceuticals Inc. | Unavailable | Sep 18, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Alvogen | Available | Sep 17, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Aurobindo Pharma USA | Unavailable | Jul 21, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Granules Pharmaceuticals Inc. | Unavailable | Sep 18, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Epic Pharma, LLC | Limited Availability | Sep 15, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Epic Pharma, LLC | Limited Availability | Sep 15, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | SpecGx LLC | Available | Aug 20, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Elite Laboratories, Inc. | Available | Sep 16, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Elite Laboratories, Inc. | Available | Sep 16, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Teva Pharmaceuticals USA, Inc. | Available | Sep 15, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Epic Pharma, LLC | Limited Availability | Sep 15, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Aurobindo Pharma USA | Unavailable | Jul 21, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Lannett Company, Inc. | Available | Sep 15, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate,… | Sunrise Pharmaceutical, Inc. | Available | Sep 16, 2026 |
| Atropine Sulfate Injection Atropine Sulfate, Injection, .1 mg/1 mL (NDC 16729-484-90) | Accord Healthcare Inc. | Unavailable | Sep 15, 2026 |
| Atropine Sulfate Injection Atropine Sulfate, Injection, 1 mg/1 mL (NDC 16729-526-08) | Accord Healthcare Inc. | Unavailable | Sep 1, 2026 |
| Atropine Sulfate Injection Atropine Sulfate, Injection, 0.4 mg/1 mL (NDC 0641-6251-10) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Atropine Sulfate Injection Atropine Sulfate, Injection, .4 mg/1 mL (NDC 63323-580-20) | Fresenius Kabi USA, LLC | Available | Sep 1, 2026 |
| Atropine Sulfate Injection Atropine Sulfate, Injection, 1 mg/1 mL (NDC 0517-1001-25) | American Regent, Inc. | Available | Sep 15, 2026 |
| Atropine Sulfate Injection Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 64253-400-91) | Medefil, Inc. | Available | Sep 15, 2026 |
| Atropine Sulfate Injection Atropine Sulfate, Injection, .4 mg/1 mL (NDC 70069-631-25) | Somerset Therapeutics, LLC | Available | Sep 11, 2026 |
| Atropine Sulfate Injection Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 0409-1630-10) | Hospira, Inc., a Pfizer Company | Unavailable | Aug 24, 2026 |
| Atropine Sulfate Injection Atropine Sulfate, Injection, .4 mg/1 mL (NDC 0517-1004-25) | American Regent, Inc. | Available | Sep 15, 2026 |
| Atropine Sulfate Injection Atropine Sulfate, Injection, 0.25 mg/5 mL (0.05 mg/mL) Syringes (NDC 0409-9630-05) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Atropine Sulfate Injection Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-525-08) | Accord Healthcare Inc. | Unavailable | Sep 1, 2026 |
| Atropine Sulfate Injection Atropine Sulfate, Injection, 1 mg/1 mL (NDC 70069-641-25) | Somerset Therapeutics, LLC | Available | Sep 11, 2026 |
| Atropine Sulfate Injection Atropine Sulfate, Injection, .4 mg/1 mL (NDC 70069-481-10) | Somerset Therapeutics, LLC | Available | Sep 11, 2026 |
| Atropine Sulfate Injection Atropine Sulfate, Injection, 0.1 mg/1 mL (NDC 16729-484-45) | Accord Healthcare Inc. | Available | Sep 15, 2026 |
| Atropine Sulfate Injection Atropine Sulfate, Injection, .05 mg/1 mL (NDC 16729-483-03) | Accord Healthcare Inc. | Unavailable | Sep 15, 2026 |
| Atropine Sulfate Injection Atropine Sulfate, Injection, .1 mg/1 mL (NDC 76329-3340-1) | Amphastar Pharmaceuticals, Inc. | Available | Sep 16, 2026 |
| Atropine Sulfate Injection Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-512-43) | Accord Healthcare Inc. | Unavailable | Sep 1, 2026 |
| Azacitidine Injection Vidaza, Injection, 100 mg (NDC 59572-102-01) | Bristol Myers Squibb Co. | Available | Sep 15, 2026 |
| Azacitidine Injection Azacitidine, Injection, 100 mg (NDC 68001-313-56) | Teva Pharmaceuticals USA, Inc. | Unavailable | Sep 15, 2026 |
| Azacitidine Injection Azacitidine, Injection, 100 mg/4 mL (NDC 55150-393-01) | Eugia US LLC | Unavailable | Sep 17, 2026 |
| Azacitidine Injection Azacitidine, Injection, 100 mg (NDC 43598-305-62) | Dr. Reddy's Laboratories, Inc. | Available | Aug 5, 2026 |
| Azacitidine Injection Azacitidine, Injection, 100 mg/ Vial (NDC 0143-9606-01) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Azacitidine Injection Azacitidine, Injection, 100 mg (NDC 16729-306-10) | Accord Healthcare Inc. | Available | Sep 15, 2026 |
| Azacitidine Injection Azacitidine, Injection, 100 mg/30 mL (NDC 63323-771-39) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Azacitidine Injection Azacitidine, Injection, 100 mg (NDC 72485-201-01) | Armas Pharmaceuticals Inc | Limited Availability | Jun 8, 2026 |
| Azacitidine Injection Azacitidine, Injection, 100 mg/30 mL (NDC 71288-115-30) | Meitheal Pharmaceuticals, Inc. | Available | Aug 27, 2026 |
| Bacitracin Ophthalmic Ointment Bacitracin, Ophthalmic Ointment, 3.5 g (NDC 0574-4022-35) | Padagis US LLC | Unavailable | Jun 1, 2026 |
| Bumetanide Injection Bumetanide, Injection, .25 mg/1 mL (NDC 65219-572-10) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Bumetanide Injection Bumetanide, Injection, 2.5 mg/10 mL (0.25 mg/mL) (NDC 83301-0081-2) | Mullan Pharmaceutical Inc. | Available | Sep 16, 2026 |
| Bumetanide Injection Bumetanide, Injection, .25 mg/1 mL (NDC 0641-6007-10) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Bumetanide Injection Bumetanide, Injection, 0.25 mg/1 mL (NDC 72205-101-07) | MSN Laboratories Private Limited | Available | Sep 16, 2026 |
| Bumetanide Injection Bumetanide, Injection, 0.25 mg/1 mL (NDC 72205-102-07) | MSN Laboratories Private Limited | Available | Sep 16, 2026 |
| Bumetanide Injection Bumetanide, Injection, .25 mg/1 mL (NDC 65219-570-04) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Bumetanide Injection Bumetanide, Injection, .25 mg/1 mL (NDC 0641-6008-10) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Bumetanide Injection Bumetanide, Injection, 0.25 mg/mL, 10 mL (NDC 72205-102-01) | MSN Laboratories Private Limited | Available | Sep 16, 2026 |
| Bumetanide Injection Bumetanide, Injection, 0.25 mg/mL, 4mL (NDC 72205-101-01) | MSN Laboratories Private Limited | Available | Sep 16, 2026 |
| Bumetanide Injection Bumetanide, Injection, .25 mg/1 mL (NDC 25021-321-04) | Sagent Pharmaceuticals | Limited Availability | Sep 18, 2026 |
| Bumetanide Injection Bumetanide, Injection, 1 mg/4 mL (0.25 mg/mL) (NDC 83301-0080-2) | Mullan Pharmaceutical Inc. | Available | Sep 16, 2026 |
| Bumetanide Injection Bumetanide, Injection, .25 mg/1 mL (NDC 25021-321-10) | Sagent Pharmaceuticals | Available | Sep 18, 2026 |
| Bupivacaine Hydrochloride Injection Marcaine, Injection, 0.75% 15 mg/2 mL (7.5 mg/mL) in Dextrose 8.25% (NDC 0409-1761-10) | Hospira, Inc., a Pfizer Company | Unavailable | Sep 22, 2026 |
| Bupivacaine Hydrochloride Injection Marcaine, Injection, Marcaine 225 mg/30 mL (7.5 mg/mL) (NDC 0409-2253-01) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-172-30) | Eugia US LLC | Available | Sep 17, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-726-52) | Kindos Pharmaceuticals Co. Ltd. | Limited Availability | May 5, 2026 |
| Bupivacaine Hydrochloride Injection Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-17) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-169-10) | Eugia US LLC | Available | Sep 17, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 73293-0002-2) | Huons Co., Ltd | Unavailable | Jul 30, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 150 mg/30 mL (5 mg/mL) (NDC 0409-1162-02) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 225 mg/30 mL (7.5 mg/mL) (NDC 0409-1165-02) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-249-50) | Eugia US LLC | Available | Sep 17, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 75 mg/30 mL (2.5 mg/mL) (NDC 0409-1159-02) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 31722-275-32) | Aspiro Pharma Limited | Available | Jul 17, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-753-10) | Somerset Therapeutics, LLC | Available | Sep 11, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride PRESERVATIVE FREE, Injection, 2.5 mg/1 mL 5mg / 1mL (NDC 72266-263-10) | ONESOURCE SPECIALTY PTE LTD | Available | Sep 18, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-725-32) | Kindos Pharmaceuticals Co. Ltd. | Limited Availability | May 5, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-250-50) | Eugia US LLC | Available | Sep 17, 2026 |
| Bupivacaine Hydrochloride Injection Marcaine, Injection, 25 mg/10 mL (2.5 mg/mL) (NDC 0409-2510-01) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-10) | Somerset Therapeutics, LLC | Available | Sep 11, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 31722-275-34) | Aspiro Pharma Limited | Available | Jul 17, 2026 |
| Bupivacaine Hydrochloride Injection Marcaine, Injection, Marcaine 75 mg/10 mL (7.5 mg/mL) (NDC 0409-1165-01) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-168-30) | Eugia US LLC | Available | Sep 17, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 31722-276-34) | Aspiro Pharma Limited | Available | Jul 17, 2026 |
| Bupivacaine Hydrochloride Injection Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-37) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-1162-01) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-01) | Somerset Therapeutics, LLC | Available | Sep 11, 2026 |
| Bupivacaine Hydrochloride Injection Marcaine, Injection, 150 mg/30 mL (5 mg/mL) (NDC 0409-1530-01) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Bupivacaine Hydrochloride Injection Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-37) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, Bupivacaine Spinal 15 mg/2 mL (7.5 mg/mL in 8.25% dextrose) (NDC 0409-3613-01) | Hospira, Inc., a Pfizer Company | Limited Availability | Sep 22, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 0409-1165-01) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 71288-728-32) | Kindos Pharmaceuticals Co. Ltd. | Limited Availability | May 5, 2026 |
| Bupivacaine Hydrochloride Injection Marcaine, Injection, Marcaine 125 mg/50 mL (2.5 mg/mL) (NDC 0409-1160-01) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Bupivacaine Hydrochloride Injection Marcaine, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-5010-01) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-753-25) | Somerset Therapeutics, LLC | Available | Sep 11, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-723-52) | Kindos Pharmaceuticals Co. Ltd. | Limited Availability | May 5, 2026 |
| Bupivacaine Hydrochloride Injection Sensorcaine, Injection, 7.5 mg/1 mL (NDC 63323-472-37) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-170-30) | Eugia US LLC | Available | Sep 17, 2026 |
| Bupivacaine Hydrochloride Injection Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-17) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Bupivacaine Hydrochloride Injection Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-467-57) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-753-01) | Somerset Therapeutics, LLC | Available | Sep 11, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 125 mg/50 mL (2.5 mg/mL) (NDC 0409-1160-01) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Bupivacaine Hydrochloride Injection Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-465-57) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-171-10) | Eugia US LLC | Available | Sep 17, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-167-10) | Eugia US LLC | Available | Sep 17, 2026 |
| Bupivacaine Hydrochloride Injection Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-31) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 31722-277-34) | Aspiro Pharma Limited | Available | Jul 17, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 25 mg/10 mL (2.5 mg/mL) (NDC 0409-1159-01) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Bupivacaine Hydrochloride Injection Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-31) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Bupivacaine Hydrochloride Injection Sensorcaine, Injection, 7.5 mg/1 mL (NDC 63323-472-17) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-25) | Somerset Therapeutics, LLC | Available | Sep 11, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 250 mg/50 mL (5 mg/mL) (NDC 0409-1163-01) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 31722-276-32) | Aspiro Pharma Limited | Available | Jul 17, 2026 |
| Bupivacaine Hydrochloride Injection Marcaine, Injection, 250 mg/50 mL (NDC 0409-0525-25) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Bupivacaine Hydrochloride Injection Marcaine, Injection, 225 mg/30 mL (NDC 0409-2253-25) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-722-32) | Kindos Pharmaceuticals Co. Ltd. | Limited Availability | May 5, 2026 |
| Bupivacaine Hydrochloride Injection Marcaine, Injection, 75 mg/30 mL (2.5 mg/mL) (NDC 0409-7535-01) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 31722-277-32) | Aspiro Pharma Limited | Available | Jul 17, 2026 |
| Bupivacaine Hydrochloride Injection Marcaine, Injection, 0.75% 15 mg/2 mL (NDC 0409-1761-62) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-461-57) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection Bupivacaine Hydrochloride And Epinephrine, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-9045-01) | Hospira, Inc., a Pfizer Company | Unavailable | Sep 22, 2026 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection Bupivacaine Hydrochloride and Epinephrine, Injection, 150 mg/30 mL (5 mg/mL) (NDC 0409-9045-17) | Hospira, Inc., a Pfizer Company | Unavailable | Sep 22, 2026 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 125 mg/50 mL (2.5 mg/mL… | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 150 mg/30 mL (5 mg/mL… | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection Bupivacaine Hydrochloride And Epinephrine, Injection, 75 mg/30 mL (2.5 mg/mL) (NDC 0409-9042-17) | Hospira, Inc., a Pfizer Company | Unavailable | Sep 22, 2026 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 250 mg/50 mL (5 mg/mL… | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-17) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection Bupivacaine Hydrochloride and Epinephrine, Injection, 125 mg/50 mL (2.5 mg/mL) (NDC 0409-9043-01) | Hospira, Inc., a Pfizer Company | Unavailable | Sep 22, 2026 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 75 mg/30 mL (2.5 mg/mL… | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-468-17) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection Bupivacaine Hydrochloride And Epinephrine, Injection, 250 mg/50 mL (5 mg/mL) (NDC 0409-9046-01) | Hospira, Inc., a Pfizer Company | Unavailable | Sep 22, 2026 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-468-37) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-37) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-463-57) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 50 mg/10 mL (5 mg/mL… | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection Sensorcaine, Injection, 7.5 mg/1 mL; .005 mg/1 mL (NDC 63323-460-37) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection Bupivacaine Hydrochloride And Epinephrine, Injection, 25 mg/10 mL (2.5 mg/mL) (NDC 0409-9042-01) | Hospira, Inc., a Pfizer Company | Unavailable | Sep 22, 2026 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 25 mg/10 mL (2.5 mg/mL… | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-31) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Carboplatin Injection Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) (NDC 61703-339-18) | Hospira, Inc., a Pfizer Company | Limited Availability | Sep 9, 2026 |
| Carboplatin Injection Carboplatin, Injection, 10 mg/1 mL (NDC 63323-172-60) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Carboplatin Injection Carboplatin, Injection, 50mg/5mL (NDC 54288-164-01) | Gland Pharma Limited | Unavailable | Sep 15, 2026 |
| Carboplatin Injection Carboplatin, Injection, 150mg/15mL (NDC 54288-165-01) | Gland Pharma Limited | Available | Sep 15, 2026 |
| Carboplatin Injection Carboplatin, Injection, 450 mg/45 mL (NDC 55150-335-01) | Eugia US LLC | Unavailable | Sep 17, 2026 |
| Carboplatin Injection Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) (NDC 61703-150-05) | Hospira, Inc., a Pfizer Company | Unavailable | Sep 9, 2026 |
| Carboplatin Injection Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-3) | Teyro Labs | Unavailable | Sep 16, 2026 |
| Carboplatin Injection Kyxata, Injection, 500 mg/50 mL (10 mg/mL) (NDC 83831-142-50) | Avyxa Pharma, LLC | Available | Sep 1, 2026 |
| Carboplatin Injection Kyxata, Injection, 80 mg/8 mL (10 mg/mL) (NDC 83831-141-08) | Avyxa Pharma, LLC | Available | Sep 1, 2026 |
| Carboplatin Injection Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) (NDC 61703-339-56) | Hospira, Inc., a Pfizer Company | Limited Availability | Sep 9, 2026 |
| Carboplatin Injection Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-12) | Accord Healthcare Inc. | Unavailable | Sep 15, 2026 |
| Carboplatin Injection Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-262-05) | Hospira, Inc., a Pfizer Company | Unavailable | Sep 9, 2026 |
| Carboplatin Injection Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-34) | Accord Healthcare Inc. | Unavailable | Sep 15, 2026 |
| Carboplatin Injection Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-339-50) | Hospira, Inc., a Pfizer Company | Limited Availability | Sep 9, 2026 |
| Carboplatin Injection Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-1) | Teyro Labs | Unavailable | Sep 16, 2026 |
| Carboplatin Injection Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4244-01) | Teva Pharmaceuticals USA, Inc. | Unavailable | Sep 15, 2026 |
| Carboplatin Injection Carboplatin, Injection, 600 mg/65 mL (NDC 54288-167-01) | Gland Pharma Limited | Limited Availability | Sep 15, 2026 |
| Carboplatin Injection Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) (NDC 61703-339-22) | Hospira, Inc., a Pfizer Company | Limited Availability | Sep 9, 2026 |
| Carboplatin Injection Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) (NDC 61703-600-05) | Hospira, Inc., a Pfizer Company | Unavailable | Sep 9, 2026 |
| Carboplatin Injection Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-31) | Accord Healthcare Inc. | Unavailable | Sep 15, 2026 |
| Carboplatin Injection Carboplatin, Injection, 450mg/45mL (NDC 54288-166-01) | Gland Pharma Limited | Limited Availability | Sep 15, 2026 |
| Carboplatin Injection Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4248-01) | Teva Pharmaceuticals USA, Inc. | Limited Availability | Sep 15, 2026 |
| Carboplatin Injection Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) (NDC 61703-360-18) | Hospira, Inc., a Pfizer Company | Unavailable | Sep 9, 2026 |
| Carboplatin Injection Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-6) | Teyro Labs | Unavailable | Sep 16, 2026 |
| Carboplatin Injection Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-33) | Accord Healthcare Inc. | Unavailable | Sep 15, 2026 |
| Carboplatin Injection Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-7) | Teyro Labs | Unavailable | Sep 16, 2026 |
| Carboplatin Injection Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4239-01) | Teva Pharmaceuticals USA, Inc. | Limited Availability | Sep 15, 2026 |
| Carboplatin Injection Carboplatin, Injection, 600 mg/60 mL (NDC 55150-386-01) | Eugia US LLC | Available | Sep 17, 2026 |
| Carboplatin Injection Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4246-01) | Teva Pharmaceuticals USA, Inc. | Limited Availability | Sep 15, 2026 |
| Cefotaxime Sodium Powder, for Solution Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 0143-9931-25) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Cefotaxime Sodium Powder, for Solution Cefotaxime Sodium, Powder, for Solution, 500 mg (NDC 0143-9930-10) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Cefotaxime Sodium Powder, for Solution Cefotaxime Sodium, Powder, for Solution, 2 g (NDC 0143-9933-25) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Cefotaxime Sodium Powder, for Solution Cefotaxime Sodium, Powder, for Solution, 2 g (NDC 21586-012-02) | SteriMax, Inc. | Available | Jun 15, 2026 |
| Cefotaxime Sodium Powder, for Solution Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 21586-011-02) | SteriMax, Inc. | Available | Jun 15, 2026 |
| Cefotaxime Sodium Powder, for Solution Cefotaxime Sodium, Powder, for Solution, 10 g (NDC 0143-9935-01) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Clindamycin Phosphate Injection Cleocin Phosphate, Injection, Cleocin Phosphate 300 mg/2 mL (150 mg/mL) (NDC 0009-0870-26) | Pfizer Inc. | Unavailable | Sep 21, 2026 |
| Clindamycin Phosphate Injection Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 72572-074-24) | Sandoz Inc. | Available | Sep 18, 2026 |
| Clindamycin Phosphate Injection Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-02) | Sagent Pharmaceuticals | Limited Availability | Sep 18, 2026 |
| Clindamycin Phosphate Injection Cleocin Phosphate, Injection, Cleocin Phosphate 600 mg/4 mL (150 mg/mL) (NDC 0009-0775-26) | Pfizer Inc. | Available | Sep 21, 2026 |
| Clindamycin Phosphate Injection Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-3410-50) | Baxter Healthcare | Available | Sep 17, 2026 |
| Clindamycin Phosphate Injection Clindamycin Phosphate, Injection, 600 mg/50 mL (NDC 0338-3612-50) | Baxter Healthcare | Unavailable | Sep 17, 2026 |
| Clindamycin Phosphate Injection Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 72572-076-24) | Sandoz Inc. | Available | Sep 18, 2026 |
| Clindamycin Phosphate Injection Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 0781-3290-09) | Sandoz Inc. | Available | Sep 18, 2026 |
| Clindamycin Phosphate Injection Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-06) | Sagent Pharmaceuticals | Limited Availability | Sep 18, 2026 |
| Clindamycin Phosphate Injection Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-9553-50) | Baxter Healthcare | Available | Sep 17, 2026 |
| Clindamycin Phosphate Injection Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-04) | Sagent Pharmaceuticals | Unavailable | Sep 18, 2026 |
| Clindamycin Phosphate Injection Cleocin Phosphate, Injection, Cleocin Phosphate 900 mg/6 mL (150 mg/mL) (NDC 0009-0902-18) | Pfizer Inc. | Available | Sep 21, 2026 |
| Clindamycin Phosphate Injection Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9545-50) | Baxter Healthcare | Available | Sep 17, 2026 |
| Clindamycin Phosphate Injection Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 0781-3289-09) | Sandoz Inc. | Available | Sep 18, 2026 |
| Clindamycin Phosphate Injection Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 6 mg/1 mL (NDC 0781-3288-09) | Sandoz Inc. | Available | Sep 18, 2026 |
| Clindamycin Phosphate Injection Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9549-50) | Baxter Healthcare | Available | Sep 17, 2026 |
| Clindamycin Phosphate Injection Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-3814-50) | Baxter Healthcare | Limited Availability | Sep 17, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, 1 mg (NDC 0093-3212-01) | Teva Pharmaceuticals USA, Inc. | Limited Availability | Aug 17, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, 1 mg (NDC 72888-153-05) | Rubicon Research Private Limited | Available | Jun 1, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, 2 mg (NDC 59651-724-05) | Aurobindo Pharma USA | Available | Jun 2, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, 1 mg (NDC 72888-153-30) | Rubicon Research Private Limited | Available | Jun 1, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, 1 mg (NDC 43547-407-10) | Prinston Pharmaceutical, Inc. | Available | Sep 2, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, .5 mg (NDC 0093-0832-05) | Teva Pharmaceuticals USA, Inc. | Available | Sep 15, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, 1 mg (NDC 59651-723-99) | Aurobindo Pharma USA | Available | Jun 2, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, .5 mg (NDC 16729-136-16) | Accord Healthcare Inc. | Available | Sep 15, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, .5 mg (NDC 59651-722-99) | Aurobindo Pharma USA | Available | Jun 2, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, 2 mg (NDC 16729-138-00) | Accord Healthcare Inc. | Available | Sep 15, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, .5 mg (NDC 43547-406-50) | Prinston Pharmaceutical, Inc. | Available | Sep 2, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, .5 mg (NDC 59651-722-01) | Aurobindo Pharma USA | Available | Jun 2, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, 1 mg (NDC 0093-3212-05) | Teva Pharmaceuticals USA, Inc. | Available | Sep 15, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, 1 mg (NDC 16729-137-16) | Accord Healthcare Inc. | Available | Sep 15, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, 1 mg (NDC 16729-137-00) | Accord Healthcare Inc. | Available | Sep 15, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, 1 mg (NDC 59651-723-01) | Aurobindo Pharma USA | Available | Jun 2, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, 2 mg (NDC 0093-3213-05) | Teva Pharmaceuticals USA, Inc. | Available | Sep 15, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, .5 mg (NDC 72888-152-01) | Rubicon Research Private Limited | Available | Jun 1, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, 1 mg (NDC 72888-153-01) | Rubicon Research Private Limited | Available | Jun 1, 2026 |
| Clonazepam Tablet Klonopin, Tablet, 2 mg (NDC 61269-620-10) | Cheplapharm Arzneimittel GmbH | Available | Sep 16, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, 1 mg (NDC 43547-407-50) | Prinston Pharmaceutical, Inc. | Available | Sep 2, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, .5 mg (NDC 43547-406-11) | Prinston Pharmaceutical, Inc. | Available | Sep 2, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, 2 mg (NDC 72888-154-30) | Rubicon Research Private Limited | Available | Jun 1, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, .5 mg (NDC 72888-152-30) | Rubicon Research Private Limited | Available | Jun 1, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, 2 mg (NDC 72888-154-01) | Rubicon Research Private Limited | Available | Jun 1, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, .5 mg (NDC 72888-152-05) | Rubicon Research Private Limited | Available | Jun 1, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, .5 mg (NDC 43547-406-10) | Prinston Pharmaceutical, Inc. | Available | Sep 2, 2026 |
| Clonazepam Tablet Klonopin, Tablet, 1 mg (NDC 61269-610-10) | Cheplapharm Arzneimittel GmbH | Available | Sep 16, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, .5 mg (NDC 72888-152-00) | Rubicon Research Private Limited | Available | Jun 1, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, 2 mg (NDC 72888-154-05) | Rubicon Research Private Limited | Available | Jun 1, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, .5 mg (NDC 0093-0832-01) | Teva Pharmaceuticals USA, Inc. | Available | Sep 15, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, 2 mg (NDC 43547-408-10) | Prinston Pharmaceutical, Inc. | Available | Sep 2, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, 2 mg (NDC 59651-724-01) | Aurobindo Pharma USA | Available | Jun 2, 2026 |
| Clonazepam Tablet Klonopin, Tablet, .5 mg (NDC 61269-605-10) | Cheplapharm Arzneimittel GmbH | Available | Sep 16, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, 2 mg (NDC 16729-138-16) | Accord Healthcare Inc. | Available | Sep 15, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, 1 mg (NDC 72888-153-00) | Rubicon Research Private Limited | Available | Jun 1, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, .5 mg (NDC 16729-136-00) | Accord Healthcare Inc. | Available | Sep 15, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, 1 mg (NDC 43547-407-11) | Prinston Pharmaceutical, Inc. | Available | Sep 2, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, 2 mg (NDC 0093-3213-01) | Teva Pharmaceuticals USA, Inc. | Available | Sep 15, 2026 |
| Clonazepam Tablet Clonazepam, Tablet, 2 mg (NDC 43547-408-50) | Prinston Pharmaceutical, Inc. | Available | Sep 2, 2026 |
| Conivaptan Hydrochloride Injection Vaprisol Dextrose In Plastic Container, Injection, 20 mg/100 mL (NDC 66220-160-10) | Cumberland Pharmaceuticals Inc. | Unavailable | Sep 16, 2026 |
| Cromolyn Sodium Concentrate Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 69784-200-96) | Ailex Pharmaceuticals | Limited Availability | Aug 31, 2026 |
| Cromolyn Sodium Concentrate Gastrocrom, Concentrate, 20 mg/1 mL (NDC 0037-0678-96) | Mylan Specialty, a Viatris Company | Available | Sep 17, 2026 |
| Cromolyn Sodium Concentrate Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 42571-132-52) | Micro Labs LTD | Available | Sep 16, 2026 |
| Cromolyn Sodium Concentrate Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 76204-025-96) | Ailex Pharmaceuticals | Limited Availability | Aug 31, 2026 |
| Cromolyn Sodium Concentrate Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 16571-600-96) | Rising Pharma Holdings, Inc. | Available | Sep 1, 2026 |
| Cromolyn Sodium Concentrate Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 81665-104-96) | Ailex Pharmaceuticals | Available | Aug 31, 2026 |
| Desmopressin Acetate Spray Desmopressin Acetate (needs No Refrigeration), Spray, 10 ug (NDC 60505-0815-0) | Apotex Corp. | Available | Sep 16, 2026 |
| Desmopressin Acetate Spray Ddavp, Spray, .1 ug/1 mL (NDC 55566-2500-0) | Ferring | Unavailable | May 1, 2026 |
| Desmopressin Acetate Spray Desmopressin Acetate, Spray, 10 ug/.1 mL (NDC 69918-501-05) | Ferring | Unavailable | May 1, 2026 |
| Desmopressin Acetate Spray Stimate, Spray, 1.5 mg/1 mL (NDC 0053-6871-00) | Ferring | Unavailable | May 1, 2026 |
| Dexamethasone Sodium Phosphate Injection Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-0212-10) | Fresenius Kabi USA, LLC | Limited Availability | Sep 15, 2026 |
| Dexamethasone Sodium Phosphate Injection Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6146-25) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Dexamethasone Sodium Phosphate Injection Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 55150-304-25) | Eugia US LLC | Available | Sep 17, 2026 |
| Dexamethasone Sodium Phosphate Injection Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-423-12) | Mylan Institutional, a Viatris Company | Available | Sep 17, 2026 |
| Dexamethasone Sodium Phosphate Injection Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 67457-420-10) | Mylan Institutional, a Viatris Company | Available | Sep 17, 2026 |
| Dexamethasone Sodium Phosphate Injection Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 0641-0367-25) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Dexamethasone Sodium Phosphate Injection Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-421-30) | Mylan Institutional, a Viatris Company | Available | Sep 17, 2026 |
| Dexamethasone Sodium Phosphate Injection Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-422-54) | Mylan Institutional, a Viatris Company | Available | Sep 17, 2026 |
| Dexamethasone Sodium Phosphate Injection Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6145-25) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Dexamethasone Sodium Phosphate Injection Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 63323-506-01) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Dexamethasone Sodium Phosphate Injection Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 70069-025-10) | Somerset Therapeutics, LLC | Available | Sep 11, 2026 |
| Dexamethasone Sodium Phosphate Injection Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-212-10) | Fresenius Kabi USA, LLC | Limited Availability | Sep 15, 2026 |
| Dexamethasone Sodium Phosphate Injection Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-30) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Dexamethasone Sodium Phosphate Injection Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 63323-516-10) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Dexamethasone Sodium Phosphate Injection Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-05) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Dexamethasone Sodium Phosphate Injection Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-0210-10) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Dexamethasone Sodium Phosphate Injection Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-01) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Dexamethasone Sodium Phosphate Injection Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-210-10) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Dexamethasone Sodium Phosphate Injection Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 70069-021-25) | Somerset Therapeutics, LLC | Available | Sep 11, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 70121-1389-7) | Amneal Pharmaceuticals | Available | Jun 17, 2026 |
| Dexmedetomidine Hydrochloride Injection Precedex, Injection, 400 mcg/100 mL (NDC 0409-7853-24) | Pfizer Inc. | Available | Sep 21, 2026 |
| Dexmedetomidine Hydrochloride Injection Precedex, Injection, 80 mcg/20 mL (4 mcg/mL) (NDC 0409-1660-20) | Pfizer Inc. | Available | Sep 21, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 200 ug/2 mL (NDC 66794-230-42) | Gland Pharma Limited | Available | Jul 22, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 70069-758-04) | Somerset Therapeutics, LLC | Available | Sep 11, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 63323-421-02) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Dexmedetomidine Hydrochloride Injection Precedex, Injection, 1000 mcg/250 mL Single Dose Glass Bottle (NDC 0409-1434-01) | Pfizer Inc. | Available | Sep 21, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 70121-1388-8) | Amneal Pharmaceuticals | Available | Jun 17, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 67457-925-10) | Mylan Institutional, a Viatris Company | Available | Sep 17, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 55150-209-02) | Eugia US LLC | Available | Sep 17, 2026 |
| Dexmedetomidine Hydrochloride Injection Precedex, Injection, 200 mcg/50 mL (NDC 0409-7838-24) | Pfizer Inc. | Available | Sep 21, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 43598-975-58) | Gland Pharma Limited | Available | Jul 22, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 67457-251-02) | Mylan Institutional, a Viatris Company | Available | Sep 17, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 4 mcg/mL, 50 mL (NDC 70121-1388-1) | Amneal Pharmaceuticals | Available | Jun 17, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 44567-601-04) | HQ Specialty Pharma | Available | Aug 17, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-239-93) | Accord Healthcare Inc. | Unavailable | Sep 15, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 70069-759-04) | Somerset Therapeutics, LLC | Available | Sep 11, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 44567-603-24) | HQ Specialty Pharma | Available | Aug 17, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 0143-9532-25) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Dexmedetomidine Hydrochloride Injection Precedex, Injection, 80 mcg/20 mL (4 mcg/mL) (NDC 0409-3301-10) | Pfizer Inc. | Available | Sep 8, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 43598-976-58) | Gland Pharma Limited | Available | Jul 22, 2026 |
| Dexmedetomidine Hydrochloride Injection Precedex, Injection, 1000 mcg/250 mL (NDC 0409-7875-12) | Pfizer Inc. | Available | Sep 21, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 42023-186-20) | Par Health, USA LLC | Unavailable | Sep 17, 2026 |
| Dexmedetomidine Hydrochloride Injection Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-4596-20) | Pfizer Inc. | Available | Sep 21, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 67457-924-50) | Mylan Institutional, a Viatris Company | Available | Sep 17, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-00) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Dexmedetomidine Hydrochloride Injection Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-0155-02) | Pfizer Inc. | Available | Sep 21, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (4 ug/1 mL) (NDC 72572-127-10) | Azurity Pharmaceuticals, Inc | Available | Sep 16, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-432-93) | Accord Healthcare Inc. | Unavailable | Sep 15, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-50) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (NDC 0781-3494-95) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Available | Sep 15, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 0338-9557-12) | Baxter Healthcare | Available | Sep 17, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 55150-297-10) | Eugia US LLC | Available | Sep 17, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 42023-146-25) | Par Health, USA LLC | Available | Aug 18, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (NDC 0781-3495-95) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Available | Sep 15, 2026 |
| Dexmedetomidine Hydrochloride Injection Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-1174-10) | Pfizer Inc. | Available | Sep 21, 2026 |
| Dexmedetomidine Hydrochloride Injection Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-1596-10) | Pfizer Inc. | Available | Aug 24, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (4 ug/1 mL) (NDC 52536-125-10) | Azurity Pharmaceuticals, Inc | Available | Sep 16, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 71288-505-03) | Meitheal Pharmaceuticals, Inc. | Available | Aug 27, 2026 |
| Dexmedetomidine Hydrochloride Injection Precedex, Injection, 200 mcg/2 mL (100 mcg/mL) (NDC 0409-1638-02) | Pfizer Inc. | Available | Sep 8, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 55150-296-10) | Eugia US LLC | Available | Sep 17, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 43066-557-12) | Baxter Healthcare | Available | Sep 17, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 0338-9555-24) | Baxter Healthcare | Unavailable | Aug 17, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 44567-602-24) | HQ Specialty Pharma | Available | Aug 17, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 4 mcg/mL, 100 mL (NDC 70121-1389-1) | Amneal Pharmaceuticals | Available | Jun 17, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 44567-600-04) | HQ Specialty Pharma | Available | Aug 17, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-20) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (4 ug/1 mL) (NDC 72572-128-08) | Azurity Pharmaceuticals, Inc | Available | Sep 16, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 43066-555-24) | Baxter Healthcare | Available | Sep 17, 2026 |
| Dexmedetomidine Hydrochloride Injection Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-1660-50) | Pfizer Inc. | Available | Sep 21, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 200 mcg/2 mL (NDC 83634-600-02) | Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) | Available | Sep 8, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 42023-187-10) | Par Health, USA LLC | Unavailable | Sep 17, 2026 |
| Dexmedetomidine Hydrochloride Injection Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-1454-20) | Pfizer Inc. | Available | Sep 21, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 80 mcg/20 mL (NDC 0781-3493-95) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Available | Sep 15, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (4 ug/1 mL) (NDC 52536-126-08) | Azurity Pharmaceuticals, Inc | Available | Sep 16, 2026 |
| Dexmedetomidine Hydrochloride Injection Precedex, Injection, 1000 mcg/250 mL Glass Bottle NovaPlus (NDC 0409-2815-01) | Pfizer Inc. | Available | Sep 21, 2026 |
| Dextrose Monohydrate 10% Injection Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-00) | B. Braun Medical Inc. | Available | Sep 22, 2026 |
| Dextrose Monohydrate 10% Injection Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-02) | Baxter Healthcare | Available | Sep 17, 2026 |
| Dextrose Monohydrate 10% Injection Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-75) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Dextrose Monohydrate 10% Injection Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-74) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Dextrose Monohydrate 10% Injection Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-02) | Otsuka ICU Medical LLC | Available | Sep 16, 2026 |
| Dextrose Monohydrate 10% Injection Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-04) | Baxter Healthcare | Available | Sep 17, 2026 |
| Dextrose Monohydrate 10% Injection Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-10) | B. Braun Medical Inc. | Available | Sep 22, 2026 |
| Dextrose Monohydrate 10% Injection Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-03) | Baxter Healthcare | Available | Sep 17, 2026 |
| Dextrose Monohydrate 10% Injection Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-03) | Otsuka ICU Medical LLC | Available | Sep 16, 2026 |
| Dextrose Monohydrate 10% Injection Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-76) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Dextrose Monohydrate 10% Injection Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-09) | Otsuka ICU Medical LLC | Available | Sep 16, 2026 |
| Dextrose Monohydrate 10% Injection Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7938-19) | Otsuka ICU Medical LLC | Unavailable | Sep 16, 2026 |
| Dextrose Monohydrate 10% Injection Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-20) | B. Braun Medical Inc. | Available | Sep 22, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-41) | Baxter Healthcare | Available | Sep 17, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0074-30) | Baxter Healthcare | Available | Sep 17, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-464-50) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-38) | Baxter Healthcare | Available | Sep 17, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-03) | Baxter Healthcare | Available | Sep 17, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-11) | Baxter Healthcare | Available | Sep 17, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-36) | Otsuka ICU Medical LLC | Available | Sep 16, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-23) | Otsuka ICU Medical LLC | Available | Sep 16, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose 5% In Plastic Container, Injection, 2.5 g/50 mL (NDC 0338-9664-40) | Baxter Healthcare | Available | Sep 17, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 0264-1510-32) | B. Braun Medical Inc. | Available | Sep 22, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-18) | Baxter Healthcare | Available | Sep 17, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-03) | Otsuka ICU Medical LLC | Available | Sep 16, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-10) | Baxter Healthcare | Available | Sep 17, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-55) | Otsuka ICU Medical LLC | Available | Sep 16, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-31) | Baxter Healthcare | Available | Sep 17, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0551-11) | Baxter Healthcare | Available | Sep 17, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-458-30) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0551-18) | Baxter Healthcare | Available | Sep 17, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-20) | Otsuka ICU Medical LLC | Available | Sep 16, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-13) | Otsuka ICU Medical LLC | Available | Sep 16, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-61) | Otsuka ICU Medical LLC | Available | Sep 16, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose Monohydrate 5%, Injection, 5 g/100 mL (NDC 0264-7510-10) | B. Braun Medical Inc. | Available | Sep 22, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-02) | Baxter Healthcare | Available | Sep 17, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-02) | Otsuka ICU Medical LLC | Available | Sep 16, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-456-60) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-460-20) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-48) | Baxter Healthcare | Available | Sep 17, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-9666-35) | Baxter Healthcare | Available | Sep 17, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose Monohydrate 5%, Injection, 5 g/100 mL (NDC 0264-7510-20) | B. Braun Medical Inc. | Available | Sep 22, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0070-10) | Baxter Healthcare | Available | Sep 17, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-09) | Otsuka ICU Medical LLC | Available | Sep 16, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 0264-1510-31) | B. Braun Medical Inc. | Available | Sep 22, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-462-10) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0078-20) | Baxter Healthcare | Available | Sep 17, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-37) | Otsuka ICU Medical LLC | Available | Sep 16, 2026 |
| Dextrose Monohydrate 5% Injection Dextrose Monohydrate 5%, Injection, 5 g/100 mL (NDC 0264-7510-00) | B. Braun Medical Inc. | Available | Sep 22, 2026 |
| Dextrose Monohydrate 50% Injection Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-6648-02) | Hospira, Inc., a Pfizer Company | Limited Availability | Aug 24, 2026 |
| Dextrose Monohydrate 50% Injection Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-7517-16) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Dextrose Monohydrate 50% Injection Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 76329-3302-1) | Amphastar Pharmaceuticals, Inc. | Available | Sep 16, 2026 |
| Dextrose Monohydrate 70% Injection DEXTROSE 70% IN PLASTIC CONTAINER, Injection, 70 g/100 mL (NDC 0990-7918-19) | Otsuka ICU Medical LLC | Available | Sep 16, 2026 |
| Dextrose Monohydrate 70% Injection Dextrose Monohydrate 70%, Injection, 70 g/100 mL (NDC 0264-7387-50) | B. Braun Medical Inc. | Available | Sep 22, 2026 |
| Dextrose Monohydrate 70% Injection Dextrose Monohydrate 70%, Injection, 70 g/100 mL (NDC 0338-0719-06) | Baxter Healthcare | Limited Availability | Sep 17, 2026 |
| Dextrose Monohydrate 70% Injection DEXTROSE 70% IN PLASTIC CONTAINER, Injection, 70 g/100 mL (NDC 0990-7120-07) | Otsuka ICU Medical LLC | Available | Sep 16, 2026 |
| Dobutamine Hydrochloride Injection Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/100 mL (NDC 0338-1077-02) | Baxter Healthcare | Available | Sep 17, 2026 |
| Dobutamine Hydrochloride Injection Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 250 mg/250mL (1 mg/mL) (NDC 0409-0025-10) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Dobutamine Hydrochloride Injection Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-01) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Dobutamine Hydrochloride Injection Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-88) | Hospira, Inc., a Pfizer Company | Unavailable | Sep 22, 2026 |
| Dobutamine Hydrochloride Injection Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-02) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Dobutamine Hydrochloride Injection Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 500 mg/250mL (2 mg/mL) (NDC 0409-0151-10) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Dobutamine Hydrochloride Injection Dobutamine Hydrochloride, Injection, 250 mg/20 mL (NDC 70436-203-80) | Hainan Poly Pharm. Co., Ltd. | Available | Sep 16, 2026 |
| Dobutamine Hydrochloride Injection Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 1,000 mg/250mL (4 mg/mL) (NDC 0409-1100-10) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Dobutamine Hydrochloride Injection Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 200 mg/100 mL (NDC 0338-1075-02) | Baxter Healthcare | Available | Sep 17, 2026 |
| Dobutamine Hydrochloride Injection Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 100 mg/100 mL (NDC 0338-1073-02) | Baxter Healthcare | Available | Sep 17, 2026 |
| Dopamine Hydrochloride Injection Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9252-25) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Dopamine Hydrochloride Injection Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-03) | Baxter Healthcare | Available | Sep 17, 2026 |
| Dopamine Hydrochloride Injection Dopamine Hydrochloride, Injection, 200 mg/5mL (40 mg/1 mL) (NDC 0409-5820-01) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Dopamine Hydrochloride Injection Dopamine Hydrochloride, Injection, 400 mg/10mL (40 mg/1 mL) (NDC 0409-9104-20) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Dopamine Hydrochloride Injection Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/500 mL (1.6 mg/1 mL) (NDC 0409-7809-24) | Hospira, Inc., a Pfizer Company | Unavailable | Sep 22, 2026 |
| Dopamine Hydrochloride Injection Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/250 mL (3.2 mg/1 mL) (NDC 0409-1858-12) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Dopamine Hydrochloride Injection Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/250 mL (1.6 mg/1 mL) (NDC 0409-0042-12) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Dopamine Hydrochloride Injection Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9254-25) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Dopamine Hydrochloride Injection Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-02) | Baxter Healthcare | Available | Sep 17, 2026 |
| Dopamine Hydrochloride Injection Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-03) | Baxter Healthcare | Available | Sep 17, 2026 |
| Dopamine Hydrochloride Injection Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-02) | Baxter Healthcare | Available | Sep 17, 2026 |
| Echothiophate Iodide Ophthalmic Solution Phospholine Iodide, Ophthalmic Solution, 0.125% (NDC 48102-053-05) | Fera Pharmaceuticals | Available | Sep 1, 2026 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-37) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-27) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-17) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-27) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection Lidocaine Hydrochloride And Epinephrine, Injection, 250 mg/50 mL (0.5%; 1:200,000) (NDC 0409-3177-01) | Hospira, Inc., a Pfizer Company | Unavailable | Sep 22, 2026 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-37) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:200,000) (NDC 0409-3183-01) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection Lidocaine Hydrochloride And Epinephrine, Injection, 1 g/50 mL (2%; 1:100,000) (NDC 0409-3182-03) | Hospira, Inc., a Pfizer Company | Limited Availability | Sep 22, 2026 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection Lidocaine Hydrochloride and Epinephrine, Injection, 600 mg/30 mL (2%; 1:100,000) (NDC 0409-3182-02) | Hospira, Inc., a Pfizer Company | Limited Availability | Sep 22, 2026 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-17) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-27) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection Lidocaine Hydrochloride And Epinephrine, Injection, 450 mg/30 mL (1.5%; 1:200,000) (NDC 0409-3181-01) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection Lidocaine Hydrochloride And Epinephrine, Injection, 75 mg/5 mL (1.5%; 1:200,000) (NDC 0409-1209-01) | Hospira, Inc., a Pfizer Company | Unavailable | Sep 22, 2026 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection Lidocaine Hydrochloride And Epinephrine, Injection, 200 mg/20 mL (1%; 1:100,000) (NDC 0409-3178-01) | Hospira, Inc., a Pfizer Company | Unavailable | Sep 22, 2026 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection Lidocaine Hydrochloride And Epinephrine, Injection, 500 mg/50 mL (1%; 1:100,000) (NDC 0409-3178-03) | Hospira, Inc., a Pfizer Company | Limited Availability | Sep 22, 2026 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:100,000) (NDC 0409-3182-01) | Hospira, Inc., a Pfizer Company | Unavailable | Sep 22, 2026 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection Xylocaine, Injection, .005 mg/1 mL; 5 mg/1 mL (NDC 63323-481-57) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-57) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-57) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-17) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection Lidocaine Hydrochloride And Epinephrine, Injection, 300 mg/30 mL (1%; 1:100,000) (NDC 0409-3178-02) | Hospira, Inc., a Pfizer Company | Unavailable | Sep 22, 2026 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-17) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Etomidate Injection Amidate, Injection, 2 mg/1 mL (NDC 0409-6695-01) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Etomidate Injection Etomidate, Injection, 2mg/1 mL (NDC 65219-445-10) | Caplin Steriles, Ltd. | Available | Jun 16, 2026 |
| Etomidate Injection Etomidate, Injection, 2 mg/1 mL (NDC 0143-9311-10) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Etomidate Injection Etomidate, Injection, 20 mg/10 mL (NDC 55150-221-10) | Eugia US LLC | Unavailable | Sep 17, 2026 |
| Etomidate Injection Etomidate, Injection, 2 mg/1 mL (NDC 0143-9506-10) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Etomidate Injection Etomidate, Injection, 2mg/mL (NDC 65219-447-20) | Caplin Steriles, Ltd. | Available | Jun 16, 2026 |
| Etomidate Injection Amidate, Injection, 2 mg/mL (NDC 0409-6695-02) | Hospira, Inc., a Pfizer Company | Unavailable | Aug 24, 2026 |
| Etomidate Injection Etomidate, Injection, 2 mg/mL (NDC 72485-509-10) | Caplin Steriles, Ltd. | Available | Jun 16, 2026 |
| Etomidate Injection Etomidate, Injection, 2 mg/1 mL (NDC 72266-147-10) | Gland Pharma Limited | Available | Jul 22, 2026 |
| Etomidate Injection Etomidate, Injection, 2 mg/mL (NDC 72485-508-10) | Caplin Steriles, Ltd. | Available | Jun 16, 2026 |
| Etomidate Injection Etomidate, Injection, 2 mg/1 mL (NDC 72266-146-10) | Gland Pharma Limited | Available | Jul 22, 2026 |
| Etomidate Injection Etomidate, Injection, 2 mg/1 mL (NDC 72572-161-10) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Etomidate Injection Etomidate, Injection, 2 mg/1 mL (NDC 0143-9507-10) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Etomidate Injection Etomidate, Injection, 2 mg/1 mL (NDC 0143-9310-10) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Etomidate Injection Etomidate, Injection, 40 mg/20 mL (NDC 55150-222-20) | Eugia US LLC | Unavailable | Sep 17, 2026 |
| Etomidate Injection Etomidate, Injection, 2 mg/1 mL (NDC 67457-902-10) | Mylan Institutional, a Viatris Company | Available | Sep 17, 2026 |
| Etomidate Injection Etomidate, Injection, 2 mg/1 mL (NDC 72572-160-10) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Etomidate Injection Etomidate, Injection, 2 mg/1 mL (NDC 67457-903-20) | Mylan Institutional, a Viatris Company | Available | Sep 17, 2026 |
| Fentanyl Citrate Injection Fentanyl Citrate, Injection, 1000 mcg/20 mL (50 ug/1 mL) (NDC 0409-9094-31) | Hospira, Inc., a Pfizer Company | Limited Availability | Sep 9, 2026 |
| Fentanyl Citrate Injection Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6025-10) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Fentanyl Citrate Injection Fentanyl Citrate, Injection, 500 mcg/10 mL (50 ug/1 mL) (NDC 0409-9094-28) | Hospira, Inc., a Pfizer Company | Available | Sep 9, 2026 |
| Fentanyl Citrate Injection Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6247-25) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Fentanyl Citrate Injection Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6024-10) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Fentanyl Citrate Injection Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-01) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Fentanyl Citrate Injection Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-05) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Fentanyl Citrate Injection Fentanyl Citrate, Injection, 250 mcg/5 mL (50 ug/1 mL) (NDC 0409-9094-25) | Hospira, Inc., a Pfizer Company | Available | Sep 9, 2026 |
| Fentanyl Citrate Injection Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6028-25) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Fentanyl Citrate Injection Fentanyl Citrate, Injection, 2500 mcg/50 mL (50 ug/1 mL) (NDC 0409-9094-61) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Fentanyl Citrate Injection Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-20) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Fentanyl Citrate Injection Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-02) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Fentanyl Citrate Injection Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6027-25) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Fentanyl Citrate Injection Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6029-25) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Fentanyl Citrate Injection Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6030-01) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Fentanyl Citrate Injection Fentanyl Citrate, Injection, 100 mcg/2 mL (50 ug/1 mL) (NDC 0409-9094-22) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Fentanyl Citrate Injection Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-50) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Fentanyl Citrate Injection Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 63323-808-11) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Fentanyl Citrate Injection Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6026-05) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Flurazepam Hydrochloride Capsule Flurazepam Hydrochloride, Capsule, 30 mg (NDC 0378-4430-01) | Rising Pharma Holdings, Inc. | Unavailable | Sep 1, 2026 |
| Flurazepam Hydrochloride Capsule Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-30) | Chartwell Molecular Holdings LLC | Available | Sep 15, 2026 |
| Flurazepam Hydrochloride Capsule Flurazepam Hydrochloride, Capsule, 15 mg (NDC 0378-4415-01) | Rising Pharma Holdings, Inc. | Unavailable | Sep 1, 2026 |
| Flurazepam Hydrochloride Capsule Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-30) | Chartwell Molecular Holdings LLC | Available | Sep 15, 2026 |
| Flurazepam Hydrochloride Capsule Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-90) | Chartwell Molecular Holdings LLC | Available | Sep 15, 2026 |
| Flurazepam Hydrochloride Capsule Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-90) | Chartwell Molecular Holdings LLC | Available | Sep 15, 2026 |
| Furosemide Injection Furosemide, Injection, 100 mg/ 10mL (10 mg/1 mL) (NDC 0409-6102-10) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Furosemide Injection Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-04) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Furosemide Injection Furosemide, Injection, 10 mg/1 mL (NDC 36000-284-25) | Baxter Healthcare | Available | Sep 17, 2026 |
| Furosemide Injection Furosemide, Injection, 40 mg/4 mL (NDC 55150-323-25) | Eugia US LLC | Available | Sep 17, 2026 |
| Furosemide Injection Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-44) | Avet Pharmaceuticals, Inc. | Unavailable | Sep 1, 2026 |
| Furosemide Injection Furosemide, Injection, 10 mg/1 mL (NDC 16729-500-08) | Accord Healthcare Inc. | Unavailable | Sep 15, 2026 |
| Furosemide Injection Furosemide, Injection, 10 mg/1 mL (NDC 16729-502-43) | Accord Healthcare Inc. | Unavailable | Sep 15, 2026 |
| Furosemide Injection Furosemide, Injection, 10 mg/1 mL (NDC 71288-203-05) | Meitheal Pharmaceuticals, Inc. | Available | Aug 27, 2026 |
| Furosemide Injection Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-02) | Gland Pharma Limited | Unavailable | Jul 22, 2026 |
| Furosemide Injection Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-10) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Furosemide Injection Furosemide, Injection, 40 mg/4 mL (10 mg/1 mL) (NDC 0409-6102-04) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Furosemide Injection Furosemide, Injection, 40 mg/4 mL (10 mg/1 mL) (NDC 0409-6102-26) | Hospira, Inc., a Pfizer Company | Unavailable | Sep 9, 2026 |
| Furosemide Injection Furosemide, Injection, 20 mg/2 mL (NDC 55150-322-25) | Eugia US LLC | Unavailable | Sep 17, 2026 |
| Furosemide Injection Furosemide, Injection, 10 mg/1 mL (NDC 36000-283-25) | Baxter Healthcare | Available | Sep 17, 2026 |
| Furosemide Injection Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-10) | Gland Pharma Limited | Unavailable | Jul 22, 2026 |
| Furosemide Injection Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-42) | Avet Pharmaceuticals, Inc. | Unavailable | Sep 1, 2026 |
| Furosemide Injection Furosemide, Injection, 100 mg/ 10mL (10 mg/1 mL) (NDC 0409-6102-27) | Hospira, Inc., a Pfizer Company | Unavailable | Sep 9, 2026 |
| Furosemide Injection Furosemide, Injection, 10 mg/1 mL (NDC 16729-501-43) | Accord Healthcare Inc. | Unavailable | Sep 15, 2026 |
| Furosemide Injection Furosemide, Injection, 20 mg/2 mL (10 mg/1 mL) (NDC 0409-6102-02) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Furosemide Injection Furosemide, Injection, 10 mg/mL, 2 mL (NDC 71288-205-03) | Meitheal Pharmaceuticals, Inc. | Available | Aug 27, 2026 |
| Furosemide Injection Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-02) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Furosemide Injection Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-41) | Avet Pharmaceuticals, Inc. | Available | Sep 1, 2026 |
| Furosemide Injection Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-04) | Gland Pharma Limited | Unavailable | Jul 22, 2026 |
| Furosemide Injection Furosemide, Injection, 10 mg/1 mL (NDC 71288-203-11) | Meitheal Pharmaceuticals, Inc. | Available | Aug 27, 2026 |
| Furosemide Injection Furosemide, Injection, 20 mg/2 mL (10 mg/1 mL) (NDC 0409-6102-25) | Hospira, Inc., a Pfizer Company | Unavailable | Sep 9, 2026 |
| Furosemide Injection Furosemide, Injection, 10 mg/1 mL (NDC 36000-282-25) | Baxter Healthcare | Available | Sep 17, 2026 |
| Furosemide Injection Furosemide, Injection, 100 mg/10 mL (NDC 55150-324-25) | Eugia US LLC | Available | Sep 17, 2026 |
| Furosemide Oral Solution Furosemide, Oral Solution, 10 mg/1 mL (NDC 0054-3294-50) | Hikma Pharmaceuticals USA, Inc. | Limited Availability | Sep 18, 2026 |
| Furosemide Oral Solution Furosemide, Oral Solution, 40 mg/5 mL (NDC 0054-3298-63) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Furosemide Oral Solution Furosemide, Oral Solution, 10 mg/1 mL (NDC 0054-3294-46) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Heparin Sodium Injection Heparin Sodium, Injection, 2,000 Units/1,000 mL (2 Units/mL) (NDC 0409-2222-12) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Heparin Sodium Injection Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-10) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Heparin Sodium Injection Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-77) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Heparin Sodium Injection Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0431-03) | Baxter Healthcare | Available | Sep 17, 2026 |
| Heparin Sodium Injection Heparin Sodium, Injection, 1,000 Units/500 mL (2 Units/mL) (NDC 0409-1005-20) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Heparin Sodium Injection Heparin Sodium 2,000 Units in Sodium Chloride 0.9% in Plastic Container, Injection, 200 [USP'U]/100 mL (NDC… | B. Braun Medical Inc. | Limited Availability | Sep 22, 2026 |
| Heparin Sodium Injection Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0433-04) | Baxter Healthcare | Available | Sep 17, 2026 |
| Heparin Sodium Injection Heparin Sodium 1,000 Units In Sodium Chloride 0.9% In Plastic Container, Injection, 200 [USP'U]/100 mL (NDC… | B. Braun Medical Inc. | Limited Availability | Sep 22, 2026 |
| Hydromorphone Hydrochloride Injection Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-1312-36) | Hospira, Inc., a Pfizer Company | Limited Availability | Sep 9, 2026 |
| Hydromorphone Hydrochloride Injection Dilaudid, Injection, .2 mg/1 mL (NDC 76045-121-11) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Hydromorphone Hydrochloride Injection Hydromorphone Hydrochloride, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-2634-05) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Hydromorphone Hydrochloride Injection Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-10) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Hydromorphone Hydrochloride Injection Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-3365-10) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Hydromorphone Hydrochloride Injection Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-6254-01) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Hydromorphone Hydrochloride Injection Hydromorphone Hydrochloride, Injection, 0.5 mg/0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC… | Hospira, Inc., a Pfizer Company | Limited Supply Available. Next Delivery: September 2026; Est | Sep 9, 2026 |
| Hydromorphone Hydrochloride Injection Hydromorphone Hydrochloride, Injection, 0.25 mg/ 0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC… | Hospira, Inc., a Pfizer Company | Unavailable | Sep 9, 2026 |
| Hydromorphone Hydrochloride Injection Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-0121-25) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Hydromorphone Hydrochloride Injection Hydromorphone Hydrochloride, Injection, 500 mg/50 mL (10 mg/mL) (NDC 0409-2634-50) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Hydromorphone Hydrochloride Injection Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0409-2634-01) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Hydromorphone Hydrochloride Injection Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0113-03) | Teva Pharmaceuticals USA, Inc. | Limited Availability | Sep 15, 2026 |
| Hydromorphone Hydrochloride Injection Hydromorphone Hydrochloride, Injection, 4 mg/1 mL Syringes (NDC 0409-1304-31) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Hydromorphone Hydrochloride Injection Hydromorphone Hydrochloride, Injection, 4 mg/1 mL (NDC 63323-854-10) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Hydromorphone Hydrochloride Injection Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0110-03) | Teva Pharmaceuticals USA, Inc. | Available | Sep 15, 2026 |
| Hydromorphone Hydrochloride Injection Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-50) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Hydromorphone Hydrochloride Injection Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-15) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Hydromorphone Hydrochloride Injection Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-11) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Hydromorphone Hydrochloride Injection Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 63323-853-25) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Hydromorphone Hydrochloride Injection Hydromorphone Hydrochloride, Injection, 1 mg/1 mL Syringes (NDC 0409-1283-31) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Hydromorphone Hydrochloride Injection Dilaudid, Injection, 2 mg/1 mL (NDC 76045-010-11) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Hydromorphone Hydrochloride Injection Hydromorphone Hydrochloride, Injection, 2 mg/1 mL Syringes (NDC 0409-1312-30) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Hydromorphone Hydrochloride Injection Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-852-25) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Hydromorphone Hydrochloride Injection Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0018-01) | Teva Pharmaceuticals USA, Inc. | Available | Sep 15, 2026 |
| Hydromorphone Hydrochloride Injection Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 0409-1283-37) | Hospira, Inc., a Pfizer Company | Unavailable | Sep 9, 2026 |
| Hydromorphone Hydrochloride Injection Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-06) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Hydroxocobalamin Injection Hydroxocobalamin, Injection, 1000 MCG/ML, 30 ML Multi-Dose Vial (NDC 0591-2888-30) | Teva Pharmaceuticals USA, Inc. | Unavailable | Sep 15, 2026 |
| Hydroxocobalamin Injection Cyanokit, Injection, 5 g/250mL (NDC 50633-310-11) | BTG International Inc. | Limited Availability | Sep 15, 2026 |
| Ifosfamide Injection Ifosfamide, Injection, 1 g/1 (NDC 63323-142-10) | Fresenius Kabi USA, LLC | Limited Availability | Sep 15, 2026 |
| Ifosfamide Injection Ifosfamide, Injection, 1 g/1 (NDC 21586-211-02) | SteriMax, Inc. | Available | Sep 8, 2026 |
| Ifosfamide Injection Ifosfamide, Injection, 50 mg/1 mL (NDC 0143-9530-01) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Ifosfamide Injection Ifosfamide, Injection, 3 g/60 mL (NDC 10019-926-02) | Baxter Healthcare | Available | Sep 17, 2026 |
| Ifosfamide Injection IFEX, Injection, 1 g/20 mL (NDC 0338-3991-01) | Baxter Healthcare | Unavailable | Sep 17, 2026 |
| Ifosfamide Injection IFEX, Injection, 3 g/60 mL (NDC 0338-3993-01) | Baxter Healthcare | Unavailable | Sep 17, 2026 |
| Ifosfamide Injection Ifosfamide, Injection, 50 mg/1 mL (NDC 0143-9531-01) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Ifosfamide Injection Ifosfamide, Injection, 1 g/20 mL (NDC 10019-925-01) | Baxter Healthcare | Available | Sep 17, 2026 |
| Isocarboxazid Tablet Marplan, Tablet, 10 mg, 100 count bottle (NDC 72336-032-01) | Lifsa Drugs LLC | Limited Availability | Aug 6, 2026 |
| Ketorolac Tromethamine Injection Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0409-3793-25) | Hospira, Inc., a Pfizer Company | Unavailable | Sep 9, 2026 |
| Ketorolac Tromethamine Injection Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 76045-104-10) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Ketorolac Tromethamine Injection Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01) | Gland Pharma Limited | Available | Jul 22, 2026 |
| Ketorolac Tromethamine Injection Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02) | Sagent Pharmaceuticals | Available | Sep 18, 2026 |
| Ketorolac Tromethamine Injection Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 62332-599-25) | Alembic Pharmaceuticals | Available | May 15, 2026 |
| Ketorolac Tromethamine Injection Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01) | Sagent Pharmaceuticals | Unavailable | Sep 18, 2026 |
| Ketorolac Tromethamine Injection Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0409-3795-01) | Hospira, Inc., a Pfizer Company | Unavailable | Sep 22, 2026 |
| Ketorolac Tromethamine Injection Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 76045-105-20) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Ketorolac Tromethamine Injection Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 63323-161-01) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Ketorolac Tromethamine Injection Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0338-0072-25) | Baxter Healthcare | Available | Sep 17, 2026 |
| Ketorolac Tromethamine Injection Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01) | Gland Pharma Limited | Available | Jul 22, 2026 |
| Ketorolac Tromethamine Injection Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 62332-600-25) | Alembic Pharmaceuticals | Available | May 15, 2026 |
| Ketorolac Tromethamine Injection Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02) | Gland Pharma Limited | Available | Jul 22, 2026 |
| Ketorolac Tromethamine Injection Ketorolac Tromethamine, Injection, 60 mg/2 mL (30 mg/mL) (NDC 0409-3796-01) | Hospira, Inc., a Pfizer Company | Unavailable | Sep 22, 2026 |
| Ketorolac Tromethamine Injection Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0641-6041-25) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Ketorolac Tromethamine Injection Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01) | Sagent Pharmaceuticals | Available | Sep 18, 2026 |
| Ketorolac Tromethamine Injection Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-119-25) | Gland Pharma Limited | Available | Jul 22, 2026 |
| Ketorolac Tromethamine Injection Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6042-25) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Ketorolac Tromethamine Injection Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-118-25) | Gland Pharma Limited | Available | Jul 22, 2026 |
| Ketorolac Tromethamine Injection Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 62332-601-25) | Alembic Pharmaceuticals | Available | May 15, 2026 |
| Ketorolac Tromethamine Injection Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0338-0069-10) | Baxter Healthcare | Unavailable | Sep 17, 2026 |
| Ketorolac Tromethamine Injection Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 76045-107-10) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Ketorolac Tromethamine Injection Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-01) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Ketorolac Tromethamine Injection Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-02) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Ketorolac Tromethamine Injection Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6043-25) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride, Preservative Free, Injection, 10 mg/1 mL (NDC 0143-9595-25) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 55150-165-05) | Eugia US LLC | Unavailable | Sep 17, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride, Preservative Free, Injection, 20 mg/1 mL (NDC 0143-9594-25) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 73293-0001-2) | Huons Co., Ltd. (South Korea) | Unavailable | Jul 30, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride Preservative Free, Injection, 20 mg/2 mL (1%; 10 mg/mL) (NDC 0409-4713-32) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride, Injection, 20 mg/2 mL (NDC 83634-653-02) | Anthea Pharma | Available | Sep 15, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-252-20) | Eugia US LLC | Unavailable | Sep 17, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-201-10) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-161-02) | Eugia US LLC | Unavailable | Sep 17, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride, Injection, 200 mg/10 mL (2%; 20 mg/mL) (NDC 0409-4282-02) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 63323-202-02) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Lidocaine Hydrochloride Injection Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-27) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride, Injection, 300 mg/30 mL (1%; 10 mg/mL) (NDC 0409-4279-02) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride In Plastic Container, Injection, 200 mg/20 mL (1%; 10 mg/mL) (NDC 0409-4276-01) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 65282-1605-1) | Spectra Medical Devices, LLC | Unavailable | May 15, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-164-02) | Eugia US LLC | Available | Sep 17, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-255-20) | Eugia US LLC | Unavailable | Sep 17, 2026 |
| Lidocaine Hydrochloride Injection Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-57) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 76329-3390-1) | Amphastar Pharmaceuticals, Inc. | Limited Availability | Sep 16, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride And Dextrose, Injection, 8 mg/1 mL (NDC 0338-0411-02) | Baxter Healthcare | Available | Sep 17, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 0143-9577-10) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydochloride, Injection, 50 mg/5 mL (NDC 83634-653-05) | Anthea Pharma | Available | Sep 15, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 100 mg/5mL (2%,20 mg/1 mL) Syringes (NDC… | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride In Plastic Container, Injection, 400 mg/20 mL (2%; 20 mg/mL) (NDC 0409-4277-01) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride, Injection, 100 mg/5 mL (2%; 20 mg/mL) (NDC 0409-2066-05) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Lidocaine Hydrochloride Injection Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-27) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-251-10) | Eugia US LLC | Unavailable | Sep 17, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride, Injection, 200 mg/20 mL (NDC 83634-651-20) | Anthea Pharma | Available | Sep 15, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride In Plastic Container, Injection, 500 mg/50 mL (1%; 10 mg/mL) (NDC 0409-4276-02) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .8 g/100 mL (NDC 0264-9598-20) | B. Braun Medical Inc. | Available | Sep 22, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-162-05) | Eugia US LLC | Available | Sep 17, 2026 |
| Lidocaine Hydrochloride Injection Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-27) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride And Dextrose, Injection, 4 mg/1 mL (NDC 0338-0409-03) | Baxter Healthcare | Available | Sep 17, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride In Plastic Container, Injection, 1,000 mg/50 mL (2%; 20 mg/mL) (NDC 0409-4277-02) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-254-10) | Eugia US LLC | Unavailable | Sep 17, 2026 |
| Lidocaine Hydrochloride Injection Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-97) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-10) | B. Braun Medical Inc. | Available | Sep 22, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride Preservative Free, Injection, 200 mg/5 mL (4%; 40 mg/mL) (NDC 0409-4283-01) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 0143-9575-10) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Lidocaine Hydrochloride Injection Xylocaine, Injection, 20 mg/1 mL (NDC 63323-496-97) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4278-01) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Lidocaine Hydrochloride Injection Xylocaine, Injection, 5 mg/1 mL (NDC 63323-491-57) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride, Injection, 500 mg/50 mL (NDC 83634-651-50) | Anthea Pharma | Available | Sep 15, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride, Injection, 100 mg/10 mL (NDC 83634-651-10) | Anthea Pharma | Available | Sep 15, 2026 |
| Lidocaine Hydrochloride Injection Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-31) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-159-74) | Eugia US LLC | Unavailable | Sep 17, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride Preservative Free, Injection, 50 mg/5 mL (1%; 10 mg/mL) (NDC 0409-4713-02) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Lidocaine Hydrochloride Injection Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-91) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Lidocaine Hydrochloride Injection Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-57) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-20) | B. Braun Medical Inc. | Available | Sep 22, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride, Injection, 40 mg/2 mL (2%; 20 mg/mL) (NDC 0409-4282-01) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Lidocaine Hydrochloride Injection Xylocaine, Injection, 5 mg/1 mL (NDC 63323-484-57) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 50 mg/5mL (1%, 10 mg/1 mL) Syringes (NDC… | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-256-50) | Eugia US LLC | Unavailable | Sep 17, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride In Plastic Container, Injection, 10 mg/1 mL (NDC 63323-201-02) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride, Injection, 300 mg/30 mL (NDC 83634-653-30) | Anthea Pharma | Available | Sep 15, 2026 |
| Lidocaine Hydrochloride Injection Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-37) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride Preservative Free, Injection, 300 mg/20 mL (1.5%; 15 mg/mL) (NDC 0409-4776-01) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride Preservative Free, Injection, 20 mg/1 mL (NDC 63323-208-05) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Lidocaine Hydrochloride Injection Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-17) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Lidocaine Hydrochloride Injection Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-07) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride In Plastic Container, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4275-01) | Hospira, Inc., a Pfizer Company | Unavailable | Sep 22, 2026 |
| Lidocaine Hydrochloride Injection Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-27) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-163-30) | Eugia US LLC | Available | Sep 17, 2026 |
| Lidocaine Hydrochloride Injection Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-57) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Liraglutide Injection Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-20) | Novo Nordisk, Inc. | Available | Sep 22, 2026 |
| Liraglutide Injection Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-22) | Novo Nordisk, Inc. | Available | Sep 22, 2026 |
| Liraglutide Injection Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-02) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Liraglutide Injection Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15) | Novo Nordisk, Inc. | Limited Availability | Sep 22, 2026 |
| Liraglutide Injection Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-12) | Novo Nordisk, Inc. | Limited Availability | Sep 22, 2026 |
| Liraglutide Injection Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-84) | Meitheal Pharmaceuticals, Inc. | Available | Aug 27, 2026 |
| Liraglutide Injection Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-03) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Liraglutide Injection Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-85) | Meitheal Pharmaceuticals, Inc. | Available | Aug 27, 2026 |
| Liraglutide Injection Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-13) | Novo Nordisk, Inc. | Limited Availability | Sep 22, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 64850-550-01) | Elite Laboratories, Inc. | Limited Availability | Sep 16, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 60505-4742-1) | Apotex Corp. | Available | Sep 16, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0378-6859-77) | Mylan Pharmaceuticals Inc., a Viatris Company | Available | Sep 17, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 64850-554-01) | Elite Laboratories, Inc. | Limited Availability | Sep 16, 2026 |
| Lisdexamfetamine Dimesylate Capsule Vyvanse, Capsule, 50 mg (NDC 59417-105-10) | Takeda Pharmaceuticals USA Inc. | Available | Sep 15, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0527-4667-37) | Lannett Company, Inc. | Available | Sep 15, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 42858-166-01) | Rhodes Pharmaceuticals L.P. | Available | Jun 24, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 43547-603-10) | Solco Healthcare US, LLC | Limited Availability | Jun 29, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0378-6856-77) | Mylan Pharmaceuticals Inc., a Viatris Company | Available | Sep 17, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 60505-4743-1) | Apotex Corp. | Available | Sep 16, 2026 |
| Lisdexamfetamine Dimesylate Capsule Vyvanse, Capsule, 30 mg (NDC 59417-103-10) | Takeda Pharmaceuticals USA Inc. | Available | Sep 15, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 64850-552-01) | Elite Laboratories, Inc. | Limited Availability | Sep 16, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0378-6854-77) | Mylan Pharmaceuticals Inc., a Viatris Company | Available | Sep 17, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 47781-562-01) | Alvogen | Available | Sep 17, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0054-0373-25) | Hikma Pharmaceuticals USA, Inc. | Limited Availability | Sep 18, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 64850-551-01) | Elite Laboratories, Inc. | Limited Availability | Sep 16, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 60505-4744-1) | Apotex Corp. | Available | Sep 16, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 57664-050-88) | Sun Pharmaceutical Industries, Inc. | Limited Availability | Sep 18, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0480-3566-01) | Teva Pharmaceuticals USA, Inc. | Available | Sep 15, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 60505-4739-1) | Apotex Corp. | Available | Sep 16, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 47781-564-01) | Alvogen | Available | Sep 17, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 64850-555-01) | Elite Laboratories, Inc. | Limited Availability | Sep 16, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 57664-051-88) | Sun Pharmaceutical Industries, Inc. | Limited Availability | Sep 18, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0527-4662-37) | Lannett Company, Inc. | Available | Sep 15, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0054-0375-25) | Hikma Pharmaceuticals USA, Inc. | Limited Availability | Sep 18, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 64850-553-01) | Elite Laboratories, Inc. | Limited Availability | Sep 16, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0406-5116-01) | SpecGx LLC | Available | Aug 20, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0054-0660-25) | Hikma Pharmaceuticals USA, Inc. | Limited Availability | May 12, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 65162-027-09) | Amneal Pharmaceuticals | Available | Jun 17, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0406-5113-01) | SpecGx LLC | Available | Aug 20, 2026 |
| Lisdexamfetamine Dimesylate Capsule Vyvanse, Capsule, 60 mg (NDC 59417-106-10) | Takeda Pharmaceuticals USA Inc. | Available | Sep 15, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 43547-606-10) | Solco Healthcare US, LLC | Limited Availability | Jun 29, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0480-3569-01) | Teva Pharmaceuticals USA, Inc. | Available | Sep 15, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 60505-4745-1) | Apotex Corp. | Available | Sep 16, 2026 |
| Lisdexamfetamine Dimesylate Capsule Vyvanse, Capsule, 70 mg (NDC 59417-107-10) | Takeda Pharmaceuticals USA Inc. | Available | Sep 15, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0480-3568-01) | Teva Pharmaceuticals USA, Inc. | Available | Sep 15, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 42858-167-01) | Rhodes Pharmaceuticals L.P. | Limited Availability | Jun 24, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 65162-026-09) | Amneal Pharmaceuticals | Available | Jun 17, 2026 |
| Lisdexamfetamine Dimesylate Capsule Vyvanse, Capsule, 40 mg (NDC 59417-104-10) | Takeda Pharmaceuticals USA Inc. | Available | Sep 15, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0054-0372-25) | Hikma Pharmaceuticals USA, Inc. | Limited Availability | Sep 18, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0480-3567-01) | Teva Pharmaceuticals USA, Inc. | Available | Sep 15, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 47781-566-01) | Alvogen | Available | Sep 17, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 42858-163-01) | Rhodes Pharmaceuticals L.P. | Limited Availability | Jun 24, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0480-3565-01) | Teva Pharmaceuticals USA, Inc. | Available | Sep 15, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 43547-604-10) | Solco Healthcare US, LLC | Limited Availability | Jun 29, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0054-0374-25) | Hikma Pharmaceuticals USA, Inc. | Limited Availability | Sep 18, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 43547-602-10) | Solco Healthcare US, LLC | Limited Availability | Jun 29, 2026 |
| Lisdexamfetamine Dimesylate Capsule Vyvanse, Capsule, 10 mg (NDC 59417-101-10) | Takeda Pharmaceuticals USA Inc. | Available | Sep 15, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 43547-607-10) | Solco Healthcare US, LLC | Limited Availability | Jun 29, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0527-4666-37) | Lannett Company, Inc. | Available | Sep 15, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 47781-568-01) | Alvogen | Available | Sep 17, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 57664-049-88) | Sun Pharmaceutical Industries, Inc. | Limited Availability | Sep 18, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0406-5111-01) | SpecGx LLC | Available | Aug 20, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0054-0370-25) | Hikma Pharmaceuticals USA, Inc. | Limited Availability | Sep 18, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 65162-025-09) | Amneal Pharmaceuticals | Available | Jun 17, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 42858-164-01) | Rhodes Pharmaceuticals L.P. | Limited Availability | Jun 24, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 65162-023-09) | Amneal Pharmaceuticals | Available | Jun 17, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 57664-047-88) | Sun Pharmaceutical Industries, Inc. | Limited Availability | Sep 18, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0480-3564-01) | Teva Pharmaceuticals USA, Inc. | Available | Sep 15, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0527-4665-37) | Lannett Company, Inc. | Available | Sep 15, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 65162-024-09) | Amneal Pharmaceuticals | Available | Jun 17, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0527-4663-37) | Lannett Company, Inc. | Available | Sep 15, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 47781-563-01) | Alvogen | Available | Sep 17, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0480-3570-01) | Teva Pharmaceuticals USA, Inc. | Available | Sep 15, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 60505-4740-1) | Apotex Corp. | Unavailable | Sep 16, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 43547-605-10) | Solco Healthcare US, LLC | Limited Availability | Jun 29, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 57664-047-88) | Sun Pharmaceutical Industries, Inc. | Limited Availability | Sep 18, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0378-6855-77) | Mylan Pharmaceuticals Inc., a Viatris Company | Available | Sep 17, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0406-5115-01) | SpecGx LLC | Available | Aug 20, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 64850-556-01) | Elite Laboratories, Inc. | Limited Availability | Sep 16, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 65162-028-09) | Amneal Pharmaceuticals | Available | Jun 17, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 47781-565-01) | Alvogen | Available | Sep 17, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0378-6860-77) | Mylan Pharmaceuticals Inc., a Viatris Company | Available | Sep 17, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 42858-162-01) | Rhodes Pharmaceuticals L.P. | Limited Availability | Jun 24, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0378-6857-77) | Mylan Pharmaceuticals Inc., a Viatris Company | Available | Sep 17, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0378-6858-77) | Mylan Pharmaceuticals Inc., a Viatris Company | Available | Sep 17, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0406-5117-01) | SpecGx LLC | Available | Aug 20, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 60505-4741-1) | Apotex Corp. | Available | Sep 16, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0527-4661-37) | Lannett Company, Inc. | Available | Sep 15, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0406-5114-01) | SpecGx LLC | Available | Aug 20, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 47781-567-01) | Alvogen | Available | Sep 17, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 42858-161-01) | Rhodes Pharmaceuticals L.P. | Available | Jun 24, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 57664-046-88) | Sun Pharmaceutical Industries, Inc. | Limited Availability | Sep 18, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 43547-608-10) | Solco Healthcare US, LLC | Limited Availability | Jun 29, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0406-5112-01) | SpecGx LLC | Available | Aug 20, 2026 |
| Lisdexamfetamine Dimesylate Capsule Vyvanse, Capsule, 20 mg (NDC 59417-102-10) | Takeda Pharmaceuticals USA Inc. | Available | Sep 15, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 57664-052-88) | Sun Pharmaceutical Industries, Inc. | Limited Availability | Sep 18, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 42858-165-01) | Rhodes Pharmaceuticals L.P. | Limited Availability | Jun 24, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0054-0371-25) | Hikma Pharmaceuticals USA, Inc. | Limited Availability | Sep 18, 2026 |
| Lisdexamfetamine Dimesylate Capsule Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0527-4664-37) | Lannett Company, Inc. | Available | Sep 15, 2026 |
| Lisdexamfetamine Dimesylate Tablet, Chewable Lisdexamfetamine Dimesylate, Tablet, Chewable, 60 mg (NDC 57664-088-88) | Sun Pharmaceutical Industries, Inc. | Available | Sep 18, 2026 |
| Lisdexamfetamine Dimesylate Tablet, Chewable Vyvanse, Tablet, Chewable, 10 mg (NDC 59417-115-01) | Takeda Pharmaceuticals USA Inc. | Available | Sep 15, 2026 |
| Lisdexamfetamine Dimesylate Tablet, Chewable Lisdexamfetamine Dimesylate, Tablet, Chewable, 20 mg (NDC 57664-084-88) | Sun Pharmaceutical Industries, Inc. | Available | Sep 18, 2026 |
| Lisdexamfetamine Dimesylate Tablet, Chewable Lisdexamfetamine Dimesylate, Tablet, Chewable, 30 mg (NDC 57664-085-88) | Sun Pharmaceutical Industries, Inc. | Available | Sep 18, 2026 |
| Lisdexamfetamine Dimesylate Tablet, Chewable Lisdexamfetamine Dimesylate, Tablet, Chewable, 30 mg (NDC 72205-134-91) | Novadoz Pharmaceuticals LLC | Available | Sep 16, 2026 |
| Lisdexamfetamine Dimesylate Tablet, Chewable Vyvanse, Tablet, Chewable, 60 mg (NDC 59417-120-01) | Takeda Pharmaceuticals USA Inc. | Available | Sep 15, 2026 |
| Lisdexamfetamine Dimesylate Tablet, Chewable Vyvanse, Tablet, Chewable, 40 mg (NDC 59417-118-01) | Takeda Pharmaceuticals USA Inc. | Available | Sep 15, 2026 |
| Lisdexamfetamine Dimesylate Tablet, Chewable Vyvanse, Tablet, Chewable, 30 mg (NDC 59417-117-01) | Takeda Pharmaceuticals USA Inc. | Available | Sep 15, 2026 |
| Lisdexamfetamine Dimesylate Tablet, Chewable Lisdexamfetamine Dimesylate, Tablet, Chewable, 10 mg (NDC 57664-083-88) | Sun Pharmaceutical Industries, Inc. | Available | Sep 18, 2026 |
| Lisdexamfetamine Dimesylate Tablet, Chewable Lisdexamfetamine Dimesylate, Tablet, Chewable, 10 mg (NDC 72205-132-91) | Novadoz Pharmaceuticals LLC | Available | Sep 16, 2026 |
| Lisdexamfetamine Dimesylate Tablet, Chewable Vyvanse, Tablet, Chewable, 20 mg (NDC 59417-116-01) | Takeda Pharmaceuticals USA Inc. | Available | Sep 15, 2026 |
| Lisdexamfetamine Dimesylate Tablet, Chewable Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 72205-136-91) | Novadoz Pharmaceuticals LLC | Available | Sep 16, 2026 |
| Lisdexamfetamine Dimesylate Tablet, Chewable Vyvanse, Tablet, Chewable, 50 mg (NDC 59417-119-01) | Takeda Pharmaceuticals USA Inc. | Available | Sep 15, 2026 |
| Lisdexamfetamine Dimesylate Tablet, Chewable Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 57664-087-88) | Sun Pharmaceutical Industries, Inc. | Available | Sep 18, 2026 |
| Lisdexamfetamine Dimesylate Tablet, Chewable Lisdexamfetamine Dimesylate, Tablet, Chewable, 40 mg (NDC 57664-086-88) | Sun Pharmaceutical Industries, Inc. | Available | Sep 18, 2026 |
| Lisdexamfetamine Dimesylate Tablet, Chewable Lisdexamfetamine Dimesylate, Tablet, Chewable, 40 mg (NDC 72205-135-91) | Novadoz Pharmaceuticals LLC | Available | Sep 16, 2026 |
| Lisdexamfetamine Dimesylate Tablet, Chewable Lisdexamfetamine Dimesylate, Tablet, Chewable, 20 mg (NDC 72205-133-91) | Novadoz Pharmaceuticals LLC | Available | Sep 16, 2026 |
| Lisdexamfetamine Dimesylate Tablet, Chewable Lisdexamfetamine Dimesylate, Tablet, Chewable, 60 mg (NDC 72205-137-91) | Novadoz Pharmaceuticals LLC | Available | Sep 16, 2026 |
| Lorazepam Injection Lorazepam, Injection, 2 mg/1 mL (NDC 76329-8261-1) | Amphastar Pharmaceuticals, Inc. | Available | Sep 16, 2026 |
| Lorazepam Injection Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6044-25) | Hikma Pharmaceuticals USA, Inc. | Limited Availability | Sep 18, 2026 |
| Lorazepam Injection Ativan, Injection, 2 mg/1 mL (NDC 0641-6000-10) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Lorazepam Injection Lorazepam, Injection, 4 mg/1 mL (NDC 0641-6047-10) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Lorazepam Injection Lorazepam, Injection, 2 mg/1 mL Syringes (NDC 0409-1985-30) | Hospira, Inc., a Pfizer Company | Limited Availability | Sep 22, 2026 |
| Lorazepam Injection Lorazepam, Injection, 2 mg/1 mL (NDC 65219-368-02) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Lorazepam Injection Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6046-10) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Lorazepam Injection Ativan, Injection, 2 mg/1 mL (NDC 0641-6001-25) | Hikma Pharmaceuticals USA, Inc. | Limited Availability | Sep 18, 2026 |
| Lorazepam Injection Ativan, Injection, 4 mg/1 mL (NDC 0641-6003-25) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Lorazepam Injection Ativan, Injection, 4 mg/1 mL (NDC 0641-6002-10) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Lorazepam Injection Lorazepam, Injection, 4 mg/1 mL (NDC 0641-6045-25) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Meperidine Hydrochloride Injection Demerol, Injection, 25 mg/1 mL (NDC 0409-1176-30) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Meperidine Hydrochloride Injection Meperidine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-6052-25) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Meperidine Hydrochloride Injection Meperidine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-6053-25) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Meperidine Hydrochloride Injection Meperidine Hydrochloride, Injection, 100 mg/1 mL (NDC 0641-6054-25) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Meperidine Hydrochloride Injection Demerol, Injection, 50 mg/1 mL (NDC 0409-1181-30) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Meperidine Hydrochloride Injection Demerol, Injection, 50 mg/1 mL (NDC 0409-1178-30) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Methotrexate Sodium Injection Methotrexate Sodium, Injection, 50 mg/2 mL (25 mg/mL) (NDC 61703-350-10) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Methotrexate Sodium Injection Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 16729-277-35) | Accord Healthcare Inc. | Unavailable | Sep 15, 2026 |
| Methotrexate Sodium Injection Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 16729-277-30) | Accord Healthcare Inc. | Unavailable | Sep 15, 2026 |
| Methotrexate Sodium Injection Methotrexate, Preservative Free, Injection, 25 mg/1 mL (NDC 0143-9519-10) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Methotrexate Sodium Injection Methotrexate Sodium, Injection, 50 mg/2 mL (25 mg/mL) (NDC 61703-350-38) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Methotrexate Sodium Injection Methotrexate Sodium, Injection, 25 mg/1 mL (NDC 63323-123-10) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Methotrexate Sodium Injection Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3675-01) | Teva Pharmaceuticals USA, Inc. | Limited Availability | Sep 15, 2026 |
| Methotrexate Sodium Injection Methotrexate Sodium, Injection, 1 g/40 mL (25 mg/mL) (NDC 61703-408-41) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Methotrexate Sodium Injection Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3678-01) | Teva Pharmaceuticals USA, Inc. | Limited Availability | Sep 15, 2026 |
| Methotrexate Sodium Injection Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3671-01) | Teva Pharmaceuticals USA, Inc. | Limited Availability | Sep 15, 2026 |
| Methotrexate Sodium Injection Methotrexate, Preservative Free, Injection, 1 g (NDC 0143-9830-01) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Methotrexate Sodium Injection Methotrexate Sodium, Injection, 1 g/40 mL (25 mg/mL) (NDC 61703-124-40) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Methotrexate Sodium Injection Methotrexate Sodium, Injection, 1 g/40 mL (25 mg/mL) (NDC 61703-408-25) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Methotrexate Sodium Injection Methotrexate Preservative Free, Injection, 1 g (NDC 63323-122-50) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Methylphenidate Film, Extended Release Methylphenidate, Film, Extended Release, 30 mg (NDC 0574-2430-65) | Noven Pharmaceuticals, Inc. | Available | Sep 2, 2026 |
| Methylphenidate Film, Extended Release Methylphenidate, Film, Extended Release, 20 mg (NDC 0574-2420-65) | Noven Pharmaceuticals, Inc. | Available | Sep 2, 2026 |
| Methylphenidate Film, Extended Release Methylphenidate, Film, Extended Release, 10 mg (NDC 0574-2410-65) | Noven Pharmaceuticals, Inc. | Available | Sep 2, 2026 |
| Methylphenidate Film, Extended Release Methylphenidate, Film, Extended Release, 15 mg (NDC 0574-2415-65) | Noven Pharmaceuticals, Inc. | Available | Sep 2, 2026 |
| Methylphenidate Hydrochloride Tablet, Extended Release Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-10) | Vertical Pharmaceuticals, LLC | Available | Sep 16, 2026 |
| Methylphenidate Hydrochloride Tablet, Extended Release Relexxii, Tablet, Extended Release, 45 mg (NDC 68025-088-30) | Vertical Pharmaceuticals, LLC | Available | Sep 16, 2026 |
| Methylphenidate Hydrochloride Tablet, Extended Release Concerta, Tablet, Extended Release, 27 mg (NDC 50458-588-01) | Janssen Pharmaceuticals | Available | Sep 17, 2026 |
| Methylphenidate Hydrochloride Tablet, Extended Release Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 13811-708-10) | Trigen Laboratories, LLC | Limited Availability | Sep 16, 2026 |
| Methylphenidate Hydrochloride Tablet, Extended Release Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-10) | Vertical Pharmaceuticals, LLC | Available | Sep 16, 2026 |
| Methylphenidate Hydrochloride Tablet, Extended Release Methylphenidate Hydrochloride, Tablet, Extended Release, 45 mg (NDC 13811-711-30) | Trigen Laboratories, LLC | Limited Availability | Sep 16, 2026 |
| Methylphenidate Hydrochloride Tablet, Extended Release Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-30) | Vertical Pharmaceuticals, LLC | Available | Sep 16, 2026 |
| Methylphenidate Hydrochloride Tablet, Extended Release Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 62175-312-37) | Lannett Company, Inc. | Limited Availability | Sep 15, 2026 |
| Methylphenidate Hydrochloride Tablet, Extended Release Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 62175-311-37) | Lannett Company, Inc. | Limited Availability | Sep 15, 2026 |
| Methylphenidate Hydrochloride Tablet, Extended Release Methylphenidate Hydrochloride, Tablet, Extended Release, 63 mg (NDC 13811-700-30) | Trigen Laboratories, LLC | Limited Availability | Sep 16, 2026 |
| Methylphenidate Hydrochloride Tablet, Extended Release Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 62037-727-01) | Teva Pharmaceuticals USA, Inc. | Available | Sep 15, 2026 |
| Methylphenidate Hydrochloride Tablet, Extended Release Concerta, Tablet, Extended Release, 36 mg (NDC 50458-586-01) | Janssen Pharmaceuticals | Available | Sep 17, 2026 |
| Methylphenidate Hydrochloride Tablet, Extended Release Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 57664-609-88) | Sun Pharmaceutical Industries, Inc. | Unavailable | Sep 18, 2026 |
| Methylphenidate Hydrochloride Tablet, Extended Release Relexxii, Tablet, Extended Release, 63 mg (NDC 68025-089-30) | Vertical Pharmaceuticals, LLC | Available | Sep 16, 2026 |
| Methylphenidate Hydrochloride Tablet, Extended Release Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-30) | Vertical Pharmaceuticals, LLC | Available | Sep 16, 2026 |
| Methylphenidate Hydrochloride Tablet, Extended Release Concerta, Tablet, Extended Release, 54 mg (NDC 50458-587-01) | Janssen Pharmaceuticals | Available | Sep 17, 2026 |
| Methylphenidate Hydrochloride Tablet, Extended Release Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 57664-607-88) | Sun Pharmaceutical Industries, Inc. | Unavailable | Sep 18, 2026 |
| Methylphenidate Hydrochloride Tablet, Extended Release Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-10) | Vertical Pharmaceuticals, LLC | Available | Sep 16, 2026 |
| Methylphenidate Hydrochloride Tablet, Extended Release Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-10) | Vertical Pharmaceuticals, LLC | Available | Sep 16, 2026 |
| Methylphenidate Hydrochloride Tablet, Extended Release Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-30) | Vertical Pharmaceuticals, LLC | Available | Sep 16, 2026 |
| Methylphenidate Hydrochloride Tablet, Extended Release Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 13811-706-10) | Trigen Laboratories, LLC | Limited Availability | Sep 16, 2026 |
| Methylphenidate Hydrochloride Tablet, Extended Release Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 62037-734-01) | Teva Pharmaceuticals USA, Inc. | Available | Sep 15, 2026 |
| Methylphenidate Hydrochloride Tablet, Extended Release Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 62037-725-01) | Teva Pharmaceuticals USA, Inc. | Limited Availability | Sep 15, 2026 |
| Methylphenidate Hydrochloride Tablet, Extended Release Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-30) | Vertical Pharmaceuticals, LLC | Available | Sep 16, 2026 |
| Methylphenidate Hydrochloride Tablet, Extended Release Concerta, Tablet, Extended Release, 18 mg (NDC 50458-585-01) | Janssen Pharmaceuticals | Available | Sep 17, 2026 |
| Methylphenidate Hydrochloride Tablet, Extended Release Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 62175-310-37) | Lannett Company, Inc. | Available | Sep 15, 2026 |
| Methylphenidate Hydrochloride Tablet, Extended Release Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 62175-313-37) | Lannett Company, Inc. | Available | Sep 15, 2026 |
| Methylphenidate Hydrochloride Tablet, Extended Release Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 57664-608-88) | Sun Pharmaceutical Industries, Inc. | Unavailable | Sep 18, 2026 |
| Methylphenidate Hydrochloride Tablet, Extended Release Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 13811-707-10) | Trigen Laboratories, LLC | Limited Availability | Sep 16, 2026 |
| Methylphenidate Hydrochloride Tablet, Extended Release Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 13811-709-10) | Trigen Laboratories, LLC | Limited Availability | Sep 16, 2026 |
| Methylphenidate Hydrochloride Tablet, Extended Release Methylphenidate Hydrochloride, Tablet, Extended Release, 72 mg (NDC 13811-710-30) | Trigen Laboratories, LLC | Limited Availability | Sep 16, 2026 |
| Methylphenidate Hydrochloride Tablet, Extended Release Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 62037-726-01) | Teva Pharmaceuticals USA, Inc. | Limited Availability | Sep 15, 2026 |
| Methylphenidate Hydrochloride Tablet, Extended Release Relexxii, Tablet, Extended Release, 72 mg (NDC 68025-084-30) | Vertical Pharmaceuticals, LLC | Available | Sep 16, 2026 |
| Methylphenidate Hydrochloride Tablet, Extended Release Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 57664-606-88) | Sun Pharmaceutical Industries, Inc. | Unavailable | Sep 18, 2026 |
| Methylprednisolone Acetate Injection Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 42023-240-01) | Par Health, USA LLC | Unavailable | Sep 17, 2026 |
| Methylprednisolone Acetate Injection Depo-medrol, Injection, 20 mg/1 mL (NDC 0009-0274-01) | Pfizer Inc. | Available | Sep 21, 2026 |
| Methylprednisolone Acetate Injection Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-12) | Pfizer Inc. | Available | Sep 21, 2026 |
| Methylprednisolone Acetate Injection Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-03) | Pfizer Inc. | Limited Availability | Sep 21, 2026 |
| Methylprednisolone Acetate Injection Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 55150-313-01) | Eugia US LLC | Unavailable | Sep 17, 2026 |
| Methylprednisolone Acetate Injection Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-03) | Pfizer Inc. | Limited Availability | Sep 21, 2026 |
| Methylprednisolone Acetate Injection Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 55150-314-01) | Eugia US LLC | Unavailable | Sep 17, 2026 |
| Methylprednisolone Acetate Injection Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-02) | Pfizer Inc. | Available | Sep 21, 2026 |
| Methylprednisolone Acetate Injection Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 25021-820-10) | Sagent Pharmaceuticals | Unavailable | Sep 18, 2026 |
| Methylprednisolone Acetate Injection Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 70121-1573-5) | Amneal Pharmaceuticals | Available | Jun 17, 2026 |
| Methylprednisolone Acetate Injection Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 70121-1574-5) | Amneal Pharmaceuticals | Available | Jun 17, 2026 |
| Methylprednisolone Acetate Injection Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 25021-821-05) | Sagent Pharmaceuticals | Limited Availability | Sep 18, 2026 |
| Methylprednisolone Acetate Injection Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 70121-1574-1) | Amneal Pharmaceuticals | Available | Jun 17, 2026 |
| Methylprednisolone Acetate Injection Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-22) | Pfizer Inc. | Unavailable | Sep 21, 2026 |
| Methylprednisolone Acetate Injection Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-02) | Pfizer Inc. | Available | Sep 21, 2026 |
| Methylprednisolone Acetate Injection Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-52) | Pfizer Inc. | Available | Sep 21, 2026 |
| Methylprednisolone Acetate Injection Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-03) | Pfizer Inc. | Limited Availability | Sep 21, 2026 |
| Methylprednisolone Acetate Injection Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-01) | Pfizer Inc. | Limited Availability | Sep 21, 2026 |
| Methylprednisolone Acetate Injection Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-01) | Pfizer Inc. | Limited Availability | Sep 21, 2026 |
| Methylprednisolone Acetate Injection Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 25021-820-05) | Sagent Pharmaceuticals | Unavailable | Sep 18, 2026 |
| Methylprednisolone Acetate Injection Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-23) | Pfizer Inc. | Unavailable | Sep 21, 2026 |
| Methylprednisolone Acetate Injection Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-51) | Pfizer Inc. | Available | Sep 21, 2026 |
| Methylprednisolone Acetate Injection Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 70121-1573-1) | Amneal Pharmaceuticals | Limited Availability | Jun 17, 2026 |
| Metronidazole Injection Metronidazole In Plastic Container, Injection, 500 mg/100 mL (NDC 47335-993-01) | Gland Pharma Limited | Unavailable | Jul 22, 2026 |
| Metronidazole Injection Metronidazole, Injection, 500 mg/100 mL (NDC 25021-131-82) | InfoRLife SA | Limited Availability | Aug 18, 2026 |
| Metronidazole Injection Metronidazole in Flexible Container, Injection, 500 mg/100 mL (NDC 0409-0152-24) | InfoRLife SA | Limited Availability | Aug 18, 2026 |
| Metronidazole Injection Flagyl I.v. Rtu In Plastic Container, Injection, 500 mg/100 mL (NDC 0338-1055-48) | Baxter Healthcare | Available | Sep 17, 2026 |
| Midazolam Hydrochloride Injection Midazolam Hydrochloride Preservative Free, Injection, 5 mg/mL (5 mg/mL) (NDC 0409-2308-01) | Hospira, Inc., a Pfizer Company | Unavailable | Sep 22, 2026 |
| Midazolam Hydrochloride Injection Midazolam Hydrochloride Preservative Free, Injection, 10 mg/2 mL (5 mg/mL) (NDC 0409-2308-02) | Hospira, Inc., a Pfizer Company | Unavailable | Sep 22, 2026 |
| Midazolam Hydrochloride Injection Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-25) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Midazolam Hydrochloride Injection Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6057-25) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Midazolam Hydrochloride Injection Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-12) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Midazolam Hydrochloride Injection Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-02) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Midazolam Hydrochloride Injection Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-10) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Midazolam Hydrochloride Injection Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6061-25) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Midazolam Hydrochloride Injection Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 23155-601-42) | Avet Pharmaceuticals, Inc. | Available | Sep 1, 2026 |
| Midazolam Hydrochloride Injection Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC 0409-0001-25) | Hospira, Inc., a Pfizer Company | Limited Availability | Sep 9, 2026 |
| Midazolam Hydrochloride Injection Midazolam Hydrochloride Preservative Free, Injection, 5 mg/5 mL (1 mg/mL) (NDC 0409-2305-05) | Hospira, Inc., a Pfizer Company | Unavailable | Sep 22, 2026 |
| Midazolam Hydrochloride Injection Midazolam Hydrochloride, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-2596-05) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Midazolam Hydrochloride Injection Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6060-10) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Midazolam Hydrochloride Injection Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 25021-655-02) | Gland Pharma Limited | Unavailable | Jul 22, 2026 |
| Midazolam Hydrochloride Injection Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-25) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Midazolam Hydrochloride Injection Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-611-10) | WG Critical Care | Available | Sep 1, 2026 |
| Midazolam Hydrochloride Injection Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-610-10) | WG Critical Care | Available | Sep 1, 2026 |
| Midazolam Hydrochloride Injection Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6056-10) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Midazolam Hydrochloride Injection Midazolam Hydrochloride, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-2587-05) | Hospira, Inc., a Pfizer Company | Unavailable | Sep 22, 2026 |
| Midazolam Hydrochloride Injection Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-10) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Midazolam Hydrochloride Injection Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6059-01) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Midazolam Hydrochloride Injection Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 23155-600-41) | Avet Pharmaceuticals, Inc. | Limited Availability | Sep 1, 2026 |
| Midazolam Hydrochloride Injection Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2 mL (NDC 76045-211-20) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Midazolam Hydrochloride Injection Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-661-10) | Gland Pharma Limited | Unavailable | Jul 22, 2026 |
| Midazolam Hydrochloride Injection Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC 0409-0001-25) | Hospira, Inc., a Pfizer Company | Limited Availability | Sep 22, 2026 |
| Midazolam Hydrochloride Injection Midazolam Hydrochloride, Injection, 25 mg/5 mL (5 mg/mL) (NDC 0409-2596-03) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Midazolam Hydrochloride Injection Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 23155-601-41) | Avet Pharmaceuticals, Inc. | Available | Sep 1, 2026 |
| Morphine Sulfate Injection Mitigo, Injection, 200 mg/20 mL (NDC 66794-160-02) | Piramal Critical Care Inc. | Available | Sep 15, 2026 |
| Morphine Sulfate Injection Morphine Sulfate, Injection, 2 mg/1 mL (NDC 76045-004-11) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Morphine Sulfate Injection Morphine Sulfate, Injection, 4 mg/1 mL (NDC 76045-005-11) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Morphine Sulfate Injection Morphine Sulfate, Injection, 8 mg/1 mL (NDC 0641-6126-25) | Hikma Pharmaceuticals USA, Inc. | unavailable | Sep 18, 2026 |
| Morphine Sulfate Injection Mitigo, Injection, 500 mg/20 mL (NDC 66794-162-02) | Piramal Critical Care Inc. | Available | Sep 15, 2026 |
| Morphine Sulfate Injection Morphine Sulfate, Injection, 50 mg/1 mL (NDC 0409-1896-20) | Hospira, Inc., a Pfizer Company | Unavailable | Sep 9, 2026 |
| Morphine Sulfate Injection Morphine Sulfate, Injection, 2 mg/1 mL (NDC 0409-1890-23) | Hospira, Inc., a Pfizer Company | Limited Availability | Sep 9, 2026 |
| Morphine Sulfate Injection Morphine Sulfate, Injection, 5 mg/1 mL (NDC 63323-455-01) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Morphine Sulfate Injection Infumorph 200 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 10 mg/1 mL (NDC 0641-6039-01) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Morphine Sulfate Injection Morphine Sulfate, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-3815-12) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Morphine Sulfate Injection Morphine Sulfate, Injection, 10 mg/1 mL (NDC 63323-451-01) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Morphine Sulfate Injection Morphine Sulfate, Injection, 10 mg/1 mL Syringes (NDC 0409-1893-01) | Hospira, Inc., a Pfizer Company | Unavailable | Sep 22, 2026 |
| Morphine Sulfate Injection Morphine Sulfate, Injection, 50 mg/1 mL (NDC 0409-2022-01) | Hospira, Inc., a Pfizer Company | Available | Sep 11, 2026 |
| Morphine Sulfate Injection Morphine Sulfate, Injection, 1 mg/1 mL (NDC 76329-1912-1) | Amphastar Pharmaceuticals, Inc. | Available | Sep 16, 2026 |
| Morphine Sulfate Injection Morphine Sulfate, Injection, 4 mg/1 mL Syringes (NDC 0409-1891-01) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Morphine Sulfate Injection Morphine Sulfate, Injection, 2 mg/1 mL (NDC 63323-452-01) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Morphine Sulfate Injection Duramorph, Injection, 1 mg/1 mL (NDC 0641-6019-10) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Morphine Sulfate Injection Infumorph 500 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 25 mg/1 mL (NDC 0641-6040-01) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Morphine Sulfate Injection Morphine Sulfate, Injection, 2 mg/1 mL Syringes (NDC 0409-1890-01) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Morphine Sulfate Injection Morphine Sulfate, Injection, 4 mg/1 mL (NDC 0641-6125-25) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Morphine Sulfate Injection Morphine Sulfate, Injection, 10 mg/1 mL (NDC 0641-6127-25) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Morphine Sulfate Injection Morphine Sulfate, Injection, 4 mg/1 mL (NDC 63323-454-01) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Morphine Sulfate Injection Morphine Sulfate, Injection, 5 mg/10 mL (0.5 mg/mL) (NDC 0409-3814-12) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Morphine Sulfate Injection Duramorph, Injection, .5 mg/1 mL (NDC 0641-6020-10) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Penicillin G Benzathine Injection Bicillin L-A, Injection, 2400000 [iU]/4 mL (NDC 60793-702-10) | Pfizer Inc. | Limited Availability | Sep 21, 2026 |
| Penicillin G Benzathine Injection Bicillin L-A, Injection, 1200000 [iU]/2 mL (NDC 60793-701-10) | Pfizer Inc. | Limited Availability | Sep 21, 2026 |
| Penicillin G Benzathine Injection Lentocilin, Injection, 1200000 U/4 mL (NDC 84383-110-01) | Laboratorios Atral | Available | Sep 15, 2026 |
| Penicillin G Benzathine Injection Bicillin L-A, Injection, 600000 [iU]/1 mL (NDC 60793-700-10) | Pfizer Inc. | Unavailable | Sep 21, 2026 |
| Pentostatin Injection Nipent, Injection, 10 mg, single dose vial (NDC 0409-0801-01) | Hospira, Inc., a Pfizer Company | Unavailable | Aug 27, 2026 |
| Promethazine Hydrochloride Injection Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-1495-35) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Promethazine Hydrochloride Injection Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-0929-25) | Hikma Pharmaceuticals USA, Inc. | Limited Availability | Sep 18, 2026 |
| Promethazine Hydrochloride Injection Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-1496-35) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Promethazine Hydrochloride Injection Phenergan, Injection, 50 mg/1 mL (NDC 0641-6085-25) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Promethazine Hydrochloride Injection Phenergan, Injection, 50 mg/1 mL (NDC 0641-6083-25) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Promethazine Hydrochloride Injection Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 39822-5550-6) | XGen Pharmaceuticals DJB, Inc. | Unvailable | Sep 22, 2026 |
| Promethazine Hydrochloride Injection Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-0928-25) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Promethazine Hydrochloride Injection Phenergan, Injection, 25 mg/1 mL (NDC 0641-6084-25) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Promethazine Hydrochloride Injection Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 39822-5525-3) | XGen Pharmaceuticals DJB, Inc. | Available | Sep 22, 2026 |
| Promethazine Hydrochloride Injection Phenergan, Injection, 25 mg/1 mL (NDC 0641-6082-25) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Propranolol Hydrochloride Injection Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-604-01) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Propranolol Hydrochloride Injection Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 0143-9872-10) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Quinapril Hydrochloride Tablet Quinapril Hydrochloride, Tablet, 20 mg (NDC 43547-412-09) | Solco Healthcare US, LLC | Unavailable | Jun 29, 2026 |
| Quinapril Hydrochloride Tablet Quinapril Hydrochloride, Tablet, 10 mg (NDC 65862-618-90) | Aurobindo Pharma USA | Unavailable | Jun 2, 2026 |
| Quinapril Hydrochloride Tablet Quinapril Hydrochloride, Tablet, 5 mg (NDC 62135-484-60) | Chartwell Molecular Holdings LLC | Available | Sep 15, 2026 |
| Quinapril Hydrochloride Tablet Quinapril Hydrochloride, Tablet, 40 mg (NDC 62135-487-90) | Chartwell Molecular Holdings LLC | Available | Sep 15, 2026 |
| Quinapril Hydrochloride Tablet Quinapril Hydrochloride, Tablet, 10 mg (NDC 62135-485-90) | Chartwell Molecular Holdings LLC | Available | Sep 15, 2026 |
| Quinapril Hydrochloride Tablet Quinapril Hydrochloride, Tablet, 40 mg (NDC 43547-413-09) | Solco Healthcare US, LLC | Unavailable | Jun 29, 2026 |
| Quinapril Hydrochloride Tablet Quinapril Hydrochloride, Tablet, 40 mg (NDC 65862-620-90) | Aurobindo Pharma USA | Unavailable | Jun 2, 2026 |
| Quinapril Hydrochloride Tablet Quinapril Hydrochloride, Tablet, 40 mg (NDC 68180-554-09) | Lupin Pharmaceuticals, Inc. | Unavailable | Sep 1, 2026 |
| Quinapril Hydrochloride Tablet Quinapril Hydrochloride, Tablet, 20 mg (NDC 68180-558-09) | Lupin Pharmaceuticals, Inc. | Unavailable | Sep 1, 2026 |
| Quinapril Hydrochloride Tablet Quinapril Hydrochloride, Tablet, 5 mg (NDC 43547-410-09) | Solco Healthcare US, LLC | Unavailable | Jun 29, 2026 |
| Quinapril Hydrochloride Tablet Quinapril Hydrochloride, Tablet, 20 mg (NDC 62135-486-90) | Chartwell Molecular Holdings LLC | Available | Sep 15, 2026 |
| Quinapril Hydrochloride Tablet Quinapril Hydrochloride, Tablet, 5 mg (NDC 65862-617-90) | Aurobindo Pharma USA | Unavailable | Jun 2, 2026 |
| Quinapril Hydrochloride Tablet Quinapril Hydrochloride, Tablet, 5 mg (NDC 68180-556-09) | Lupin Pharmaceuticals, Inc. | Unavailable | Sep 1, 2026 |
| Quinapril Hydrochloride Tablet Quinapril Hydrochloride, Tablet, 10 mg (NDC 43547-411-09) | Solco Healthcare US, LLC | Unavailable | Jun 29, 2026 |
| Quinapril Hydrochloride Tablet Quinapril Hydrochloride, Tablet, 10 mg (NDC 65862-618-90) | Aurobindo Pharma USA | Unavailable | Jun 2, 2026 |
| Quinapril Hydrochloride Tablet Quinapril Hydrochloride, Tablet, 10 mg (NDC 68180-557-09) | Lupin Pharmaceuticals, Inc. | Unavailable | Sep 1, 2026 |
| Quinapril/Hydrochlorothiazide Tablet Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (NDC 62135-668-90) | Chartwell Molecular Holdings LLC | Available | Sep 15, 2026 |
| Quinapril/Hydrochlorothiazide Tablet Quinapril/Hydrochlorothiazide, Tablet, 25 mg; 20 mg (NDC 62135-669-90) | Chartwell Molecular Holdings LLC | Available | Sep 15, 2026 |
| Quinapril/Hydrochlorothiazide Tablet Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 25 mg; 20 mg (NDC 65862-163-90) | Aurobindo Pharma USA | Unavailable | Jun 2, 2026 |
| Quinapril/Hydrochlorothiazide Tablet Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (NDC 65862-161-90) | Aurobindo Pharma USA | Unavailable | Jun 2, 2026 |
| Quinapril/Hydrochlorothiazide Tablet Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (NDC 65862-162-90) | Aurobindo Pharma USA | Unavailable | Jun 2, 2026 |
| Quinapril/Hydrochlorothiazide Tablet Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (NDC 62135-667-90) | Chartwell Molecular Holdings LLC | Available | Sep 15, 2026 |
| Remifentanil Hydrochloride Injection Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-723-03) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Remifentanil Hydrochloride Injection Ultiva, Injection, 2 mg (NDC 72078-035-02) | Mylan Institutional, a Viatris Company | Available | Sep 17, 2026 |
| Remifentanil Hydrochloride Injection Ultiva, Injection, 1 mg/1 mL (NDC 72078-034-01) | Mylan Institutional, a Viatris Company | Available | Sep 17, 2026 |
| Remifentanil Hydrochloride Injection Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-724-05) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Remifentanil Hydrochloride Injection Remifentanil Hydrochloride, Injection, 5 mg per vial (NDC 0143-9393-10) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Remifentanil Hydrochloride Injection Remifentanil Hydrochloride, Injection, 1 mg per vial (NDC 0143-9391-10) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Remifentanil Hydrochloride Injection Ultiva, Injection, 5 mg (NDC 72078-036-05) | Mylan Institutional, a Viatris Company | Available | Sep 17, 2026 |
| Remifentanil Hydrochloride Injection Remifentanil Hydrochloride, Injection, 2 mg per vial (NDC 0143-9392-10) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Remifentanil Hydrochloride Injection Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-725-10) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Rifampin Capsule Rifampin, Capsule, 300 mg (NDC 68180-659-07) | Lupin Pharmaceuticals, Inc. | Available | Sep 1, 2026 |
| Rifampin Capsule Rifampin, Capsule, 300 mg (NDC 42806-799-01) | Epic Pharma, LLC | Unavailable | Sep 15, 2026 |
| Rifampin Capsule Rifampin, Capsule, 300 mg (NDC 42806-799-05) | Epic Pharma, LLC | Unavailable | Sep 15, 2026 |
| Rifampin Capsule Rifampin, Capsule, 300 mg (NDC 42806-799-30) | Epic Pharma, LLC | Unavailable | Sep 15, 2026 |
| Rifampin Capsule Rifampin, Capsule, 150 mg (NDC 42806-801-01) | Epic Pharma, LLC | Unavailable | Sep 15, 2026 |
| Rifampin Capsule Rifampin, Capsule, 300 mg (NDC 42806-799-60) | Epic Pharma, LLC | Available | Sep 15, 2026 |
| Rifampin Capsule Rifampin, Capsule, 150 mg (NDC 68180-658-06) | Lupin Pharmaceuticals, Inc. | Available | Sep 1, 2026 |
| Rifampin Capsule Rifampin, Capsule, 150 mg (NDC 42806-801-30) | Epic Pharma, LLC | Available | Sep 15, 2026 |
| Rifampin Capsule Rifampin, Capsule, 300 mg (NDC 68180-659-06) | Lupin Pharmaceuticals, Inc. | Available | Sep 1, 2026 |
| Rifampin Injection Rifampin, Injection, 600 mg (NDC 63323-351-20) | Fresenius Kabi USA, LLC | Limited Availability | Sep 15, 2026 |
| Rifampin Injection Rifadin, Injection, 600 mg (NDC 0068-0597-01) | Sanofi-Aventis U.S. LLC | Unavailable | Sep 18, 2026 |
| Rifampin Injection Rifampin, Injection, 600 mg (NDC 67457-445-60) | Mylan Institutional, a Viatris Company | Unavailable | Sep 17, 2026 |
| Riluzole Oral Suspension Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0306-1) | EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) | Available | Sep 15, 2026 |
| Riluzole Oral Suspension Tiglutik, Oral Suspension, 50 mg/10 mL (NDC 70726-0303-1) | EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) | Unavailable | Sep 15, 2026 |
| Riluzole Oral Suspension Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0304-1) | EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) | Available | Sep 15, 2026 |
| Riluzole Oral Suspension Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0305-1) | EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) | Available | Sep 15, 2026 |
| Rocuronium Bromide Injection Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-92) | Sandoz Inc. | Available | Sep 18, 2026 |
| Rocuronium Bromide Injection Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 43066-013-10) | Baxter Healthcare | Available | Sep 17, 2026 |
| Rocuronium Bromide Injection Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9250-10) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Rocuronium Bromide Injection Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9251-10) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Rocuronium Bromide Injection Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-442-05) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Rocuronium Bromide Injection Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-1403-10) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Rocuronium Bromide Injection Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-7037-10) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Rocuronium Bromide Injection Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-700-06) | Meitheal Pharmaceuticals, Inc. | Available | Aug 27, 2026 |
| Rocuronium Bromide Injection Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 66794-228-41) | Piramal Critical Care Inc. | Available | Sep 15, 2026 |
| Rocuronium Bromide Injection Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-444-10) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Rocuronium Bromide Injection Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-065-05) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Rocuronium Bromide Injection Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 66794-229-41) | Piramal Critical Care Inc. | Limited Availability | Sep 15, 2026 |
| Rocuronium Bromide Injection Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-10) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Rocuronium Bromide Injection Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 43066-007-10) | Baxter Healthcare | Available | Sep 17, 2026 |
| Rocuronium Bromide Injection Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 25021-687-05) | Sagent Pharmaceuticals | Available | Sep 18, 2026 |
| Rocuronium Bromide Injection Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-95) | Sandoz Inc. | Available | Sep 18, 2026 |
| Rocuronium Bromide Injection Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 39822-4200-6) | XGen Pharmaceuticals DJB, Inc. | Available | Sep 22, 2026 |
| Rocuronium Bromide Injection Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-718-11) | Meitheal Pharmaceuticals, Inc. | Available | Aug 27, 2026 |
| Rocuronium Bromide Injection Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-05) | Mylan Institutional, a Viatris Company | Available | Sep 17, 2026 |
| Rocuronium Bromide Injection Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-5160-10) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Rocuronium Bromide Injection Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-05) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Rocuronium Bromide Injection Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-10) | Mylan Institutional, a Viatris Company | Available | Sep 17, 2026 |
| Rocuronium Bromide Injection Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-3189-10) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Rocuronium Bromide Injection Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 55150-226-10) | Eugia US LLC | Available | Sep 17, 2026 |
| Rocuronium Bromide Injection Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 55150-225-05) | Eugia US LLC | Available | Sep 17, 2026 |
| Rocuronium Bromide Injection Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 39822-4200-2) | XGen Pharmaceuticals DJB, Inc. | Available | Sep 22, 2026 |
| Ropivacaine Hydrochloride Injection Naropin, Injection, 2 mg/1 mL (NDC 63323-285-63) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Ropivacaine Hydrochloride Injection Naropin, Injection, 2 mg/1 mL (NDC 63323-285-20) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Ropivacaine Hydrochloride Injection Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-10) | Somerset Therapeutics, LLC | Available | Sep 11, 2026 |
| Ropivacaine Hydrochloride Injection Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-25) | Somerset Therapeutics, LLC | Available | Sep 11, 2026 |
| Ropivacaine Hydrochloride Injection Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-061-25) | Somerset Therapeutics, LLC | Available | Sep 11, 2026 |
| Ropivacaine Hydrochloride Injection Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-061-10) | Somerset Therapeutics, LLC | Available | Sep 11, 2026 |
| Ropivacaine Hydrochloride Injection Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 43066-023-10) | Caplin Steriles, Ltd. | Limited Availability | Jun 10, 2026 |
| Ropivacaine Hydrochloride Injection Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-197-20) | Eugia US LLC | Available | Sep 17, 2026 |
| Ropivacaine Hydrochloride Injection Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 43066-019-10) | Caplin Steriles, Ltd. | Available | Jun 10, 2026 |
| Ropivacaine Hydrochloride Injection Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 43066-027-10) | Caplin Steriles, Ltd. | Available | Jun 10, 2026 |
| Ropivacaine Hydrochloride Injection Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-82) | InfoRLife SA | Available | Aug 18, 2026 |
| Ropivacaine Hydrochloride Injection Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-67) | InfoRLife SA | Unavailable | Aug 18, 2026 |
| Ropivacaine Hydrochloride Injection Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 70069-067-25) | Somerset Therapeutics, LLC | Available | Sep 11, 2026 |
| Ropivacaine Hydrochloride Injection Naropin, Injection, 5 mg/1 mL (NDC 63323-286-20) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Ropivacaine Hydrochloride Injection Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-82) | InfoRLife SA | Available | Aug 18, 2026 |
| Ropivacaine Hydrochloride Injection Naropin, Injection, 5 mg/1 mL (NDC 63323-286-63) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Ropivacaine Hydrochloride Injection Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-20) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Ropivacaine Hydrochloride Injection Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-87) | InfoRLife SA | Available | Aug 18, 2026 |
| Ropivacaine Hydrochloride Injection Naropin, Injection, 2 mg/1 mL (NDC 63323-285-61) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Ropivacaine Hydrochloride Injection Naropin, Injection, 2 mg/1 mL (NDC 63323-285-65) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Ropivacaine Hydrochloride Injection Naropin, Injection, 2 mg/1 mL (NDC 63323-285-64) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Ropivacaine Hydrochloride Injection Ropivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-199-20) | Eugia US LLC | Unavailable | Sep 17, 2026 |
| Ropivacaine Hydrochloride Injection Naropin, Injection, 2 mg/1 mL (NDC 63323-285-23) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Ropivacaine Hydrochloride Injection Naropin, Injection, 10 mg/1 mL (NDC 63323-288-10) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Ropivacaine Hydrochloride Injection Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-062-10) | Somerset Therapeutics, LLC | Available | Sep 11, 2026 |
| Ropivacaine Hydrochloride Injection Naropin, Injection, 5 mg/1 mL (NDC 63323-286-23) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Ropivacaine Hydrochloride Injection Naropin, Injection, 2 mg/1 mL (NDC 63323-285-10) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Ropivacaine Hydrochloride Injection Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 43066-015-10) | Caplin Steriles, Ltd. | Limited Availability | Jun 10, 2026 |
| Ropivacaine Hydrochloride Injection Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-198-30) | Eugia US LLC | Available | Sep 17, 2026 |
| Ropivacaine Hydrochloride Injection Naropin, Injection, 2 mg/1 mL (NDC 65219-632-10) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Ropivacaine Hydrochloride Injection Naropin, Injection, 2 mg/1 mL (NDC 63323-285-13) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Ropivacaine Hydrochloride Injection Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-21) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Ropivacaine Hydrochloride Injection Naropin, Injection, 2 mg/1 mL (NDC 65219-632-20) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Ropivacaine Hydrochloride Injection Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-063-25) | Somerset Therapeutics, LLC | Available | Sep 11, 2026 |
| Ropivacaine Hydrochloride Injection Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-01) | Somerset Therapeutics, LLC | Available | Sep 11, 2026 |
| Ropivacaine Hydrochloride Injection Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-062-25) | Somerset Therapeutics, LLC | Available | Sep 11, 2026 |
| Ropivacaine Hydrochloride Injection Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-201-20) | Eugia US LLC | Available | Sep 17, 2026 |
| Ropivacaine Hydrochloride Injection Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-200-10) | Eugia US LLC | Available | Sep 17, 2026 |
| Ropivacaine Hydrochloride Injection Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-66) | InfoRLife SA | Limited Availability | Aug 18, 2026 |
| Ropivacaine Hydrochloride Injection Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 70069-067-10) | Somerset Therapeutics, LLC | Available | Sep 11, 2026 |
| Ropivacaine Hydrochloride Injection Naropin, Injection, 10 mg/1 mL (NDC 63323-288-20) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Ropivacaine Hydrochloride Injection Naropin, Injection, 5 mg/1 mL (NDC 63323-286-31) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Ropivacaine Hydrochloride Injection Naropin, Injection, 5 mg/1 mL (NDC 63323-286-00) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Ropivacaine Hydrochloride Injection Naropin, Injection, 5 mg/1 mL (NDC 63323-286-35) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Ropivacaine Hydrochloride Injection Naropin, Injection, 10 mg/1 mL (NDC 63323-288-21) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Ropivacaine Hydrochloride Injection Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 55150-196-99) | Eugia US LLC | Available | Sep 17, 2026 |
| Ropivacaine Hydrochloride Injection Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 55150-195-20) | Eugia US LLC | Unavailable | Sep 17, 2026 |
| Ropivacaine Hydrochloride Injection Naropin, Injection, 10 mg/1 mL (NDC 63323-288-11) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Ropivacaine Hydrochloride Injection Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-87) | InfoRLife SA | Available | Aug 18, 2026 |
| Sodium Acetate Injection Sodium Acetate, Injection, 200 mEq/100mL (2 mEq/mL) (NDC 71357-008-10) | Milla Pharmaceuticals | Available | Sep 16, 2026 |
| Sodium Acetate Injection Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 71357-007-10) | Milla Pharmaceuticals | Available | Sep 16, 2026 |
| Sodium Acetate Injection Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-26) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Sodium Acetate Injection Sodium Acetate, Injection, 4 meq/100 mL (NDC 63323-032-00) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Sodium Acetate Injection Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-25) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Sodium Acetate Injection Sodium Acetate, Injection, 400 mEq/100mL (4 mEq/mL) (NDC 71357-009-10) | Milla Pharmaceuticals | Limited Availability | Sep 16, 2026 |
| Sodium Acetate Injection Sodium Acetate, Injection, 164 mg/1 mL (NDC 70069-047-25) | Somerset Therapeutics, LLC | Available | Sep 11, 2026 |
| Sodium Acetate Injection Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 71357-002-10) | Milla Pharmaceuticals | Available | Sep 16, 2026 |
| Sodium Acetate Injection Sodium Acetate, Injection, 164 mg/1 mL (NDC 70069-048-20) | Somerset Therapeutics, LLC | Available | Sep 11, 2026 |
| Sodium Acetate Injection Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-05) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Sodium Acetate Injection Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-73) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Sodium Acetate Injection Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-06) | Hospira, Inc., a Pfizer Company | Limited Availability | Aug 24, 2026 |
| Sodium Acetate Injection Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 0641-6262-01) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Sodium Acetate Injection Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 0641-6261-01) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Sodium Acetate Injection Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-25) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Sodium Bicarbonate Injection Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 76329-3352-1) | Amphastar Pharmaceuticals, Inc. | Limited Availability | Sep 16, 2026 |
| Sodium Bicarbonate Injection Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 81298-7620-3) | Long Grove Pharmaceuticals LLC | Available | Sep 15, 2026 |
| Sodium Bicarbonate Injection Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 51754-5001-5) | Exela Pharma Sciences, LLC | Available | Sep 15, 2026 |
| Sodium Bicarbonate Injection Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 63323-083-05) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Sodium Bicarbonate Injection Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-02) | Hospira, Inc., a Pfizer Company | Limited Availability | Sep 9, 2026 |
| Sodium Bicarbonate Injection Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 51754-5012-4) | Exela Pharma Sciences, LLC | Available | Sep 15, 2026 |
| Sodium Bicarbonate Injection Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 63323-089-50) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Sodium Bicarbonate Injection Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) (NDC 0409-6625-14) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Sodium Bicarbonate Injection Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 51754-5011-4) | Exela Pharma Sciences, LLC | Available | Sep 15, 2026 |
| Sodium Bicarbonate Injection Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) (NDC 0409-6625-35) | Hospira, Inc., a Pfizer Company | Unavailable | Sep 9, 2026 |
| Sodium Bicarbonate Injection Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-01) | Hospira, Inc., a Pfizer Company | Unavailable | Sep 9, 2026 |
| Sterile Water Injection Sterile Water, Injection, 1 mL/1 mL (NDC 0641-6147-10) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Sterile Water Injection Sterile Water, Injection, 1000 mL/1000 mL (NDC 63323-178-76) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Sterile Water Injection Sterile Water, Injection, 10 mL/10 mL (NDC 64253-020-30) | Medefil, Inc. | Available | Sep 15, 2026 |
| Sterile Water Injection Sterile Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC 63323-185-50) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Sterile Water Injection Sterile Water, Injection, 1 mL/1 mL (NDC 0409-4887-99) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Sterile Water Injection Sterile Water, Injection, 1 mL/1 mL (NDC 0409-4887-10) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Sterile Water Injection Sterile Water, Injection, 1 mL/1 mL (NDC 0487-6105-01) | Nephron Pharmaceuticals Corporation | Limited Availability | Aug 4, 2026 |
| Sterile Water Injection Sterile Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC 63323-185-10) | Fresenius Kabi USA, LLC | Unavailable | Sep 15, 2026 |
| Sterile Water Injection Bacteriostatic Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC 0409-3977-03) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Sterile Water Injection Sterile Water, Injection, 1 mL/1 mL (NDC 0409-4887-50) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Sterile Water Injection Sterile Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC 63323-185-20) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Sterile Water Injection Sterile Water, Injection, 1 mL/1 mL (NDC 0409-4887-20) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Sterile Water Irrigant Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0990-7139-09) | Otsuka ICU Medical LLC | Unavailable | Sep 16, 2026 |
| Sterile Water Irrigant Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0990-6139-22) | Otsuka ICU Medical LLC | Unavailable | Sep 16, 2026 |
| Sterile Water Irrigant Sterile Water, Irrigant, 100 mL/100 mL (NDC 0338-0004-04) | Baxter Healthcare | Limited Availability | Sep 17, 2026 |
| Sterile Water Irrigant Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0264-2101-00) | B. Braun Medical Inc. | Available | Sep 22, 2026 |
| Sterile Water Irrigant Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0990-7139-36) | Otsuka ICU Medical LLC | Unavailable | Sep 16, 2026 |
| Sterile Water Irrigant Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0990-6139-03) | Otsuka ICU Medical LLC | Unavailable | Sep 16, 2026 |
| Sterile Water Irrigant Sterile Water, Irrigant, 100 mL/100 mL (NDC 0338-0004-02) | Baxter Healthcare | Available | Sep 17, 2026 |
| Sterile Water Irrigant Sterile Water, Irrigant, 100 mL/100 mL (NDC 0338-0004-03) | Baxter Healthcare | Available | Sep 17, 2026 |
| Sterile Water Irrigant Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0264-2101-10) | B. Braun Medical Inc. | Available | Sep 22, 2026 |
| Streptozocin Powder, For Solution Zanosar, Powder, For Solution, 100 mg/1 mL (NDC 0703-4636-01) | Teva Pharmaceuticals USA, Inc. | Unavailable | Sep 15, 2026 |
| Streptozocin Powder, For Solution Zanosar, Powder, For Solution, 1 g/10 mL (NDC 68118-100-01) | ESTEVE PHARMACEUTICALS, S.A. | Available | Sep 16, 2026 |
| Sufentanil Citrate Injection Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-01) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Sufentanil Citrate Injection Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-02) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Sufentanil Citrate Injection Sufentanil Citrate, Injection, 50 ug/1 mL (NDC 0409-3382-21) | Hospira, Inc., a Pfizer Company | Available | Sep 22, 2026 |
| Sufentanil Citrate Injection Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-05) | Hikma Pharmaceuticals USA, Inc. | Unavailable | Sep 18, 2026 |
| Technetium TC-99M Pyrophosphate Kit Injection CIS-PYRO, Injection, 12 mg/10 mL (NDC 45567-0060-1) | Sun Pharmaceutical Industries, Inc. | Unavailable | Sep 18, 2026 |
| Technetium TC-99M Pyrophosphate Kit Injection Technescan PYP, Injection, 11.9 mg/10 mL; 3.2 mg/10 mL (NDC 69945-094-20) | Curium US LLC | Unavailable | Sep 18, 2026 |
| Technetium TC-99M Pyrophosphate Kit Injection CIS-PYRO, Injection, 12 mg/10 mL (NDC 45567-0060-2) | Sun Pharmaceutical Industries, Inc. | Unavailable | Sep 18, 2026 |
| Triamcinolone Hexacetonide Injection Hexatrione, Injection, 40 mg/2 mL (NDC 59137-570-01) | Medexus | Available | Sep 15, 2026 |
| Valproate Sodium Injection Valproate Sodium, Injection, 500 mg/5 mL (NDC 0143-9785-10) | Hikma Pharmaceuticals USA, Inc. | Available | Sep 18, 2026 |
| Valproate Sodium Injection Valproate Sodium, Injection, 100 mg/1 mL (NDC 63323-494-05) | Fresenius Kabi USA, LLC | Available | Sep 15, 2026 |
| Acetaminophen; Oxycodone Hydrochloride Tablet Acetaminophen; Oxycodone Hydrochloride, Tablet, 325 mg; 5 mg (NDC 60951-602-70) | Endo Pharmaceuticals, Inc. | To Be Discontinued To Be Discontinued | Nov 3, 2025 |
| Acetaminophen; Oxycodone Hydrochloride Tablet Acetaminophen; Oxycodone Hydrochloride, Tablet, 325 mg; 2.5 mg (NDC 60951-701-70) | Endo Pharmaceuticals, Inc. | To Be Discontinued To Be Discontinued | Nov 3, 2025 |
| Acetaminophen; Oxycodone Hydrochloride Tablet Acetaminophen; Oxycodone Hydrochloride, Tablet, 325 mg; 10 mg (NDC 60951-712-70) | Endo Pharmaceuticals, Inc. | To Be Discontinued To Be Discontinued | Nov 3, 2025 |
| Acetaminophen; Oxycodone Hydrochloride Tablet Acetaminophen; Oxycodone Hydrochloride, Tablet, 325 mg; 7.5 mg (NDC 60951-700-70) | Endo Pharmaceuticals, Inc. | To Be Discontinued To Be Discontinued | Nov 3, 2025 |
| Acetaminophen; Oxycodone Hydrochloride Tablet Acetaminophen; Oxycodone Hydrochloride, Tablet, 325 mg; 5 mg (NDC 60951-602-85) | Endo Pharmaceuticals, Inc. | To Be Discontinued To Be Discontinued | Nov 3, 2025 |
| Acetaminophen; Oxycodone Hydrochloride Tablet Acetaminophen; Oxycodone Hydrochloride, Tablet, 325 mg; 2.5 mg (NDC 63481-627-70) | Endo Pharmaceuticals, Inc. | To Be Discontinued To Be Discontinued | Nov 3, 2025 |
| Activated Charcoal Oral Suspension Actidose, Oral Suspension, 208 mg/1 mL (NDC 0574-0520-76) | Padagis US LLC | To Be Discontinued To Be Discontinued | May 15, 2026 |
| Activated Charcoal Oral Suspension Actidose Aqua, Oral Suspension, 208 mg/1 mL (NDC 0574-0521-76) | Padagis US LLC | To Be Discontinued To Be Discontinued | May 15, 2026 |
| Activated Charcoal Oral Suspension Actidose Aqua, Oral Suspension, 208 mg/1 mL (NDC 0574-0521-74) | Padagis US LLC | To Be Discontinued To Be Discontinued | May 15, 2026 |
| Activated Charcoal Oral Suspension Actidose, Oral Suspension, 208 mg/1 mL (NDC 0574-0520-74) | Padagis US LLC | To Be Discontinued To Be Discontinued | May 15, 2026 |
| Activated Charcoal Oral Suspension Actidose Aqua, Oral Suspension, 208 mg/1 mL (NDC 0574-0521-25) | Padagis US LLC | To Be Discontinued To Be Discontinued | May 15, 2026 |
| Adalimumab-adaz Injection Hyrimoz, Injection, 80 mg/.8 mL (NDC 61314-454-68) | Sandoz Inc. | To Be Discontinued To Be Discontinued | Jan 13, 2026 |
| Adalimumab-adaz Injection Hyrimoz, Injection, Kit (NDC 61314-531-64) | Sandoz Inc. | To Be Discontinued To Be Discontinued | Jan 13, 2026 |
| Adalimumab-adaz Injection Hyrimoz, Injection, 80 mg/.8 mL (NDC 61314-454-36) | Sandoz Inc. | To Be Discontinued To Be Discontinued | Jan 13, 2026 |
| Adalimumab-adaz Injection Hyrimoz, Injection, 40 mg/.4 mL (NDC 61314-473-64) | Sandoz Inc. | To Be Discontinued To Be Discontinued | Jan 13, 2026 |
| Adalimumab-adaz Injection Hyrimoz, Injection, Kit (NDC 61314-517-36) | Sandoz Inc. | To Be Discontinued To Be Discontinued | Jan 13, 2026 |
| Adalimumab-afzb Injection Abrilada, Injection, Kit (NDC 0025-0325-01) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Oct 9, 2025 |
| Adalimumab-ryvk Kit Simlandi, Kit, Kit (NDC 51759-523-21) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Nov 13, 2025 |
| Albuterol Sulfate Solution Albuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 76204-027-01) | Ritedose Pharmaceuticals, LLC | Resolved Resolved | Aug 27, 2026 |
| Albuterol Sulfate Solution Albuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 64980-642-03) | Rising Pharma Holdings, Inc. | Resolved Resolved | Aug 27, 2026 |
| Albuterol Sulfate Solution Albuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 0487-9901-30) | Nephron Pharmaceuticals Corporation | Resolved Resolved | Aug 27, 2026 |
| Allopurinol Tablet Allopurinol, Tablet, 100 mg (NDC 0591-5543-01) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Feb 19, 2026 |
| Allopurinol Tablet Allopurinol, Tablet, 300 mg (NDC 0591-5544-05) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Feb 19, 2026 |
| Allopurinol Tablet Allopurinol, Tablet, 100 mg (NDC 0591-5543-10) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Feb 19, 2026 |
| Allopurinol Tablet Allopurinol, Tablet, 300 mg (NDC 0591-5544-01) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Feb 19, 2026 |
| Alteplase Injection Activase, Injection, 1 KIT in 1 CARTON (50242-085-27) * 100 mL in 1 VIAL, SINGLE-USE * 100 mL in 1 VIAL, SINGLE USE… | Genentech, Inc | To Be Discontinued To Be Discontinued | May 21, 2026 |
| Ampicillin Sodium Injection Ampicillin Sodium, Injection, 1 g (NDC 0781-9412-92) | Sandoz Inc. | To Be Discontinued To Be Discontinued | Dec 8, 2025 |
| Ampicillin Sodium Injection Ampicillin Sodium, Injection, 1 g (NDC 0781-9404-95) | Sandoz Inc. | To Be Discontinued To Be Discontinued | Dec 8, 2025 |
| Ampicillin Sodium Injection Ampicillin Sodium, Injection, 2 g (NDC 0781-9408-95) | Sandoz Inc. | To Be Discontinued To Be Discontinued | Dec 8, 2025 |
| Ampicillin Sodium Injection Ampicillin Sodium, Injection, 2 g (NDC 0781-9413-92) | Sandoz Inc. | To Be Discontinued To Be Discontinued | Dec 8, 2025 |
| Ampicillin Sodium Injection Ampicillin Sodium, Injection, 10 g (NDC 0781-9409-95) | Sandoz Inc. | To Be Discontinued To Be Discontinued | Dec 8, 2025 |
| Anagrelide Hydrochloride Capsule Anagrelide Hydrochloride, Capsule, 1 mg (NDC 0172-5240-60) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Nov 19, 2025 |
| Anagrelide Hydrochloride Capsule Anagrelide Hydrochloride, Capsule, 0.5 mg (NDC 0172-5241-60) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Nov 19, 2025 |
| Aprepitant Oral Powder for Suspension Emend, Oral Powder for Suspension, 125 mg (NDC 0006-3066-03) | Merck Sharp & Dohme LLC | To Be Discontinued To Be Discontinued | Apr 8, 2026 |
| Arsenic Trioxide Injection Arsenic Trioxide, Injection, 1 mg/1 mL (NDC 50742-438-10) | Ingenus Pharmaceuticals LLC | To Be Discontinued To Be Discontinued | Feb 24, 2026 |
| Arsenic Trioxide Injection Arsenic Trioxide, Injection, 1 mg/1 mL (NDC 63323-637-10) | Fresenius Kabi USA, LLC | To Be Discontinued To Be Discontinued | Sep 21, 2026 |
| Aspirin Suppository Aspirin, Suppository, 300 mg (NDC 0574-7034-12) | Padagis US LLC | To Be Discontinued To Be Discontinued | Jul 23, 2026 |
| Atazanavir Sulfate; Cobicistat Tablet Evotaz, Tablet, 300 mg; 150 mg (NDC 0003-3641-11) | Bristol Myers Squibb Co. | To Be Discontinued To Be Discontinued | Nov 3, 2025 |
| Atropine Sulfate Injection Atropine Sulfate, Injection, (Adult)1 mg/10 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC… | Hospira, Inc., a Pfizer Company | To Be Discontinued To Be Discontinued | Nov 7, 2025 |
| Atropine Sulfate Injection Atropine Sulfate, Injection, (Adult) 0.5 mg/5 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC… | Hospira, Inc., a Pfizer Company | To Be Discontinued To Be Discontinued | Nov 7, 2025 |
| Azithromycin Injection Zithromax IV, Injection, 500 mg/5 mL (NDC 0069-3150-83) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Jan 20, 2026 |
| Azithromycin Tablet Zithromax, Tablet, 250 mg (NDC 0069-4061-01) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Apr 9, 2026 |
| Azithromycin Tablet Zithromax, Tablet, 500 mg (NDC 0069-3070-30) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Apr 9, 2026 |
| Belladonna and Opium Suppository Belladonna and Opium, Suppository, 16.2 mg; 30 mg (NDC 0574-7045-12) | Padagis US LLC | To Be Discontinued To Be Discontinued | Jul 23, 2026 |
| Belladonna and Opium Suppository Belladonna and Opium, Suppository, 16.2 mg; 30 mg (NDC 0574-7045-04) | Padagis US LLC | To Be Discontinued To Be Discontinued | Jul 23, 2026 |
| Belladonna and Opium Suppository Belladonna and Opium, Suppository, 16.2 mg; 60 mg (NDC 0574-7040-04) | Padagis US LLC | To Be Discontinued To Be Discontinued | Jul 23, 2026 |
| Belladonna and Opium Suppository Belladonna and Opium, Suppository, 16.2 mg; 60 mg (NDC 0574-7040-12) | Padagis US LLC | To Be Discontinued To Be Discontinued | Jul 23, 2026 |
| Bendamustine Hydrochloride Injection, Solution Treanda, Injection, Solution, 25 mg/5 mL, 1 vial, Single-Dose in 1 carton (NDC 63459-390-08) | Cephalon, LLC (a wholly owned subsidiary of Teva Pharmaceutical Industries, Ltd.) | To Be Discontinued To Be Discontinued | Jul 23, 2026 |
| Benztropine Mesylate Injection Benztropine Mesylate, Injection, 1 mg/1 mL (NDC 63323-970-02) | Fresenius Kabi USA, LLC | To Be Discontinued To Be Discontinued | Jan 27, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-722-32) | Kindos Pharmaceuticals Co. Ltd. | To Be Discontinued To Be Discontinued | May 5, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-725-32) | Kindos Pharmaceuticals Co. Ltd. | To Be Discontinued To Be Discontinued | May 5, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-726-52) | Kindos Pharmaceuticals Co. Ltd. | To Be Discontinued To Be Discontinued | May 5, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 71288-728-32) | Kindos Pharmaceuticals Co. Ltd. | To Be Discontinued To Be Discontinued | May 5, 2026 |
| Bupivacaine Hydrochloride Injection Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-723-52) | Kindos Pharmaceuticals Co. Ltd. | To Be Discontinued To Be Discontinued | May 5, 2026 |
| Busulfan Injection Busulfan, Injection, 6 mg/1 mL (NDC 67457-893-08) | Mylan Institutional, a Viatris Company | To Be Discontinued To Be Discontinued | Oct 24, 2025 |
| Calcitriol Capsule Calcitriol, Capsule, .5 ug (NDC 0093-7353-01) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Dec 4, 2025 |
| Calcitriol Capsule Calcitriol, Capsule, .25 ug (NDC 0093-7352-01) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Dec 4, 2025 |
| Calcium Chloride Injection Calcium Chloride, Injection, 100 mg/1 mL (NDC 0409-4928-34) | Hospira, Inc., a Pfizer Company | To Be Discontinued To Be Discontinued | Nov 7, 2025 |
| Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538… | Vantive US Healthcare LLC | To Be Discontinued To Be Discontinued | Aug 3, 2026 |
| Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538… | Vantive US Healthcare LLC | To Be Discontinued To Be Discontinued | Aug 3, 2026 |
| Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538… | Vantive US Healthcare LLC | To Be Discontinued To Be Discontinued | Aug 3, 2026 |
| Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538… | Vantive US Healthcare LLC | To Be Discontinued To Be Discontinued | Aug 3, 2026 |
| Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL;… | Vantive US Healthcare LLC | To Be Discontinued To Be Discontinued | Aug 3, 2026 |
| Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538… | Vantive US Healthcare LLC | To Be Discontinued To Be Discontinued | Aug 3, 2026 |
| Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538… | Vantive US Healthcare LLC | To Be Discontinued To Be Discontinued | Aug 3, 2026 |
| Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL;… | Vantive US Healthcare LLC | To Be Discontinued To Be Discontinued | Aug 3, 2026 |
| Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL;… | Vantive US Healthcare LLC | To Be Discontinued To Be Discontinued | Aug 3, 2026 |
| Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538… | Vantive US Healthcare LLC | To Be Discontinued To Be Discontinued | Aug 3, 2026 |
| Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538… | Vantive US Healthcare LLC | To Be Discontinued To Be Discontinued | Aug 3, 2026 |
| Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538… | Vantive US Healthcare LLC | To Be Discontinued To Be Discontinued | Aug 3, 2026 |
| Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538… | Vantive US Healthcare LLC | To Be Discontinued To Be Discontinued | Aug 3, 2026 |
| Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL;… | Vantive US Healthcare LLC | To Be Discontinued To Be Discontinued | Aug 3, 2026 |
| Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538… | Vantive US Healthcare LLC | To Be Discontinued To Be Discontinued | Aug 3, 2026 |
| Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL;… | Vantive US Healthcare LLC | To Be Discontinued To Be Discontinued | Aug 3, 2026 |
| Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL;… | Vantive US Healthcare LLC | To Be Discontinued To Be Discontinued | Aug 3, 2026 |
| Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538… | Vantive US Healthcare LLC | To Be Discontinued To Be Discontinued | Aug 3, 2026 |
| Carbamazepine Capsule, Extended Release Carbatrol, Capsule, Extended Release, 200 mg (NDC 54092-172-12) | Takeda Pharmaceuticals USA Inc. | To Be Discontinued To Be Discontinued | Dec 19, 2025 |
| Carbamazepine Capsule, Extended Release Carbatrol, Capsule, Extended Release, 100 mg (NDC 54092-171-12) | Takeda Pharmaceuticals USA Inc. | To Be Discontinued To Be Discontinued | Dec 19, 2025 |
| Carbamazepine Capsule, Extended Release Carbatrol, Capsule, Extended Release, 300 mg (NDC 54092-173-12) | Takeda Pharmaceuticals USA Inc. | To Be Discontinued To Be Discontinued | Dec 19, 2025 |
| Carboplatin Injection Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-6) | Teyro Labs | To Be Discontinued To Be Discontinued | Jun 1, 2026 |
| Carboplatin Injection Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-3) | Teyro Labs | To Be Discontinued To Be Discontinued | Jun 1, 2026 |
| Carboplatin Injection Carboplatin, Injection, 450 mg/45 mL (NDC 50742-447-45) | Ingenus Pharmaceuticals LLC | To Be Discontinued To Be Discontinued | Feb 20, 2026 |
| Carboplatin Injection Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-7) | Teyro Labs | To Be Discontinued To Be Discontinued | Jun 1, 2026 |
| Carboplatin Injection Carboplatin, Injection, 600 mg/60 mL (NDC 50742-448-60) | Ingenus Pharmaceuticals LLC | To Be Discontinued To Be Discontinued | Feb 20, 2026 |
| Carboplatin Injection Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-1) | Teyro Labs | To Be Discontinued To Be Discontinued | Jun 1, 2026 |
| Caspofungin Acetate Injection Caspofungin Acetate, Injection, 7 mg/1 mL (NDC 63323-358-10) | Fresenius Kabi USA, LLC | To Be Discontinued To Be Discontinued | Jan 12, 2026 |
| Caspofungin Acetate Injection Caspofungin Acetate, Injection, 7 mg/1 mL (NDC 0781-3423-94) | Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) | To Be Discontinued To Be Discontinued | Jun 30, 2026 |
| Caspofungin Acetate Injection Caspofungin Acetate, Injection, 5 mg/1 mL (NDC 0781-3421-94) | Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) | To Be Discontinued To Be Discontinued | Jun 30, 2026 |
| Cefepime Hydrochloride Injection Cefepime Hydrochloride, Injection, 1 g (NDC 63323-326-20) | Fresenius Kabi USA, LLC | To Be Discontinued To Be Discontinued | Feb 10, 2026 |
| Cefepime Hydrochloride Injection Cefepime Hydrochloride, Injection, 2 g (NDC 63323-340-20) | Fresenius Kabi USA, LLC | To Be Discontinued To Be Discontinued | Feb 10, 2026 |
| Ceftazidime Injection Tazicef, Injection, 2 g (NDC 0409-5093-11) | Hospira, Inc., a Pfizer Company | To Be Discontinued To Be Discontinued | Nov 14, 2025 |
| Ceftazidime Injection Tazicef, Injection, 1 g (NDC 0409-5092-16) | Hospira, Inc., a Pfizer Company | To Be Discontinued To Be Discontinued | Nov 14, 2025 |
| Cetrorelix Acetate Injection Cetrorelix Acetate, Injection, Kit (NDC 0480-5795-08) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Nov 13, 2025 |
| Chlorothiazide Oral Suspension Diuril, Oral Suspension, 250 mg/5mL (NDC 65649-311-12) | Salix Pharmaceuticals, a division of Bausch Health US, LLC | To Be Discontinued To Be Discontinued | Feb 10, 2026 |
| Cisatracurium Besylate Injection Cisatracurium Besylate, Injection, 20 mg/10 mL (2 mg/mL) Multidose Vial (NDC 0409-1208-01) | Hospira, Inc., a Pfizer Company | To Be Discontinued To Be Discontinued | May 6, 2026 |
| Cisatracurium Besylate Injection Cisatracurium Besylate, Injection, 200 mg/20ml (10 mg/mL) Single Dose Vial (NDC 0409-1103-01) | Hospira, Inc., a Pfizer Company | To Be Discontinued To Be Discontinued | May 6, 2026 |
| Cisatracurium Besylate Injection Cisatracurium Besylate, Injection, 10 mg/5ml (2 mg/mL) Single Dose Vial (NDC 0409-1098-02) | Hospira, Inc., a Pfizer Company | To Be Discontinued To Be Discontinued | Sep 11, 2026 |
| Clindamycin Hydrochloride Capsule Cleocin Hydrochloride, Capsule, 75 mg (NDC 0009-0331-02) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Feb 25, 2026 |
| Clindamycin Hydrochloride Capsule Cleocin Hydrochloride, Capsule, 300 mg (NDC 0009-0395-14) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Feb 25, 2026 |
| Clindamycin Hydrochloride Capsule Cleocin Hydrochloride, Capsule, 150 mg (NDC 0009-0225-02) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Feb 25, 2026 |
| Clindamycin Palmitate Hydrochloride Injection Clindamycin Palmitate Hydrochloride, Injection, 75 mg/5 mL (NDC 53746-468-19) | Amneal Pharmaceuticals | To Be Discontinued To Be Discontinued | Feb 27, 2026 |
| Clindamycin Palmitate Hydrochloride Injection Clindamycin Palmitate Hydrochloride, Injection, 75 mg/5 mL (NDC 53746-468-19) | Amneal Pharmaceuticals | To Be Discontinued To Be Discontinued | Mar 26, 2026 |
| Clindamycin Phosphate Injection Cleocin Phosphate, Injection, 600 mg/4 mL (150 mg/mL); 4 mL Vial (NDC 0009-0775-26) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Jun 1, 2026 |
| Clindamycin Phosphate Injection Cleocin Phosphate, Injection, 900 mg/6 mL (150 mg/mL); 6 mL Vial (NDC 0009-0902-18) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Jun 1, 2026 |
| Clindamycin Phosphate Injection Cleocin Phosphate, Injection, 300 mg/2 mL (150 mg/mL); 2 mL Vial (NDC 0009-0870-26) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Jun 1, 2026 |
| Clindamycin Phosphate Injection Cleocin Phosphate, Injection, 300 mg/2 mL (150 mg/mL); 2 mL Vial NovaPlus (NDC 0009-3051-02) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Jun 1, 2026 |
| Clindamycin Phosphate Injection Cleocin Phosphate, Injection, 600 mg/4 mL (150 mg/mL); 4 mL Vial NovaPlus (NDC 0009-4073-04) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Jun 1, 2026 |
| Clindamycin Phosphate Injection Cleocin Phosphate, Injection, 900 mg/6 mL (150 mg/mL); 6 mL Vial NovaPlus (NDC 0009-5095-06) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Jun 1, 2026 |
| Cobicistat Tablet Tybost, Tablet, 150 mg (NDC 61958-1401-1) | Gilead Sciences, Inc. | To Be Discontinued To Be Discontinued | Oct 7, 2025 |
| Crinecerfont Capsule Crenessity, Capsule, 25 mg (NDC 70370-5025-1) | Neurocrine Biosciences, Inc. | To Be Discontinued To Be Discontinued | Apr 28, 2026 |
| Dacomitinib Tablet Vizimpro, Tablet, 15 mg (NDC 0069-0197-30) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Jun 8, 2026 |
| Dacomitinib Tablet Vizimpro, Tablet, 45 mg (NDC 0069-2299-30) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Jun 8, 2026 |
| Dacomitinib Tablet Vizimpro, Tablet, 30 mg (NDC 0069-1198-30) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Jun 8, 2026 |
| Dapsone Gel Dapsone, Gel, 7.5% (NDC 69238-1627-6) | Amneal Pharmaceuticals | To Be Discontinued To Be Discontinued | Mar 27, 2026 |
| Daptomycin Injection Daptomycin, Injection, 500 mg/10 mL (NDC 0143-9378-01) | Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) | To Be Discontinued To Be Discontinued | Jun 30, 2026 |
| Daptomycin Injection Daptomycin, Injection, 500 mg/10 mL (NDC 57884-3151-1) | Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) | To Be Discontinued To Be Discontinued | Jun 30, 2026 |
| Decitabine Injection Decitabine, Injection, 50 mg (NDC 68001-573-41) | Ingenus Pharmaceuticals LLC | To Be Discontinued To Be Discontinued | Feb 20, 2026 |
| Decitabine Injection Decitabine, Injection, 50 mg (NDC 50742-430-01) | Ingenus Pharmaceuticals LLC | To Be Discontinued To Be Discontinued | Feb 20, 2026 |
| Deferiprone Tablet Ferriprox, Tablet, 500 mg (NDC 10122-100-10) | Chiesi USA, Inc. | To Be Discontinued To Be Discontinued | Nov 7, 2025 |
| Dehydrated Alcohol Injection, Solution Dehydrated Alcohol, Injection, Solution, 1 mL/1 mL (10 pack) (NDC 16729-710-45) | Accord Healthcare Inc. | To Be Discontinued To Be Discontinued | May 27, 2026 |
| Desflurane Liquid for Inhalation Desflurane, Liquid for Inhalation, 240 mL/240 mL (NDC 0781-6172-86) | Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) | To Be Discontinued To Be Discontinued | Jul 2, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-239-93) | Accord Healthcare Inc. | To Be Discontinued To Be Discontinued | Apr 21, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 71225-126-06) | Slayback Pharma | To Be Discontinued To Be Discontinued | Jun 5, 2026 |
| Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 71225-126-05) | Slayback Pharma | To Be Discontinued To Be Discontinued | Jun 5, 2026 |
| Dextrose Monohydrate 50% Injection Dextrose Monohydrate 50%, Injection, 50% Dextrose Injection 0.5 g/mL; ABBOJECT® Glass Syringe (NDC 0409-4902-34) | Hospira, Inc., a Pfizer Company | To Be Discontinued To Be Discontinued | Nov 7, 2025 |
| Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride Solution DELFLEX, Solution, 18.4 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 46163-212-95) | Fresenius Medical Care North America | To Be Discontinued To Be Discontinued | Sep 10, 2026 |
| Diclofenac Sodium Tablet, Delayed Release Diclofenac Sodium, Tablet, Delayed Release, 50 mg (NDC 0228-2550-96) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Aug 13, 2026 |
| Diclofenac Sodium Tablet, Delayed Release Diclofenac Sodium, Tablet, Delayed Release, 75 mg (NDC 0228-2551-96) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Aug 13, 2026 |
| Diclofenac Sodium Tablet, Delayed Release Diclofenac Sodium, Tablet, Delayed Release, 50 mg (NDC 0228-2550-06) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Aug 13, 2026 |
| Diclofenac Sodium Tablet, Delayed Release Diclofenac Sodium, Tablet, Delayed Release, 50 mg (NDC 0228-2550-11) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Aug 13, 2026 |
| Diclofenac Sodium Tablet, Delayed Release Diclofenac Sodium, Tablet, Delayed Release, 75 mg (NDC 0228-2551-06) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Aug 13, 2026 |
| Diclofenac Sodium Tablet, Delayed Release Diclofenac Sodium, Tablet, Delayed Release, 75 mg (NDC 0228-2551-11) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Aug 13, 2026 |
| Diltiazem Hydrochloride Injection Diltiazem Hydrochloride, Injection, 100 mg Single Dose ADD-Vantage® Glass Vial (NDC 0409-4350-03) | Hospira, Inc., a Pfizer Company | To Be Discontinued To Be Discontinued | Jan 5, 2026 |
| Disopyramide Phosphate Capsule, Extended Release Norpace CR, Capsule, Extended Release, 150 mg (NDC 0025-2742-31) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Aug 24, 2026 |
| Disopyramide Phosphate Capsule, Extended Release Norpace CR, Capsule, Extended Release, 100 mg (NDC 0025-2732-31) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Aug 24, 2026 |
| Docetaxel Injection Docetaxel, Injection, 10 mg/1 mL (NDC 50742-463-16) | Ingenus Pharmaceuticals LLC | To Be Discontinued To Be Discontinued | Feb 20, 2026 |
| Docetaxel Injection Docetaxel, Injection, 10 mg/1 mL (NDC 50742-431-08) | Ingenus Pharmaceuticals LLC | To Be Discontinued To Be Discontinued | Feb 20, 2026 |
| Donepezil Hydrochloride; Memantine Hydrochloride Capsule, Extended Release Donepezil Hydrochloride; Memantine Hydrochloride, Capsule, Extended Release, 10 mg; 14 mg (NDC 69238-1248-3) | Amneal Pharmaceuticals | To Be Discontinued To Be Discontinued | Jun 15, 2026 |
| Donepezil Hydrochloride; Memantine Hydrochloride Capsule, Extended Release Donepezil Hydrochloride; Memantine Hydrochloride, Capsule, Extended Release, 10 mg; 28 mg (NDC 69238-1247-3) | Amneal Pharmaceuticals | To Be Discontinued To Be Discontinued | Jun 15, 2026 |
| Doxercalciferol Injection Hectorol, Injection, 4 mcg/2 mL injection 50 single-dose vials (NDC 58468-0123-1) | Sanofi-Aventis U.S. LLC | To Be Discontinued To Be Discontinued | Dec 10, 2025 |
| Doxercalciferol Injection Hectorol, Injection, 2 mcg/mL injection 50 single-dose vials (NDC 58468-0126-1) | Sanofi-Aventis U.S. LLC | To Be Discontinued To Be Discontinued | Dec 10, 2025 |
| Doxercalciferol Injection Hectorol, Injection, 4 mcg/2 mL injection 50 multiple-dose vials (NDC 58468-0127-1) | Sanofi-Aventis U.S. LLC | To Be Discontinued To Be Discontinued | Dec 10, 2025 |
| Doxycycline Hyclate Tablet Doxycycline Hyclate, Tablet, 100 mg (NDC 0378-0167-13) | Mylan Pharmaceuticals Inc., a Viatris Company | To Be Discontinued To Be Discontinued | Jan 12, 2026 |
| Doxycycline Hyclate Tablet Doxycycline Hyclate, Tablet, 100 mg (NDC 0378-0167-02) | Mylan Pharmaceuticals Inc., a Viatris Company | To Be Discontinued To Be Discontinued | Jan 12, 2026 |
| Doxycycline Hyclate Tablet, Delayed Release Doxycycline Hyclate, Tablet, Delayed Release, 50 mg (NDC 0591-4550-22) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Jul 30, 2026 |
| Doxycycline Hyclate Tablet, Delayed Release Doxycycline Hyclate, Tablet, Delayed Release, 200 mg (NDC 0591-4575-60) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Jul 30, 2026 |
| Doxylamine Succinate and Pyridoxine Hydrochloride Tablet, Delayed Release Doxylamine Succinate and Pyridoxine Hydrochloride, Tablet, Delayed Release, 10 mg; 10 mg (NDC 0378-4615-01) | Mylan Pharmaceuticals Inc., a Viatris Company | To Be Discontinued To Be Discontinued | Jan 12, 2026 |
| Elbasvir; Grazoprevir Tablet Zepatier, Tablet, 50 mg; 100 mg (NDC 0006-3074-02) | Merck Sharp & Dohme LLC | To Be Discontinued To Be Discontinued | Oct 17, 2025 |
| Emtricitabine Capsule Emtriva, Capsule, 200 mg (NDC 61958-0601-1) | Gilead Sciences, Inc. | To Be Discontinued To Be Discontinued | Jun 17, 2026 |
| Emtricitabine Oral Solution Emtriva, Oral Solution, 10 mg/1 mL (NDC 61958-0602-1) | Gilead Sciences, Inc. | To Be Discontinued To Be Discontinued | Jun 17, 2026 |
| Epinephrine Injection Epinephrine, Injection, .1 mg/1 mL (NDC 0409-4933-10) | Hospira, Inc., a Pfizer Company | To Be Discontinued To Be Discontinued | Nov 7, 2025 |
| Epinephrine Injection Epinephrine, Injection, .1 mg/1 mL (NDC 0409-4933-01) | Hospira, Inc., a Pfizer Company | To Be Discontinued To Be Discontinued | Nov 7, 2025 |
| Etravirine Tablet Intelence, Tablet, 100 mg (NDC 59676-570-01) | Janssen Research and Development | To Be Discontinued To Be Discontinued | Apr 28, 2026 |
| Etravirine Tablet Etravirine, Tablet, 100 mg (NDC 10147-0570-1) | Janssen Research and Development | To Be Discontinued To Be Discontinued | Apr 28, 2026 |
| Everolimus Tablet Everolimus, Tablet, 7.5 mg (NDC 0093-7768-24) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Mar 2, 2026 |
| Everolimus Tablet Everolimus, Tablet, 5 mg (NDC 0378-0007-85) | Mylan Pharmaceuticals Inc., a Viatris Company | To Be Discontinued To Be Discontinued | Nov 3, 2025 |
| Everolimus Tablet Everolimus, Tablet, 5 mg (NDC 0093-7767-24) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Mar 2, 2026 |
| Everolimus Tablet Everolimus, Tablet, 2 mg (NDC 0378-0005-85) | Mylan Pharmaceuticals Inc., a Viatris Company | To Be Discontinued To Be Discontinued | Nov 3, 2025 |
| Everolimus Tablet Everolimus, Tablet, 5 mg (NDC 49884-125-91) | Endo Pharmaceuticals, Inc. | To Be Discontinued To Be Discontinued | Jan 6, 2026 |
| Everolimus Tablet Everolimus, Tablet, 2.5 mg (NDC 49884-119-91) | Endo Pharmaceuticals, Inc. | To Be Discontinued To Be Discontinued | Jan 6, 2026 |
| Everolimus Tablet Everolimus, Tablet, 10 mg (NDC 0093-7769-24) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Mar 2, 2026 |
| Everolimus Tablet Everolimus, Tablet, 10 mg (NDC 49884-128-91) | Endo Pharmaceuticals, Inc. | To Be Discontinued To Be Discontinued | Jan 6, 2026 |
| Everolimus Tablet Everolimus, Tablet, 2.5 mg (NDC 0093-7766-24) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Mar 2, 2026 |
| Everolimus Tablet Everolimus, Tablet, 3 mg (NDC 0378-0006-85) | Mylan Pharmaceuticals Inc., a Viatris Company | To Be Discontinued To Be Discontinued | Nov 3, 2025 |
| Everolimus Tablet Everolimus, Tablet, 7.5 mg (NDC 49884-127-91) | Endo Pharmaceuticals, Inc. | To Be Discontinued To Be Discontinued | Jan 6, 2026 |
| Fluticasone Propionate and Salmeterol Xinafoate Aerosol, Metered Advair HFA, Aerosol, Metered, 115 ug; 21 ug (NDC 0173-0716-22) | GlaxoSmithKline | To Be Discontinued To Be Discontinued | Jul 27, 2026 |
| Fluticasone Propionate and Salmeterol Xinafoate Aerosol, Metered Advair HFA, Aerosol, Metered, 45 ug; 21 ug (NDC 0173-0715-22) | GlaxoSmithKline | To Be Discontinued To Be Discontinued | Jul 27, 2026 |
| Fluticasone Propionate and Salmeterol Xinafoate Aerosol, Metered Advair HFA, Aerosol, Metered, 230 ug; 21 ug (NDC 0173-0717-22) | GlaxoSmithKline | To Be Discontinued To Be Discontinued | Jul 27, 2026 |
| Fluvastatin Sodium Tablet, Extended Release Lescol XL, Tablet, Extended Release, 80 mg (NDC 66758-211-31) | Sandoz Inc. | To Be Discontinued To Be Discontinued | Jan 27, 2026 |
| Fluvastatin Sodium Tablet, Extended Release Fluvastatin Sodium, Tablet, Extended Release, 80 mg (NDC 0781-8017-01) | Sandoz Inc. | To Be Discontinued To Be Discontinued | Jan 27, 2026 |
| Fluvastatin Sodium Tablet, Extended Release Fluvastatin Sodium, Tablet, Extended Release, 80 mg (NDC 0781-8017-31) | Sandoz Inc. | To Be Discontinued To Be Discontinued | Jan 27, 2026 |
| Fondaparinux Sodium Injection Fondaparinux Sodium, Injection, 10 mg/.8 mL (NDC 0781-3476-95) | Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) | To Be Discontinued To Be Discontinued | Sep 29, 2025 |
| Fondaparinux Sodium Injection Fondaparinux Sodium, Injection, 7.5 mg/.6 mL (NDC 0781-3465-95) | Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) | To Be Discontinued To Be Discontinued | Sep 29, 2025 |
| Fondaparinux Sodium Injection Fondaparinux Sodium, Injection, 2.5 mg/.5 mL (NDC 0781-3443-95) | Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) | To Be Discontinued To Be Discontinued | Sep 29, 2025 |
| Fondaparinux Sodium Injection Fondaparinux Sodium, Injection, 5 mg/.4 mL (NDC 0781-3454-95) | Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) | To Be Discontinued To Be Discontinued | Sep 29, 2025 |
| Fosaprepitant Dimeglumine Injection Fosaprepitant Dimeglumine, Injection, 150 mg/5 mL (NDC 63323-972-10) | Fresenius Kabi USA, LLC | To Be Discontinued To Be Discontinued | Apr 8, 2026 |
| Frovatriptan Succinate Tablet Frova, Tablet, 2.5 mg (NDC 63481-025-09) | Endo Pharmaceuticals, Inc. | To Be Discontinued To Be Discontinued | Feb 24, 2026 |
| Frovatriptan Succinate Tablet Frova, Tablet, 2.5 mg (NDC 0603-3718-34) | Endo Pharmaceuticals, Inc. | To Be Discontinued To Be Discontinued | Nov 12, 2025 |
| Fulvestrant Injection Fulvestrant, Injection, 250 mg per 5mL (NDC 63323-715-05) | Fresenius Kabi USA, LLC | To Be Discontinued To Be Discontinued | Aug 14, 2026 |
| Furosemide Injection Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-10) | Gland Pharma Limited | To Be Discontinued To Be Discontinued | Apr 28, 2026 |
| Furosemide Injection Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-02) | Gland Pharma Limited | To Be Discontinued To Be Discontinued | Apr 28, 2026 |
| Furosemide Injection Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-04) | Gland Pharma Limited | To Be Discontinued To Be Discontinued | Apr 28, 2026 |
| Gadobutrol Injection Gadobutrol, Injection, 604.72 mg/mL (NDC 65219-281-07) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued To Be Discontinued | Jun 30, 2026 |
| Gadobutrol Injection Gadobutrol, Injection, 604.72 mg/mL (NDC 65219-281-02) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued To Be Discontinued | Jun 30, 2026 |
| Gadobutrol Injection Gadobutrol, Injection, 604.72 mg/mL (NDC 65219-281-15) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued To Be Discontinued | Jun 30, 2026 |
| Gadobutrol Injection Gadobutrol, Injection, 604.72 mg/mL (NDC 65219-281-10) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued To Be Discontinued | Jun 30, 2026 |
| Gadoterate Meglumine Injection Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-082-10) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued To Be Discontinued | May 21, 2026 |
| Gadoterate Meglumine Injection Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-082-10) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued To Be Discontinued | Jun 30, 2026 |
| Gadoterate Meglumine Injection Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-084-15) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued To Be Discontinued | May 21, 2026 |
| Gadoterate Meglumine Injection Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-086-20) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued To Be Discontinued | Jun 30, 2026 |
| Gadoterate Meglumine Injection Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-080-05) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued To Be Discontinued | Jun 30, 2026 |
| Gadoterate Meglumine Injection Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-080-05) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued To Be Discontinued | May 21, 2026 |
| Gadoterate Meglumine Injection Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-084-15) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued To Be Discontinued | Jun 30, 2026 |
| Gadoterate Meglumine Injection Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-086-20) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued To Be Discontinued | May 21, 2026 |
| Gemfibrozil Tablet Lopid, Tablet, 600 mg (NDC 0071-0737-20) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Feb 10, 2026 |
| Glyburide Tablet Diabeta, Tablet, 5 mg (NDC 0093-9364-10) | Sanofi-Aventis U.S. LLC | To Be Discontinued To Be Discontinued | Aug 10, 2026 |
| Glyburide Tablet Diabeta, Tablet, 5 mg (NDC 0093-9364-01) | Sanofi-Aventis U.S. LLC | To Be Discontinued To Be Discontinued | Aug 10, 2026 |
| Glyburide Tablet Diabeta, Tablet, 2.5 mg (NDC 0093-9433-01) | Sanofi-Aventis U.S. LLC | To Be Discontinued To Be Discontinued | Aug 10, 2026 |
| Glyburide Tablet Diabeta, Tablet, 1.25 mg (NDC 0093-9477-53) | Sanofi-Aventis U.S. LLC | To Be Discontinued To Be Discontinued | Aug 10, 2026 |
| Glycerol Phenylbutyrate Oral Liquid RAVICTI, Oral Liquid, 1.1 g/1 mL (NDC 75987-050-06) | Amgen Inc. | To Be Discontinued To Be Discontinued | Sep 1, 2026 |
| Glycerol Phenylbutyrate Oral Liquid RAVICTI, Oral Liquid, 1.1 g/1 mL (NDC 75987-050-07) | Amgen Inc. | To Be Discontinued To Be Discontinued | Sep 1, 2026 |
| Glycopyrrolate Injection Glycopyrrolate, Injection, .2 mg/1 mL (NDC 63323-578-01) | Fresenius Kabi USA, LLC | To Be Discontinued To Be Discontinued | Jul 30, 2026 |
| Glycopyrrolate Injection Glycopyrrolate, Injection, 1 mg per 5 mL (NDC 63323-578-05) | Fresenius Kabi USA, LLC | To Be Discontinued To Be Discontinued | Jul 30, 2026 |
| Glycopyrrolate Injection Glycopyrrolate, Injection, 0.2 mg per 1 mL (NDC 65219-801-01) | Fresenius Kabi USA, LLC | To Be Discontinued To Be Discontinued | Jul 30, 2026 |
| Glycopyrrolate Injection Glycopyrrolate, Injection, 0.4 mg per 2 mL (NDC 63323-578-02) | Fresenius Kabi USA, LLC | To Be Discontinued To Be Discontinued | Jul 30, 2026 |
| Guanfacine Hydrochloride Tablet, Extended Release Guanfacine Hydrochloride, Tablet, Extended Release, 1 mg (NDC 0228-2850-11) | Actavis Pharma, Inc. | To Be Discontinued To Be Discontinued | Nov 13, 2025 |
| Guanfacine Hydrochloride Tablet, Extended Release Guanfacine Hydrochloride, Tablet, Extended Release, 2 mg (NDC 0228-2851-11) | Actavis Pharma, Inc. | To Be Discontinued To Be Discontinued | Nov 13, 2025 |
| Guanfacine Hydrochloride Tablet, Extended Release Guanfacine Hydrochloride, Tablet, Extended Release, 4 mg (NDC 0228-2855-11) | Actavis Pharma, Inc. | To Be Discontinued To Be Discontinued | Nov 13, 2025 |
| Guanfacine Hydrochloride Tablet, Extended Release Guanfacine Hydrochloride, Tablet, Extended Release, 3 mg (NDC 0228-2853-11) | Actavis Pharma, Inc. | To Be Discontinued To Be Discontinued | Nov 13, 2025 |
| Haloperidol Decanoate Injection Haloperidol Decanoate, Injection, 50 mg/1 mL (NDC 63323-469-01) | Fresenius Kabi USA, LLC | To Be Discontinued To Be Discontinued | Jan 9, 2026 |
| Haloperidol Decanoate Injection Haloperidol Decanoate, Injection, 50 mg/1 mL (NDC 63323-469-05) | Fresenius Kabi USA, LLC | To Be Discontinued To Be Discontinued | Jan 9, 2026 |
| Hydrochlorothiazide Capsule Microzide, Capsule, 12.5 mg (NDC 0591-0347-01) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Nov 19, 2025 |
| Hydrochlorothiazide Capsule Microzide, Capsule, 12.5 mg (NDC 0591-0347-05) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Nov 19, 2025 |
| Hydrochlorothiazide; Quinapril Hydrochloride Tablet Accuretic, Tablet, 12.5 mg; 20 mg (NDC 0071-5212-23) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Oct 1, 2025 |
| Hydrochlorothiazide; Quinapril Hydrochloride Tablet Accuretic, Tablet, 12.5 mg; 10 mg (NDC 0071-3112-23) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Oct 1, 2025 |
| Hydrocortisone Acetate Suppository Hydrocortisone Acetate, Suppository, 30 mg (NDC 0574-7093-12) | Padagis US LLC | To Be Discontinued To Be Discontinued | Jul 23, 2026 |
| Hydrocortisone Acetate Suppository Hydrocortisone Acetate, Suppository, 25 mg (NDC 0574-7090-12) | Padagis US LLC | To Be Discontinued To Be Discontinued | Jul 23, 2026 |
| Hydromorphone Hydrochloride Suppository Hydromorphone Hydrochloride, Suppository, 3 mg (NDC 0574-7224-06) | Padagis US LLC | To Be Discontinued To Be Discontinued | Jul 23, 2026 |
| Hydroxychloroquine Sulfate Tablet Hydroxychloroquine Sulfate, Tablet, 200 mg (NDC 0093-2401-01) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Jan 5, 2026 |
| Icatibant Acetate Injection Icatibant Acetate, Injection, 10 mg/1 mL (NDC 63323-574-93) | Fresenius Kabi USA, LLC | To Be Discontinued To Be Discontinued | May 7, 2026 |
| Icatibant Acetate Injection Icatibant Acetate, Injection, 10 mg/1 mL (NDC 63323-574-86) | Fresenius Kabi USA, LLC | To Be Discontinued To Be Discontinued | May 7, 2026 |
| Icosapent Ethyl Capsule Icosapent Ethyl, Capsule, 1 g (NDC 60429-005-12) | Apotex Corp. | To Be Discontinued To Be Discontinued | Apr 1, 2026 |
| Icosapent Ethyl Capsule Icosapent Ethyl, Capsule, 1 g (NDC 61474-9711-1) | Apotex Corp. | To Be Discontinued To Be Discontinued | Apr 1, 2026 |
| Idelalisib Tablet Zydelig, Tablet, 150 mg (NDC 61958-1702-1) | Gilead Sciences, Inc. | To Be Discontinued To Be Discontinued | Apr 7, 2026 |
| Idelalisib Tablet Zydelig, Tablet, 100 mg (NDC 61958-1701-1) | Gilead Sciences, Inc. | To Be Discontinued To Be Discontinued | Apr 7, 2026 |
| Imipenem and Cilastatin Injection Primaxin, Injection, 500mg (NDC 0006-3516-59) | Merck Sharp & Dohme Corp. | To Be Discontinued To Be Discontinued | Jan 8, 2026 |
| Imipenem Anhydrous, Cilastatin, and Relebactam Anhydrous Injection RECARBRIO, Injection, 500 mg/100 mL; 500 mg/100 mL; 250 mg/100 mL (NDC 0006-3856-02) | Merck Sharp & Dohme LLC | To Be Discontinued To Be Discontinued | Sep 9, 2026 |
| Insulin Glargine Injection Basaglar, Injection, U-100 Tempo Pen (NDC 0002-8214-05) | Eli Lilly and Co. | To Be Discontinued To Be Discontinued | Oct 24, 2025 |
| Insulin Glargine-aglr Injection Rezvoglar, Injection, 100 [iU]/1 mL (NDC 0002-8980-05) | Eli Lilly and Co. | To Be Discontinued To Be Discontinued | Sep 1, 2026 |
| Insulin Lispro Injection Insulin Lispro Junior KwikPen, Injection, 100 [iU]/1 mL (NDC 0002-7752-05) | Eli Lilly and Co. | To Be Discontinued To Be Discontinued | Sep 1, 2026 |
| Insulin Lispro Injection Humalog, Injection, U-100 Tempo Pen (NDC 0002-8213-05) | Eli Lilly and Co. | To Be Discontinued To Be Discontinued | Oct 24, 2025 |
| Insulin Lispro Protamine and Insulin Lispro Injection Humalog Mix 75/25, Injection, 100 [iU]/1 mL (NDC 0002-8233-05) | Eli Lilly and Co. | To Be Discontinued To Be Discontinued | Sep 1, 2026 |
| Insulin Lispro-aabc Injection Lyumjev, Injection, U-100 Tempo Pen Sample (NDC 0002-8235-99) | Eli Lilly and Co. | To Be Discontinued To Be Discontinued | Oct 24, 2025 |
| Insulin Lispro-aabc Injection Lyumjev, Injection, U-100 Tempo Pen (NDC 0002-8235-05) | Eli Lilly and Co. | To Be Discontinued To Be Discontinued | Oct 24, 2025 |
| Irinotecan Hydrochloride Injection Irinotecan Hydrochloride, Injection, 40 mg/2 mL (NDC 25021-230-02) | Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) | To Be Discontinued To Be Discontinued | Sep 26, 2025 |
| Irinotecan Hydrochloride Injection Irinotecan Hydrochloride, Injection, 100 mg/5 mL (NDC 25021-230-05) | Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) | To Be Discontinued To Be Discontinued | Sep 26, 2025 |
| Irinotecan Hydrochloride Injection Irinotecan Hydrochloride, Injection, 100 mg/5 mL (NDC 50742-402-05) | Ingenus Pharmaceuticals LLC | To Be Discontinued To Be Discontinued | Feb 24, 2026 |
| Irinotecan Hydrochloride Injection Irinotecan Hydrochloride, Injection, 40 mg/2 mL (NDC 50742-401-02) | Ingenus Pharmaceuticals LLC | To Be Discontinued To Be Discontinued | Feb 24, 2026 |
| Iron Sucrose Injection Iron Sucrose, Injection, 50 mg/2.5 mL (NDC 67457-957-99) | Mylan Institutional, a Viatris Company | To Be Discontinued To Be Discontinued | May 21, 2026 |
| Itraconazole Capsule Sporanox, Capsule, 100 mg (NDC 50458-290-04) | Janssen Pharmaceuticals | To Be Discontinued To Be Discontinued | Feb 27, 2026 |
| Itraconazole Capsule Sporanox, Capsule, 100 mg (NDC 10147-1700-3) | Janssen Pharmaceuticals | To Be Discontinued To Be Discontinued | Feb 27, 2026 |
| Itraconazole Capsule Sporanox, Capsule, 100 mg (NDC 50458-290-01) | Janssen Pharmaceuticals | To Be Discontinued To Be Discontinued | Feb 27, 2026 |
| Ivabradine Hydrochloride Tablet Corlanor, Tablet, eq. 7.5 mg base (NDC 55513-810-60) | Amgen Inc. | To Be Discontinued To Be Discontinued | Mar 24, 2026 |
| Ivabradine Hydrochloride Tablet Corlanor, Tablet, eq. 5 mg base (NDC 55513-800-60) | Amgen Inc. | To Be Discontinued To Be Discontinued | Mar 24, 2026 |
| Ivabradine Solution Corlanor, Solution, 5 mg/5 mL (NDC 55513-813-28) | Amgen Inc. | To Be Discontinued To Be Discontinued | Mar 24, 2026 |
| Ketamine Hydrochloride Injection Ketamine Hydrochloride, Injection, 500 mg/5mL (100 mg/mL); Multiple Dose Glass Fliptop Vial Novaplus (NDC 0409-0040-10) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Nov 7, 2025 |
| Ketorolac Tromethamine Tablet Ketorolac Tromethamine, Tablet, 10 mg (NDC 0378-1134-01) | Mylan Pharmaceuticals Inc., a Viatris Company | To Be Discontinued To Be Discontinued | Apr 20, 2026 |
| Lamotrigine Tablet, Extended Release Lamotrigine, Tablet, Extended Release, 100 mg (NDC 49884-563-11) | Par Health, Inc. | To Be Discontinued To Be Discontinued | Apr 29, 2026 |
| Lamotrigine Tablet, Extended Release Lamotrigine, Tablet, Extended Release, 250 mg (NDC 49884-604-11) | Par Health, Inc. | To Be Discontinued To Be Discontinued | Apr 29, 2026 |
| Lamotrigine Tablet, Extended Release Lamotrigine, Tablet, Extended Release, 300 mg (NDC 49884-605-11) | Par Health, Inc. | To Be Discontinued To Be Discontinued | Apr 29, 2026 |
| Lamotrigine Tablet, Extended Release Lamotrigine, Tablet, Extended Release, 200 mg (NDC 49884-564-11) | Par Health, Inc. | To Be Discontinued To Be Discontinued | Apr 29, 2026 |
| Lamotrigine Tablet, Extended Release Lamotrigine, Tablet, Extended Release, 25 mg (NDC 49884-561-11) | Par Health, Inc. | To Be Discontinued To Be Discontinued | Apr 29, 2026 |
| Lamotrigine Tablet, Extended Release Lamotrigine, Tablet, Extended Release, 50 mg (NDC 49884-562-11) | Par Health, Inc. | To Be Discontinued To Be Discontinued | Apr 29, 2026 |
| Lasmiditan Succinate Tablet Reyvow, Tablet, 100 mg (NDC 0002-4491-61) | Eli Lilly and Co. | To Be Discontinued To Be Discontinued | Nov 3, 2025 |
| Lasmiditan Succinate Tablet Reyvow, Tablet, 50 mg (NDC 0002-4312-08) | Eli Lilly and Co. | To Be Discontinued To Be Discontinued | Nov 3, 2025 |
| Lasmiditan Succinate Tablet Reyvow, Tablet, 50 mg (NDC 0002-4312-62) | Eli Lilly and Co. | To Be Discontinued To Be Discontinued | Nov 3, 2025 |
| Lasmiditan Succinate Tablet Reyvow, Tablet, 100 mg (NDC 0002-4491-62) | Eli Lilly and Co. | To Be Discontinued To Be Discontinued | Nov 3, 2025 |
| Lasmiditan Succinate Tablet Reyvow, Tablet, 50 mg (NDC 0002-4312-61) | Eli Lilly and Co. | To Be Discontinued To Be Discontinued | Nov 3, 2025 |
| Lasmiditan Succinate Tablet Reyvow, Tablet, 100 mg (NDC 0002-4491-08) | Eli Lilly and Co. | To Be Discontinued To Be Discontinued | Nov 3, 2025 |
| Leflunomide Tablet Leflunomide, Tablet, 20 mg (NDC 0955-1737-30) | Sanofi-Aventis U.S. LLC | To Be Discontinued To Be Discontinued | Jun 8, 2026 |
| Leflunomide Tablet Leflunomide, Tablet, 10 mg (NDC 0955-1735-30) | Sanofi-Aventis U.S. LLC | To Be Discontinued To Be Discontinued | Jun 8, 2026 |
| Leflunomide Tablet Arava, Tablet, 10 mg (NDC 0088-2160-30) | Sanofi-Aventis U.S. LLC | To Be Discontinued To Be Discontinued | Jun 8, 2026 |
| Leflunomide Tablet Arava, Tablet, 20 mg (NDC 0088-2161-30) | Sanofi-Aventis U.S. LLC | To Be Discontinued To Be Discontinued | Jun 8, 2026 |
| Leflunomide Tablet Arava, Tablet, 100 mg (NDC 0088-2162-33) | Sanofi-Aventis U.S. LLC | To Be Discontinued To Be Discontinued | Jun 8, 2026 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride, Injection, 2%, USP (For Cardiac Use Only) 100 mg/5 mL (20 mg/mL) LifeShield® ABBOJECT® Glass… | Hospira, Inc., a Pfizer Company | To Be Discontinued To Be Discontinued | Nov 7, 2025 |
| Lidocaine Hydrochloride Injection Lidocaine Hydrochloride, Injection, 1%, USP (For Cardiac Use Only) 50 mg/5 mL (10 mg/mL) LifeShield™ ABBOJECT® Glass… | Hospira, Inc., a Pfizer Company | To Be Discontinued To Be Discontinued | Nov 7, 2025 |
| Lincomycin Hydrochloride Injection Lincocin, Injection, 2 mL multiple dose vial (NDC 0009-0104-04) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Feb 25, 2026 |
| Lincomycin Hydrochloride Injection Lincomycin Hydrochloride, Injection, 3 grams/10 mL vial x 10 count (NDC 39822-0355-6) | XGen Pharmaceuticals DJB, Inc. | To Be Discontinued To Be Discontinued | Mar 26, 2026 |
| Lincomycin Hydrochloride Injection Lincomycin Hydrochloride, Injection, 600 mg/2 mL vial x 10 count (NDC 39822-0350-2) | XGen Pharmaceuticals DJB, Inc. | To Be Discontinued To Be Discontinued | Mar 26, 2026 |
| Liraglutide Injection Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15) | Novo Nordisk, Inc. | To Be Discontinued To Be Discontinued | Aug 25, 2026 |
| Liraglutide Injection Liraglutide, Injection, 6 mg/1 mL (NDC 0480-7250-46) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | May 14, 2026 |
| Lopinavir and Ritonavir Oral Solution Kaletra, Oral Solution, 80 mg/1 mL; 20 mg/1 mL (NDC 0074-3956-46) | AbbVie Inc. | To Be Discontinued To Be Discontinued | Jul 24, 2026 |
| Lopinavir and Ritonavir Tablet Kaletra, Tablet, 100 mg; 25 mg (NDC 0074-3008-60) | AbbVie Inc. | To Be Discontinued To Be Discontinued | Jul 24, 2026 |
| Lopinavir and Ritonavir Tablet Kaletra, Tablet, 100 mg; 25 mg (NDC 0074-0522-60) | AbbVie Inc. | To Be Discontinued To Be Discontinued | Jul 24, 2026 |
| Lopinavir and Ritonavir Tablet Kaletra, Tablet, 200 mg; 50 mg (NDC 0074-6799-22) | AbbVie Inc. | To Be Discontinued To Be Discontinued | Jul 24, 2026 |
| Lopinavir and Ritonavir Tablet Kaletra, Tablet, 200 mg; 50 mg (NDC 0074-4014-12) | AbbVie Inc. | To Be Discontinued To Be Discontinued | Jul 24, 2026 |
| Lorlatinib Tablet Lorbrena, Tablet, 25 mg; 120 tablets bottle with a child-resistant closure (NDC 0069-0227-03) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Jun 15, 2026 |
| Maraviroc Solution Selzentry, Solution, 20 mg/mL Oral Solution Kit | 230 mL Oral Solution per Bottle | 1 Bottle per Carton (NDC… | ViiV Healthcare Company | To Be Discontinued To Be Discontinued | Jan 20, 2026 |
| Medroxyprogesterone Acetate Tablet PROVERA, Tablet, 2.5 mg (NDC 0009-0065-01) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Aug 31, 2026 |
| Medroxyprogesterone Acetate Tablet PROVERA, Tablet, 10 mg (NDC 0009-0051-01) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Aug 31, 2026 |
| Melphalan Hydrochloride Injection Melphalan Hydrochloride, Injection, Kit (NDC 63323-760-20) | Fresenius Kabi USA, LLC | To Be Discontinued To Be Discontinued | Sep 16, 2026 |
| Mesalamine Capsule, Extended Release Pentasa, Capsule, Extended Release, 250 mg (NDC 54092-189-81) | Takeda Pharmaceuticals USA Inc. | To Be Discontinued To Be Discontinued | Sep 16, 2026 |
| Mesalamine Capsule, Extended Release Mesalamine, Capsule, Extended Release, .375 g (NDC 0378-1375-78) | Mylan Pharmaceuticals Inc., a Viatris Company | To Be Discontinued To Be Discontinued | Aug 25, 2026 |
| Mesalamine Capsule, Extended Release Pentasa, Capsule, Extended Release, 500 mg (NDC 54092-191-12) | Takeda Pharmaceuticals USA Inc. | To Be Discontinued To Be Discontinued | Sep 16, 2026 |
| Metoprolol Succinate Tablet, Extended Release Metoprolol Succinate, Tablet, Extended Release, 50 mg (NDC 45963-676-11) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Aug 31, 2026 |
| Metoprolol Succinate Tablet, Extended Release Metoprolol Succinate, Tablet, Extended Release, 25 mg (NDC 45963-709-11) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Aug 31, 2026 |
| Metoprolol Succinate Tablet, Extended Release Metoprolol Succinate, Tablet, Extended Release, 100 mg (NDC 45963-677-96) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Aug 31, 2026 |
| Metoprolol Succinate Tablet, Extended Release Metoprolol Succinate, Tablet, Extended Release, 50 mg (NDC 45963-676-96) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Aug 31, 2026 |
| Metoprolol Succinate Tablet, Extended Release Metoprolol Succinate, Tablet, Extended Release, 100 mg (NDC 45963-677-11) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Aug 31, 2026 |
| Metoprolol Succinate Tablet, Extended Release Metoprolol Succinate, Tablet, Extended Release, 25 mg (NDC 45963-709-96) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Aug 31, 2026 |
| Metoprolol Succinate Tablet, Extended Release Metoprolol Succinate, Tablet, Extended Release, 200 mg (NDC 45963-678-11) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Aug 31, 2026 |
| Micafungin Sodium Injection Micafungin Sodium, Injection, 10 mg/1 mL (NDC 42023-229-10) | Par Health, USA LLC | To Be Discontinued To Be Discontinued | Sep 11, 2026 |
| Micafungin Sodium Injection Micafungin Sodium, Injection, 20 mg/1 mL (NDC 42023-230-10) | Par Health, USA LLC | To Be Discontinued To Be Discontinued | Sep 11, 2026 |
| Mirikizumab-mrkz Injection Omvoh, Injection, 100 mg/1 mL (NDC 0002-8870-27) | Eli Lilly and Co. | To Be Discontinued To Be Discontinued | Dec 22, 2025 |
| Mirikizumab-mrkz Injection Omvoh, Injection, 100 mg/1 mL (NDC 0002-8011-27) | Eli Lilly and Co. | To Be Discontinued To Be Discontinued | Dec 22, 2025 |
| Montelukast Sodium Tablet, Chewable Singulair, Tablet, Chewable, 4 mg (NDC 78206-170-01) | Organon | To Be Discontinued To Be Discontinued | Nov 17, 2025 |
| Morphine Sulfate Suppository Morphine Sulfate, Suppository, 5 mg (NDC 0574-7110-12) | Padagis US LLC | To Be Discontinued To Be Discontinued | Jul 23, 2026 |
| Morphine Sulfate Suppository Morphine Sulfate, Suppository, 10 mg (NDC 0574-7112-12) | Padagis US LLC | To Be Discontinued To Be Discontinued | Jul 23, 2026 |
| Morphine Sulfate Suppository Morphine Sulfate, Suppository, 30 mg (NDC 0574-7116-12) | Padagis US LLC | To Be Discontinued To Be Discontinued | Jul 23, 2026 |
| Morphine Sulfate Suppository Morphine Sulfate, Suppository, 20 mg (NDC 0574-7114-12) | Padagis US LLC | To Be Discontinued To Be Discontinued | Jul 23, 2026 |
| Morphine Sulfate Tablet Morphine Sulfate, Tablet, 15 mg (NDC 0832-0273-11) | Upsher-Smith Laboratories, LLC | To Be Discontinued To Be Discontinued | Dec 22, 2025 |
| Morphine Sulfate Tablet Morphine Sulfate, Tablet, 30 mg (NDC 0832-0274-11) | Upsher-Smith Laboratories, LLC | To Be Discontinued To Be Discontinued | Dec 22, 2025 |
| Moxifloxacin Injection Moxifloxacin, Injection, 400mg per 250mL (NDC 63323-850-74) | Fresenius Kabi USA, LLC | To Be Discontinued To Be Discontinued | Oct 29, 2025 |
| Nebivolol Hydrochloride Tablet Nebivolol Hydrochloride, Tablet, 5 mg (NDC 13668-354-30) | Torrent Pharmaceuticals Limited | To Be Discontinued To Be Discontinued | Mar 25, 2026 |
| Nebivolol Hydrochloride Tablet Nebivolol Hydrochloride, Tablet, 10 mg (NDC 13668-355-30) | Torrent Pharmaceuticals Limited | To Be Discontinued To Be Discontinued | Mar 25, 2026 |
| Nebivolol Hydrochloride Tablet Nebivolol Hydrochloride, Tablet, 10 mg (NDC 13668-355-01) | Torrent Pharmaceuticals Limited | To Be Discontinued To Be Discontinued | Mar 25, 2026 |
| Nebivolol Hydrochloride Tablet Nebivolol Hydrochloride, Tablet, 2.5 mg (NDC 13668-353-30) | Torrent Pharmaceuticals Limited | To Be Discontinued To Be Discontinued | Mar 25, 2026 |
| Nebivolol Hydrochloride Tablet Nebivolol Hydrochloride, Tablet, 20 mg (NDC 13668-356-90) | Torrent Pharmaceuticals Limited | To Be Discontinued To Be Discontinued | Mar 25, 2026 |
| Nebivolol Hydrochloride Tablet Nebivolol Hydrochloride, Tablet, 5 mg (NDC 13668-354-05) | Torrent Pharmaceuticals Limited | To Be Discontinued To Be Discontinued | Mar 25, 2026 |
| Nebivolol Hydrochloride Tablet Nebivolol Hydrochloride, Tablet, 20 mg (NDC 13668-356-30) | Torrent Pharmaceuticals Limited | To Be Discontinued To Be Discontinued | Mar 25, 2026 |
| Nebivolol Hydrochloride Tablet Nebivolol Hydrochloride, Tablet, 5 mg (NDC 13668-354-01) | Torrent Pharmaceuticals Limited | To Be Discontinued To Be Discontinued | Mar 25, 2026 |
| Nebivolol Hydrochloride Tablet Nebivolol Hydrochloride, Tablet, 5 mg (NDC 13668-354-90) | Torrent Pharmaceuticals Limited | To Be Discontinued To Be Discontinued | Mar 25, 2026 |
| Nebivolol Hydrochloride Tablet Nebivolol Hydrochloride, Tablet, 10 mg (NDC 13668-355-90) | Torrent Pharmaceuticals Limited | To Be Discontinued To Be Discontinued | Mar 25, 2026 |
| Nebivolol Hydrochloride Tablet Nebivolol Hydrochloride, Tablet, 2.5 mg (NDC 13668-353-05) | Torrent Pharmaceuticals Limited | To Be Discontinued To Be Discontinued | Mar 25, 2026 |
| Nebivolol Hydrochloride Tablet Nebivolol Hydrochloride, Tablet, 20 mg (NDC 13668-356-01) | Torrent Pharmaceuticals Limited | To Be Discontinued To Be Discontinued | Mar 25, 2026 |
| Nebivolol Hydrochloride Tablet Nebivolol Hydrochloride, Tablet, 2.5 mg (NDC 13668-353-01) | Torrent Pharmaceuticals Limited | To Be Discontinued To Be Discontinued | Mar 25, 2026 |
| Nebivolol Hydrochloride Tablet Nebivolol Hydrochloride, Tablet, 20 mg (NDC 13668-356-05) | Torrent Pharmaceuticals Limited | To Be Discontinued To Be Discontinued | Mar 25, 2026 |
| Nebivolol Hydrochloride Tablet Nebivolol Hydrochloride, Tablet, 2.5 mg (NDC 13668-353-90) | Torrent Pharmaceuticals Limited | To Be Discontinued To Be Discontinued | Mar 25, 2026 |
| Nebivolol Hydrochloride Tablet Nebivolol Hydrochloride, Tablet, 10 mg (NDC 13668-355-05) | Torrent Pharmaceuticals Limited | To Be Discontinued To Be Discontinued | Mar 25, 2026 |
| Neostigmine Methylsulfate Injection Neostigmine Methylsulfate, Injection, .5 mg/1 mL (NDC 63323-413-10) | Fresenius Kabi USA, LLC | To Be Discontinued To Be Discontinued | Jan 12, 2026 |
| Nilutamide Tablet Nilandron, Tablet, 150 mg (NDC 66993-212-38) | Advanz Pharma (US) Corp. | To Be Discontinued To Be Discontinued | Dec 1, 2025 |
| Nilutamide Tablet Nilandron, Tablet, 150 mg (NDC 59212-111-14) | Advanz Pharma (US) Corp. | To Be Discontinued To Be Discontinued | Dec 1, 2025 |
| Nitrofurantoin Oral Suspension Nitrofurantoin, Oral Suspension, 25 mg/5 mL (NDC 69238-2512-9) | Amneal Pharmaceuticals | To Be Discontinued To Be Discontinued | Apr 10, 2026 |
| Nitroglycerin Ointment Rectiv, Ointment, 0.4% (NDC 58914-301-80) | AbbVie Inc. | To Be Discontinued To Be Discontinued | Apr 14, 2026 |
| Omeprazole Delayed Release Capsule Omeprazole, Delayed Release Capsule, 40 mg (NDC 0781-2234-31) | Sandoz Inc. | To Be Discontinued To Be Discontinued | Oct 9, 2025 |
| Omeprazole Delayed Release Capsule Omeprazole, Delayed Release Capsule, 10 mg (NDC 0781-2859-01) | Sandoz Inc. | To Be Discontinued To Be Discontinued | Oct 9, 2025 |
| Omeprazole Delayed Release Capsule Omeprazole, Delayed Release Capsule, 10 mg (NDC 0781-2859-10) | Sandoz Inc. | To Be Discontinued To Be Discontinued | Oct 9, 2025 |
| Omeprazole Delayed Release Capsule Omeprazole, Delayed Release Capsule, 20 mg (NDC 0781-2868-92) | Sandoz Inc. | To Be Discontinued To Be Discontinued | Oct 9, 2025 |
| Omeprazole Delayed Release Capsule Omeprazole, Delayed Release Capsule, 20 mg (NDC 0781-2868-31) | Sandoz Inc. | To Be Discontinued To Be Discontinued | Oct 9, 2025 |
| Omeprazole Delayed Release Capsule Omeprazole, Delayed Release Capsule, 40 mg (NDC 0781-2234-01) | Sandoz Inc. | To Be Discontinued To Be Discontinued | Oct 9, 2025 |
| Omeprazole Delayed Release Capsule Omeprazole, Delayed Release Capsule, 20 mg (NDC 0781-2868-01) | Sandoz Inc. | To Be Discontinued To Be Discontinued | Oct 9, 2025 |
| Omeprazole Delayed Release Capsule Omeprazole, Delayed Release Capsule, 40 mg (NDC 0781-2234-10) | Sandoz Inc. | To Be Discontinued To Be Discontinued | Oct 9, 2025 |
| Omeprazole Delayed Release Capsule Omeprazole, Delayed Release Capsule, 20 mg (NDC 0781-2868-10) | Sandoz Inc. | To Be Discontinued To Be Discontinued | Oct 9, 2025 |
| Omeprazole Delayed Release Capsule Omeprazole, Delayed Release Capsule, 10 mg (NDC 0781-2859-31) | Sandoz Inc. | To Be Discontinued To Be Discontinued | Oct 9, 2025 |
| Oseltamivir Phosphate Capsule Tamiflu, Capsule, 45 mg (NDC 0004-0801-85) | Genentech, Inc | To Be Discontinued To Be Discontinued | Sep 30, 2025 |
| Oxaliplatin Injection Oxaliplatin, Injection, 5 mg/1 mL (NDC 25021-233-20) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued To Be Discontinued | Jun 29, 2026 |
| Oxaliplatin Injection Oxaliplatin, Injection, 5 mg/mL (NDC 63323-750-20) | Fresenius Kabi USA, LLC | To Be Discontinued To Be Discontinued | Feb 25, 2026 |
| Oxaliplatin Injection Oxaliplatin, Injection, 5 mg/1 mL (NDC 0781-3317-80) | Sandoz Inc. | To Be Discontinued To Be Discontinued | Oct 20, 2025 |
| Oxaliplatin Injection Oxaliplatin, Injection, 5 mg/1 mL (NDC 0781-3315-70) | Sandoz Inc. | To Be Discontinued To Be Discontinued | Oct 20, 2025 |
| Oxaliplatin Injection Oxaliplatin, Injection, 5 mg/mL (NDC 63323-750-10) | Fresenius Kabi USA, LLC | To Be Discontinued To Be Discontinued | Feb 25, 2026 |
| Oxaliplatin Injection Oxaliplatin, Injection, 5 mg/1 mL (NDC 25021-233-10) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued To Be Discontinued | Jun 29, 2026 |
| Palbociclib Capsule Ibrance, Capsule, 100 mg (NDC 0069-0188-21) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Apr 22, 2026 |
| Palbociclib Capsule Ibrance, Capsule, 75 mg (NDC 0069-0187-21) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Apr 22, 2026 |
| Palonosetron Hydrochloride Injection Palonosetron Hydrochloride, Injection, .25 mg/5 mL (NDC 0703-4094-01) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Nov 14, 2025 |
| Palovarotene Capsule SOHONOS, Capsule, 2.5 mg (NDC 15054-0025-1) | Ipsen Biopharmaceuticals, Inc. | To Be Discontinued To Be Discontinued | Aug 31, 2026 |
| Paricalcitol Capsule Zemplar, Capsule, 2 ug (NDC 0074-9037-30) | AbbVie Inc. | To Be Discontinued To Be Discontinued | Oct 7, 2025 |
| Paricalcitol Capsule Zemplar, Capsule, 1 ug (NDC 0074-9036-30) | AbbVie Inc. | To Be Discontinued To Be Discontinued | Oct 7, 2025 |
| Peginterferon alfa-2a Injection Pegasys, Injection, 180 ug/1 mL (NDC 82154-0449-1) | pharmaand GmbH (pharma&) | Resolved Resolved | Aug 27, 2026 |
| Peginterferon alfa-2a Injection Pegasys, Injection, 180 ug/.5 mL (NDC 82154-0451-4) | pharmaand GmbH (pharma&) | Resolved Resolved | Aug 27, 2026 |
| Pemetrexed Disodium Injection Alimta, Injection, 500 mg/20 mL (NDC 0002-7623-01) | Eli Lilly and Co. | To Be Discontinued To Be Discontinued | Oct 16, 2025 |
| Pemetrexed Disodium Injection Pemetrexed Disodium, Injection, 100 mg/4 mL (NDC 0781-3518-76) | Sandoz Inc. | To Be Discontinued To Be Discontinued | Oct 10, 2025 |
| Pemetrexed Disodium Injection Pemetrexed Disodium, Injection, 500 mg/20 mL (NDC 0781-3519-90) | Sandoz Inc. | To Be Discontinued To Be Discontinued | Oct 10, 2025 |
| Pemetrexed Disodium Injection Alimta, Injection, 100 mg/4 mL (NDC 0002-7640-01) | Eli Lilly and Co. | To Be Discontinued To Be Discontinued | Oct 16, 2025 |
| Pentamidine Isethionate Injection Pentamidine Isethionate, Injection, 300 mg/3 mL (NDC 39822-3050-2) | XGen Pharmaceuticals DJB, Inc. | To Be Discontinued To Be Discontinued | Mar 23, 2026 |
| Peritoneal Dialysis Solution DELFLEX® w/Dextrose, Solution, 1.5% Low Mg/Low Ca 2.5L/3L, 5/cs (NDC 49230-206-94) | Fresenius Medical Care North America | To Be Discontinued To Be Discontinued | Mar 10, 2026 |
| Peritoneal Dialysis Solution DELFLEX® w/Dextrose, Solution, 4.25% Low Mg/Low Ca 2L, 5/cs (NDC 46163-212-92) | Fresenius Medical Care North America | To Be Discontinued To Be Discontinued | Mar 10, 2026 |
| Peritoneal Dialysis Solution DELFLEX® w/Dextrose, Solution, 2.5% Low Mg/Low Ca 2L, 5/cs (NDC 49230-209-92) | Fresenius Medical Care North America | To Be Discontinued To Be Discontinued | Mar 10, 2026 |
| Peritoneal Dialysis Solution DELFLEX® w/Dextrose, Solution, 4.25% Low Mg/Low Ca 2.5L/3L, 5/cs (NDC 46163-212-94) | Fresenius Medical Care North America | To Be Discontinued To Be Discontinued | Mar 10, 2026 |
| Peritoneal Dialysis Solution DELFLEX® w/Dextrose, Solution, 2.5% Low Mg/Low Ca 2.5L/3L, 5/cs (NDC 49230-209-94) | Fresenius Medical Care North America | To Be Discontinued To Be Discontinued | Mar 10, 2026 |
| Peritoneal Dialysis Solution DELFLEX® w/Dextrose, Solution, 1.5% Low Mg/Low Ca 2L, 5/cs (NDC 46163-206-92) | Fresenius Medical Care North America | To Be Discontinued To Be Discontinued | Mar 10, 2026 |
| Phenobarbital Tablet Phenobarbital, Tablet, 97.2 mg (NDC 0603-5168-21) | Endo Pharmaceuticals, Inc. | To Be Discontinued To Be Discontinued | Oct 31, 2025 |
| Phenobarbital Tablet Phenobarbital, Tablet, 16.2 mg (NDC 0603-5165-32) | Endo Pharmaceuticals, Inc. | To Be Discontinued To Be Discontinued | Oct 31, 2025 |
| Phenobarbital Tablet Phenobarbital, Tablet, 32.4 mg (NDC 0603-5166-32) | Endo Pharmaceuticals, Inc. | To Be Discontinued To Be Discontinued | Oct 31, 2025 |
| Phenobarbital Tablet Phenobarbital, Tablet, 16.2 mg (NDC 0603-5165-21) | Endo Pharmaceuticals, Inc. | To Be Discontinued To Be Discontinued | Oct 31, 2025 |
| Phenobarbital Tablet Phenobarbital, Tablet, 64.8 mg (NDC 0603-5167-32) | Endo Pharmaceuticals, Inc. | To Be Discontinued To Be Discontinued | Oct 31, 2025 |
| Phenobarbital Tablet Phenobarbital, Tablet, 97.2 mg (NDC 0603-5168-32) | Endo Pharmaceuticals, Inc. | To Be Discontinued To Be Discontinued | Oct 31, 2025 |
| Phenobarbital Tablet Phenobarbital, Tablet, 64.8 mg (NDC 0603-5167-21) | Endo Pharmaceuticals, Inc. | To Be Discontinued To Be Discontinued | Oct 31, 2025 |
| Phenobarbital Tablet Phenobarbital, Tablet, 32.4 mg (NDC 0603-5166-21) | Endo Pharmaceuticals, Inc. | To Be Discontinued To Be Discontinued | Oct 31, 2025 |
| Phenoxybenzamine Hydrochloride Capsule Dibenzyline, Capsule, 10 mg (NDC 66993-066-02) | Advanz Pharma (US) Corp. | To Be Discontinued To Be Discontinued | Dec 1, 2025 |
| Phenoxybenzamine Hydrochloride Capsule Dibenzyline, Capsule, 10 mg (NDC 59212-001-01) | Advanz Pharma (US) Corp. | To Be Discontinued To Be Discontinued | Dec 1, 2025 |
| Phenoxybenzamine Hydrochloride Capsule Dibenzyline, Capsule, 10 mg (NDC 59212-001-02) | Advanz Pharma (US) Corp. | To Be Discontinued To Be Discontinued | Dec 1, 2025 |
| Pilocarpine Hydrochloride Ophthalmic Solution Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-03) | AbbVie Inc. | To Be Discontinued To Be Discontinued | Mar 24, 2026 |
| Pilocarpine Hydrochloride Ophthalmic Solution Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-05) | AbbVie Inc. | To Be Discontinued To Be Discontinued | Mar 24, 2026 |
| Pilocarpine Hydrochloride Ophthalmic Solution Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-06) | AbbVie Inc. | To Be Discontinued To Be Discontinued | Mar 24, 2026 |
| Pilocarpine Hydrochloride Ophthalmic Solution Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-04) | AbbVie Inc. | To Be Discontinued To Be Discontinued | Mar 24, 2026 |
| Pilocarpine Hydrochloride Ophthalmic Solution Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-01) | AbbVie Inc. | To Be Discontinued To Be Discontinued | Mar 24, 2026 |
| Pindolol Tablet Pindolol, Tablet, 5 mg (NDC 57664-655-88) | Sun Pharmaceutical Industries, Inc. | To Be Discontinued To Be Discontinued | Jan 30, 2026 |
| Pindolol Tablet Pindolol, Tablet, 10 mg (NDC 57664-656-88) | Sun Pharmaceutical Industries, Inc. | To Be Discontinued To Be Discontinued | Jan 30, 2026 |
| Piperacillin and Tazobactam Injection Piperacillin and Tazobactam, Injection, 2.25 g vial (NDC 65219-434-20) | Fresenius Kabi USA, LLC | To Be Discontinued To Be Discontinued | Jan 20, 2026 |
| Plerixafor Injection Plerixafor, Injection, 24 mg per 1.2 mL (20 mg per mL) (NDC 65219-284-12) | Fresenius Kabi USA, LLC | To Be Discontinued To Be Discontinued | Mar 13, 2026 |
| Podofilox Topical Gel Condylox , Topical Gel, 0.5% (NDC 0023-6118-03) | AbbVie Inc. | To Be Discontinued To Be Discontinued | Jan 28, 2026 |
| Podophyllum Resin Topical Tincture Podocon 25, Topical Tincture, 1 mg/4 mL (NDC 0574-0601-15) | Padagis US LLC | To Be Discontinued To Be Discontinued | Jul 23, 2026 |
| Polyethylene glycol 3350, Sodium Ascorbate, Sodium Sulfate Anhydrous, Ascorbic Acid, Sodium Chloride, and Potassium Chloride Oral Solution Plenvu, Oral Solution, KIT (NDC 65649-400-01) | Salix Pharmaceuticals, a division of Bausch Health US, LLC | To Be Discontinued To Be Discontinued | Aug 13, 2026 |
| Posaconazole Injection Noxafil, Injection, 18 mg/1 mL (NDC 0085-4331-01) | Merck Sharp & Dohme Corp. | To Be Discontinued To Be Discontinued | Dec 2, 2025 |
| Potassium Chloride Tablet, Extended Release Potassium Chloride, Tablet, Extended Release, 10 meq (NDC 62037-710-01) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Nov 21, 2025 |
| Potassium Chloride Tablet, Extended Release Potassium Chloride, Tablet, Extended Release, 20 meq (NDC 62037-720-05) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Nov 21, 2025 |
| Potassium Chloride Tablet, Extended Release Potassium Chloride, Tablet, Extended Release, 20 meq (NDC 62037-720-10) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Nov 21, 2025 |
| Potassium Chloride Tablet, Extended Release Potassium Chloride, Tablet, Extended Release, 20 meq (NDC 62037-720-01) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Nov 21, 2025 |
| Potassium Chloride, Sodium Chloride, Calcium Chloride, and Magnesium Chloride Injection, Solution Cardioplegic Solution, Injection, Solution, 17.6 mg/100 mL; 325.3 mg/100 mL; 119.3 mg/100 mL; 643 mg/100 mL (NDC… | Fresenius Kabi USA, LLC | To Be Discontinued To Be Discontinued | Aug 31, 2026 |
| Pramlintide Acetate Injection SymlinPen® 60 , Injection, 1000 ug/1 mL (NDC 0310-6615-02) | AstraZeneca AB | To Be Discontinued To Be Discontinued | Oct 27, 2025 |
| Pramlintide Acetate Injection SymlinPen® 120 , Injection, 1000 ug/1 mL (NDC 0310-6627-02) | AstraZeneca AB | To Be Discontinued To Be Discontinued | Oct 27, 2025 |
| Prazosin Hydrochloride Capsule Minipress, Capsule, 5 mg (NDC 0069-4380-71) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Apr 28, 2023 |
| Prazosin Hydrochloride Capsule Minipress, Capsule, 1 mg (NDC 0069-4310-71) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Apr 28, 2023 |
| Prazosin Hydrochloride Capsule Minipress, Capsule, 2 mg (NDC 0069-4370-71) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Apr 28, 2023 |
| Progesterone Vaginal Gel Crinone, Vaginal Gel, 4% (NDC 0023-6150-04) | AbbVie Inc. | To Be Discontinued To Be Discontinued | Mar 27, 2026 |
| Quinapril Hydrochloride Tablet Accupril, Tablet, 20 mg (NDC 0071-0532-23) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Oct 1, 2025 |
| Quinapril Hydrochloride Tablet Accupril, Tablet, 10 mg (NDC 0071-0530-23) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Oct 1, 2025 |
| Quinapril Hydrochloride Tablet Accupril, Tablet, 5 mg (NDC 0071-0527-23) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Oct 1, 2025 |
| Quinapril Hydrochloride Tablet Accupril, Tablet, 40 mg (NDC 0071-0535-23) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Oct 1, 2025 |
| Ramelteon Tablet Rozerem, Tablet, 8 mg (NDC 64764-805-30) | Takeda Pharmaceuticals USA Inc. | To Be Discontinued To Be Discontinued | Mar 19, 2026 |
| Ramelteon Tablet Rozerem, Tablet, 8 mg (NDC 64764-805-10) | Takeda Pharmaceuticals USA Inc. | To Be Discontinued To Be Discontinued | Mar 19, 2026 |
| Riboflavin 5-phosphate Ophthalmic Solution Photrexa Cross-linking Kit, Ophthalmic Solution, Kit (NDC 25357-025-03) | Glaukos Corporation | To Be Discontinued To Be Discontinued | Jan 20, 2026 |
| Rifampin Injection Rifadin, Injection, 600 mg/10 mL (NDC 0068-0597-01) | Sanofi-Aventis U.S. LLC | To Be Discontinued To Be Discontinued | Apr 20, 2026 |
| Rifapentine Tablet, Film Coated Priftin, Tablet, Film Coated, 150 mg (NDC 0088-2102-24) | Sanofi-Aventis U.S. LLC | Resolved Resolved | Aug 6, 2026 |
| Ritonavir Oral Powder Norvir, Oral Powder, 100 mg (NDC 0074-3399-30) | AbbVie Inc. | To Be Discontinued To Be Discontinued | Jul 24, 2026 |
| Ritonavir Tablet Norvir, Tablet, 100 mg (NDC 0074-2340-30) | AbbVie Inc. | To Be Discontinued To Be Discontinued | Jul 24, 2026 |
| Rivaroxaban For Suspension Xarelto, For Suspension, 155 mg (NDC 50458-575-01) | Janssen Pharmaceuticals | To Be Discontinued To Be Discontinued | Sep 18, 2026 |
| Rivastigmine Film, Extended Release Rivastigmine, Film, Extended Release, 4.6 mg/24 h (NDC 0378-9070-93) | Mylan Pharmaceuticals Inc., a Viatris Company | To Be Discontinued To Be Discontinued | Sep 18, 2026 |
| Scopolamine Transdermal System Scopolamine, Transdermal System, 1 mg (NDC 45802-580-46) | Padagis US LLC | To Be Discontinued To Be Discontinued | Nov 3, 2025 |
| Semaglutide Tablet Rybelsus, Tablet, 3 mg (NDC 0169-4303-30) | Novo Nordisk, Inc. | To Be Discontinued To Be Discontinued | Jun 4, 2026 |
| Semaglutide Tablet Rybelsus, Tablet, 7 mg (NDC 0169-4307-30) | Novo Nordisk, Inc. | To Be Discontinued To Be Discontinued | Jun 4, 2026 |
| Semaglutide Tablet Rybelsus, Tablet, 14 mg (NDC 0169-4314-30) | Novo Nordisk, Inc. | To Be Discontinued To Be Discontinued | Jun 4, 2026 |
| Sodium Bicarbonate Injection Sodium Bicarbonate, Injection, 75 mg/1 mL (NDC 0409-4916-14) | Hospira, Inc., a Pfizer Company | To Be Discontinued To Be Discontinued | Nov 7, 2025 |
| Sodium Bicarbonate Injection Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 0409-4900-14) | Hospira, Inc., a Pfizer Company | To Be Discontinued To Be Discontinued | Nov 7, 2025 |
| Sodium Bicarbonate Injection Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 0409-5534-14) | Hospira, Inc., a Pfizer Company | To Be Discontinued To Be Discontinued | Nov 7, 2025 |
| Sodium Bicarbonate Injection Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 0409-6637-14) | Hospira, Inc., a Pfizer Company | To Be Discontinued To Be Discontinued | Nov 7, 2025 |
| Sodium Chloride 0.9% Injection Sodium Chloride 0.9%, Injection, 100 mL ADD-Vantage® Flexible Container (NDC 0409-7101-67) | Hospira, Inc., a Pfizer Company | To Be Discontinued To Be Discontinued | Dec 3, 2025 |
| Sodium Chloride 0.9% Injection Sodium Chloride 0.9%, Injection, 250 mL ADD-Vantage® Flexible Container (NDC 0409-7101-02) | Hospira, Inc., a Pfizer Company | To Be Discontinued To Be Discontinued | Dec 3, 2025 |
| Sodium Chloride 0.9% Injection Sodium Chloride 0.9%, Injection, 50 mL ADD-Vantage® Flexible Container (NDC 0409-7101-66) | Hospira, Inc., a Pfizer Company | To Be Discontinued To Be Discontinued | Dec 3, 2025 |
| Sodium Oxybate Solution Sodium Oxybate, Solution, .5 g/1 mL (NDC 69238-2391-1) | Amneal Pharmaceuticals | To Be Discontinued To Be Discontinued | Dec 29, 2025 |
| Somatropin Injection Norditropin, Injection, 30 mg/3 mL (NDC 0169-7703-21) | Novo Nordisk, Inc. | To Be Discontinued To Be Discontinued | Nov 14, 2025 |
| Spironolactone Tablet Aldactone, Tablet, 100 mg (NDC 0025-1031-31) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Dec 10, 2025 |
| Spironolactone Tablet Aldactone, Tablet, 25 mg (NDC 0025-1001-31) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Dec 10, 2025 |
| Succinylcholine Chloride Injection Succinylcholine Chloride, Injection, 20 mg/1 mL (NDC 63323-943-10) | Fresenius Kabi USA, LLC | To Be Discontinued To Be Discontinued | Jul 23, 2026 |
| Sulconazole Nitrate Solution Sulconazole Nitrate, Solution, 30 mL (NDC 72143-321-30) | Journey Medical Corporation | To Be Discontinued To Be Discontinued | May 8, 2026 |
| Sulconazole Nitrate Solution Exelderm, Solution, 1.0% 5 mL (NDC 69489-721-05) | Journey Medical Corporation | To Be Discontinued To Be Discontinued | May 8, 2026 |
| Sulconazole Nitrate Solution Exelderm, Solution, 1.0% 30 mL (NDC 69489-721-30) | Journey Medical Corporation | To Be Discontinued To Be Discontinued | May 8, 2026 |
| Tafamidis Meglumine Capsule Vyndaqel, Capsule, 20 mg soft gelatin capsules; blister card (120 total capsules) (NDC 0069-8730-30) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Sep 29, 2025 |
| Tazemetostat Hydrobromide Tablet Tazverik, Tablet, 200 mg (NDC 72607-100-00) | Epizyme, Inc. (An Ipsen Company) | To Be Discontinued To Be Discontinued | Mar 27, 2026 |
| Tiagabine Hydrochloride Tablet Tiagabine Hydrochloride, Tablet, 2mg 30 count (NDC 0093-5030-56) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Apr 15, 2026 |
| Tiagabine Hydrochloride Tablet Tiagabine Hydrochloride, Tablet, 4mg 30 count (NDC 0093-5031-56) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Apr 15, 2026 |
| Tiagabine Hydrochloride Tablet Tiagabine Hydrochloride, Tablet, 12mg 30 count (NDC 0093-8072-56) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Apr 15, 2026 |
| Tiagabine Hydrochloride Tablet Tiagabine Hydrochloride, Tablet, 16mg 30 count (NDC 0093-8076-56) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Apr 15, 2026 |
| Tobramycin Sulfate Injection Tobramycin Sulfate, Injection, 80 mg/2 mL (40 mg/mL); 2 mL Multiple Dose Glass Fliptop Vial (NDC 0409-3578-01) | Hospira, Inc., a Pfizer Company | To Be Discontinued To Be Discontinued | Jul 17, 2026 |
| Tranylcypromine Sulfate Tablet Parnate, Tablet, 10 mg (NDC 0591-5590-01) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued To Be Discontinued | Oct 21, 2025 |
| Travoprost Ophthalmic Solution Travoprost, Ophthalmic Solution, 0.004%, 2.5 mL (NDC 0378-9651-32) | Mylan Pharmaceuticals Inc., a Viatris Company | To Be Discontinued To Be Discontinued | Jul 7, 2026 |
| Travoprost Ophthalmic Solution Travoprost, Ophthalmic Solution, 0.004%, 5 mL (NDC 0378-9651-50) | Mylan Pharmaceuticals Inc., a Viatris Company | To Be Discontinued To Be Discontinued | Jul 7, 2026 |
| Triamcinolone Acetonide Injection Triesence, Injection, 40 mg/1 mL (NDC 82667-800-01) | Harrow Eye, LLC | Resolved Resolved | Jul 31, 2026 |
| Triazolam Tablet Halcion, Tablet, .25 mg (NDC 0009-0017-58) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Sep 29, 2025 |
| Ursodiol Capsule Ursodiol, Capsule, 300 mg (NDC 64380-844-06) | Strides Pharma Inc. | To Be Discontinued To Be Discontinued | Apr 6, 2026 |
| Valsartan Tablet Valsartan, Tablet, 160 mg (NDC 0378-5814-77) | Mylan Pharmaceuticals Inc., a Viatris Company | To Be Discontinued To Be Discontinued | Nov 19, 2025 |
| Valsartan Tablet Valsartan, Tablet, 80 mg (NDC 0378-5813-77) | Mylan Pharmaceuticals Inc., a Viatris Company | To Be Discontinued To Be Discontinued | Nov 19, 2025 |
| Valsartan Tablet Valsartan, Tablet, 320 mg (NDC 0378-5815-77) | Mylan Pharmaceuticals Inc., a Viatris Company | To Be Discontinued To Be Discontinued | Nov 19, 2025 |
| Valsartan Tablet Valsartan, Tablet, 40 mg (NDC 0378-5807-93) | Mylan Pharmaceuticals Inc., a Viatris Company | To Be Discontinued To Be Discontinued | Nov 19, 2025 |
| Vancomycin Hydrochloride Injection Vancomycin Hydrochloride, Injection, 10 g Vial NovaPlus (NDC 0409-5017-01) | Hospira, Inc., a Pfizer Company | To Be Discontinued To Be Discontinued | Nov 14, 2025 |
| Verapamil Hydrochloride Injection Verapamil Hydrochloride, Injection, 2.5 mg/1 mL (NDC 0409-9633-05) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Nov 21, 2025 |
| Vigabatrin Oral Solution Vigpoder, Oral Solution, 50 mg/1 mL (NDC 80789-117-50) | Pyros Pharmaceuticals, Inc. | To Be Discontinued To Be Discontinued | Oct 16, 2025 |
| Voriconazole Injection Vfend, Injection, 10 mg/1 mL (NDC 0049-3190-01) | Pfizer Inc. | To Be Discontinued To Be Discontinued | Oct 16, 2025 |